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1CHAPTER 1
General Introduction
Tapeworms...
Many people have heard of them, but unfortunately, most of the knowledge is based on one
of the many urban myths that are still being told as true, like losing weight by infecting
yourself with a tapeworm.
The truth is of course far more intriguing: the tapeworm in those myths is actually the
adult stage of a fascinating parasite that can belong to a number of different genera e.g.
Diphyllobothrium, Hymenolepis and Taenia (Linnæus, 1758). The Taenia genus contains
many different species (Hoberg et al., 2000; Hoberg, 2006), but only three of them are
known to infect humans: Taenia solium (the pork tapeworm), Taenia saginata (the beef
tapeworm) and Taenia asiatica (the Asian tapeworm).
For T. saginata and T. asiatica, humans only act as the final host (taeniasis), meaning
that they harbour the adult tapeworm in the small intestine, which does not pose a
serious health threat. However, T. solium is of much more importance as humans not only
harbour the adult worm (Figures 1.1b and 1.1c), but unfortunately, also act as accidental
intermediate hosts. Intermediate hosts (normally pigs, but also humans, dogs, ...) infect
themselves when ingesting eggs which contain oncosphere larval stages (Figure 1.1d) and
can develop the metacestode larval stages (cysticerci) in the subcutaneous and muscle
tissues (cysticercosis; Figure 1.1a), the central nervous system (neurocysticercosis), the
eyes (ophthalmic cysticercosis) and a number of other organs like the liver and the lungs.
Page 1
General Introduction
1
(a) Viable cysticerci in muscle tissue. (b) Head (scolex) of an adult worm.
(c) Adult worm segments (proglottids). (d) Egg with oncosphere inside.
Figure 1.1: Larval (a and d) and adult stages (b and c) of a Taenia solium tapeworm.
Images: Dr. Sarah Gabrie¨l (a), Bjorn Victor (c), Centres for Disease Control and Prevention Image
Library (http://www.dpd.cdc.gov/dpdx/HTML/Image_Library.htm) (b and d).
In humans, neurocysticercosis can cause a number of neurological symptoms (e.g. epilepsy)
and even death, while porcine cysticercosis is responsible for serious economic losses,
because infected carcasses lose value and are often destroyed.
Most developed countries have eliminated T. solium by permanently breaking the trans-
mission cycle through proper human waste management and controlled farm and meat
industries. This is unfortunately not the case in many developing countries: T. solium is
still found in large parts of Africa, Asia and Latin America (Figure 1.2).
Wherever elimination of the parasite is not yet feasible, we need to settle for the next
best thing: control of T. solium. A number of possible control measures have been
suggested, ranging from treatment of tapeworm carriers (either selective or through mass
drug administration) and vaccination of pigs to improvement of the pig husbandry system
and sanitary conditions and health education. However, the effectiveness of these measures
needs to be evaluated and this is where diagnostic tools come in. Of course, diagnostic tools
serve other purposes as well e.g. assessment of the prevalence of taeniasis and cysticercosis
in a particular region or country (prior to the implementation of control measures) and
identification of individual cases of taeniasis/cysticercosis.
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Figure 1.2: Countries and areas at risk of cysticercosis, 2011.
Adapted from: “Global distribution of cysticercosis, 2011” (World Health Organisation)
(http://www.who.int/taeniasis/Global_distribution_cysticercosis_2011.png).
Depending on the intended purpose (e.g. clinical or epidemiological), the host and the life
cycle stage of the parasite, different diagnostic tools are employed. A number of them focus
on detecting the parasite directly (e.g. neuroimaging for brain cysts, antigen detection
for parasite proteins, meat inspection for cysts in the meat and stool examinations for
the detection of eggs and proglottids), while other assays focus on the reaction of the
host (e.g. antibody detection). The development of antigen and antibody detection assays
for human and porcine cysticercosis as well as taeniasis has received a lot of attention.
Antibody detection is generally more sensitive compared to antigen detection, but it fails
to distinguish between an active infection, a past infection and contact (without infection).
Antigen detection, on the other hand, only detects active infections (viable cysts), but
the currently used assays were originally developed to detect circulating antigens from T.
saginata cysticerci in cattle. From this it follows that their use in humans and pigs is based
on cross-reactions with T. solium antigens. Although convenient for the detection of human
(neuro)cysticercosis, the use of these assays is compromised in pigs, more specifically, in
regions where T. solium, T. hydatigena and/or T. asiatica are sympatric.
Making antigen detection more specific would greatly improve its reliability in Latin
America and Asia (where T. solium can co-occur alongside other Taenia species), but
to do that, differential proteins (i.e. proteins that are unique for T. solium) need to be
identified. To achieve this, a detailed analysis of the proteins that are produced by the
parasites (called excretion/secretion proteins) is necessary.
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The field of proteomics enables this type of protein identification studies by combining
the latest advancements in liquid chromatography, (tandem) mass spectrometry and
bioinformatics. Mass spectrometry involves the measurement of the mass-to-charge ratio
(m/z ) of charged peptides in the gas phase. The end result of such an experiment is a
dataset with spectra, which are then matched to peptides/proteins in the subsequent
data analysis step. Since this thesis involves a number of mass spectrometry experiments
and critical thoughts on data analysis, the most relevant concepts and techniques will be
introduced in a separate chapter.
Utilising these highly specialised tools to investigate the excretion/secretion proteins of
the T. solium larval stages should provide valuable insights into their nature and function.
Furthermore, comparison of this proteome with that of other Taenia species might lead to
the identification of one or several unique proteins. These may, in turn, lead to a specific
diagnostic assay for T. solium porcine cysticercosis.
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2CHAPTER 2
Taenia solium: An Introduction
2.1 Taenia solium taeniasis and cysticercosis
Taenia solium is a tapeworm belonging to the Taeniidae family (Figure 2.1). The adult
stage of the worm (Linnæus, 1758) develops in the upper third section of the small intestine
of humans, the only final host, where it causes an infection called taeniasis (Figure 2.2).
A mature tapeworm usually measures 2-7 m long and consists of a scolex, a short neck
and a strobila made up of 700-1,000 proglottids (Flisser, 1994, 2013). The scolex, which is
roughly the size of a pinhead (0.6-1 mm), has four suckers and a rostellum which has a
double crown of 22 to 32 hooks. The hooks that constitute the inner crown are slightly
larger than those present on the outer crown (160-180 µm versus 110-140 µm) (Flisser
et al., 2004). The neck is the area of proliferation from which the proglottids of the strobila
grow. Tapeworms are hermaphroditic organisms i.e. as the immature proglottids grow
further away from the neck, they develop both male and female reproductive organs. Once
these organs are fully developed, the proglottids are called mature and they measure about
2.1-2.5 mm long and 2.8-3.5 mm wide. The gravid proglottids, which contain between
50,000 and 60,000 eggs and measure 3.1-10 mm long and 3.8-8.7 mm wide, detach from
the distal end of the tapeworm and leave the body with the stools (Flisser, 2013). In
general, 2-5 segments are released roughly 2-3 times a week (Flisser, 1994). The eggs
are spherical (26-34 µm) and consist of (i) a delicate outer layer, which is often quickly
lost, (ii) a thick embryophore (prismatic keratin blocks held together by a cement-like
substance, which give the Taenia egg its radial appearance), (iii) a thin oncospheral
membrane and (iv) the oncosphere or hexacanth embryo itself (Murrell, 2005; Smyth and
McManus, 2007). The eggs may be ingested by pigs and humans through contamination
of food and water resulting from poor hygienic conditions. Furthermore, pigs display
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Intermediate host Final host
Consumption of raw or
undercooked infected pork
Porcine cysticercosis
Human taeniasis
Eggs ingested by pigs
(coprophagy or accidental)
Human (neuro)
cysticercosis
Eggs (accidentally)
ingested by humans
Proglottids/eggs
shed with stools
Figure 2.2: Taenia solium life cycle.
coprophagic behaviour, which creates further opportunities to get infected. Following
ingestion, the digestive system will liberate the oncospheres from their embryophores and
oncospheral membranes. Aided by their hooks, the oncospheres will then penetrate and
migrate through the intestinal mucosa. Once inside the blood flow, they circulate through
the body until they invade the subcutaneous tissues and the skeletal and cardiac muscle
tissues. There, they develop into metacestode larval stages (cysticerci or cysts), thereby
causing human and porcine cysticercosis. The cysticerci take approximately three months
to fully develop, in which time they can grow up to 5-15 mm in size, and stay alive for
a least one year (Flisser, 2013). Furthermore, cysticerci can also develop in the central
nervous system, causing neurocysticercosis (NCC), the eyes (ophthalmic cysticercosis)
and a number of other organs e.g. liver and lungs (Flisser, 1994; Garc´ıa et al., 2003b;
Bastos et al., 2007). Once developed, the cysticerci are (usually) separated from the host
tissues by a thin collagenous layer and undergo four involutionary stages. The first is
the vesicular stage, where the cyst is almost translucent with a visible invaginated scolex.
This also is the infectious stage. The colloidal stage begins when the scolex starts to
degenerate and the cyst fluid becomes turbid. This stage is followed by the granular stage
with further degradation of the entire cyst until finally, the cyst has fully degenerated into
a calcified nodule (Escobar, 1983; Coyle and Tanowitz, 2009). The life cycle is completed
when humans eat raw or undercooked infected pork. The digestive process liberates the
cysticerci from the meat and causes the scolex to evaginate. The scolex will then attach
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itself to the wall of the small intestine, after which the tapeworm will grow to maturity
over a period of 2-4 months (Yoshino, 1934; Flisser, 2013).
2.2 Human (neuro)cysticercosis: a dead-end . . .
Humans are not the common intermediate hosts for T. solium, pigs are. Both are infected
in the same way, but for the parasite, humans are a dead-end, since the only way to com-
plete the life cycle would be through cannibalism. For humans however, the consequences
of cyst development can range from harmless and painless to life-threatening.
Cysticercosis outside the central nervous system causes little to no major symptoms, except
in some rare cases where a massive parasite burden can cause muscular pseudohypertro-
phy and ophthalmic cysticercosis can lead to visual disturbance, proptosis and blindness
(Venkataraman and Vijayan, 1983; Chang and Keane, 2001). Subcutaneous nodules as
they are often observed in Asia and Africa (but rarely in Latin America) are usually small,
movable and painless (Garc´ıa et al., 2003b).
Morbidity and mortality are mostly due to neurocysticercosis (NCC), when the onco-
spheres have migrated through the blood-brain barrier and have developed into cysticerci
in the central nervous system. Clinical manifestations vary from person to person as
they are related to the location, the size and the number of cysts and the severity of
the host immune response. The latter largely depends on the involutionary stage of
the cysticerci. When cysts are in their vesicular stage, there is very little inflammation,
since the cysticerci direct the host immune response towards a T-helper 2 (Th2) non-
inflammatory response in a number of ways (Hewitson et al., 2009; Moreau and Chauvin,
2010; Peo´n et al., 2013; Singh et al., 2013a) e.g. by secreting proteases that degrade
interleukin (IL) 2 (Baig et al., 2005) and by stimulating immunoglobulin production.
These immunoglobulins rarely damage the parasite, but are instead taken up by the
cysticerci and degraded as a source of amino acids (White et al., 1997b; White, 2000).
Typically, the immune response at this stage is marked by the production of significant
amounts of interleukins IL-4 and IL-10 (Abbas et al., 1996; Maizels et al., 2004, 2009).
However, as the cysticerci start to degrade i.e. enter the colloidal stage, the Th2 mediated
response switches to a pro-inflammatory Th1 response, as is evidenced by an increase in
Th1 associated cytokines such as IL-12 and IL-2 (White et al., 1997b; Restrepo et al., 1998).
Regarding the location, intraparenchymal NCC is the most common presentation and
usually carries a good prognosis. While some patients with few cysts can even remain
free of symptoms, 50-80% of patients with intraparenchymal brain cysts present the most
common (and sometimes the only) symptom associated with NCC: epileptic seizures
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(Del Brutto et al., 1992a; Garc´ıa et al., 2003b). It is generally accepted that seizures
occur mainly because of active inflammation resulting from the death of the cysticerci
and subsequent parenchymal irritation (Takayanagui and Odashima, 2006). It is also
commonly observed that seizures become less frequent as the cysticerci become calcified
and the inflammation becomes less pronounced.
Extraparenchymal NCC is less common, but generally more serious. Symptoms and
prognosis depend largely on whether the cysts are located in the convexities of the cerebral
hemisphere, the ventricular system, the fissures (especially the Sylvian fissure), the basal
cisterns or the spine (Garc´ıa et al., 2005). Cysticerci in the gyri of the cerebral convexities
usually have an appearance and clinical presentation similar to intraparenchymal NCC
(Salgado et al., 1997), while intraventricular NCC may require surgery, because the cysts
can block the flow of cerebrospinal fluid, which in turn may lead to violent headaches,
hydrocephalus, intracranial hypertension and sudden death (Lobato et al., 1981; Nash,
2003; Llompart Pou et al., 2005; Torres-Corzo et al., 2006; Takayanagui and Odashima,
2006). Cysticerci that develop in the fissures are often larger than normal and their
tumour-like growth is associated with intracranial hypertension and seizures (Del Brutto
et al., 1992b; Takayanagui and Odashima, 2006). Perhaps the worst prognosis comes from
a rare form of subarachnoid NCC associated with a large translucent cyst without a scolex,
which develops in the basal cisterns (Bickerstaff et al., 1952; Garc´ıa et al., 2003b). In
some cases, cysts cluster together and resemble a bunch of grapes (racemose NCC). As
these cysts grow, they block the flow of cerebrospinal fluid causing intense inflammatory
reaction, obstructive hydrocephalus and in severe cases, death (Bickerstaff et al., 1952;
Pittella, 1997). Spinal NCC is rare (1% of all NCC cases) with clinical signs usually
caused by inflammation and compression of the spinal cord (Colli et al., 2002; White, 2000).
In 2002, Garc´ıa et al. published the consensus that was reached by a panel of experts
regarding treatment of NCC for each clinical presentation. Additional guidelines and
publications by several experts in the field further illustrate the treatment modalities
that can be offered to patients (Nash, 2003; Del Brutto et al., 2006; Nash and Garc´ıa,
2011; Del Brutto, 2012). At this point, it is important to note that the treatment of (life
threatening) symptoms is always the first priority. Patients suffering from seizures are first
given antiepileptic drugs like carbamazepine, and if the aetiology of the seizures is confirmed
i.e. intraparenchymal cysticerci are identified, the neurologist may decide to also administer
antiparasitic drugs to kill the cysticerci. Currently, two antiparasitic drugs are in use
for the treatment of NCC: praziquantel (PZQ) and albendazole (ABZ). ABZ is preferred
over PZQ because of the slightly higher efficacy, lower cost and higher availability (Sotelo
et al., 1990). That being said, ABZ only kills around 70% of all living cysts and clears
the parasites completely (in one round of treatment) in less than 40% of all cases (Botero
et al., 1993; Del Brutto et al., 2006; Carpio et al., 2008). The question of whether or not to
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treat intraparenchymal NCC still remains somewhat controversial, since the degradation of
the cysts due to the use of PZQ or ABZ can cause the inflammation that is responsible for
the onset of epileptic seizures and other neurological symptoms. Therefore, corticosteroids
like dexamethasone and prednisone are often given alongside the antiparasitic drugs
to decrease or prevent the inflammation. Hydrocephalus and intracranial hypertension
resulting from extraparenchymal NCC require immediate attention, which in many cases
means the surgical removal of cysts that (may) cause the obstruction of the ventricles, shunt
placement for hydrocephalus and sometimes removal and/or decompression of large/critical
cysts prior to use of cysticidal drugs (Garc´ıa et al., 2002; Nash, 2003; Garc´ıa et al., 2005).
However, surgery is difficult for cysts that develop in the basal cisterns, which adds to the
grim prognosis of this type of NCC. The optimal duration of cysticidal treatment for this
type of lesion is not known, but therapy should likely be sustained for longer than is the
case for intraparenchymal NCC (Garc´ıa et al., 2002).
2.3 Public health and economic importance
The T. solium taeniasis/cysticercosis complex has a major economic impact and poses
a serious threat to public health in large parts of Africa, Asia and Latin America (Phiri
et al., 2003; Zoli et al., 2003; Rajshekhar et al., 2003; Flisser et al., 2003; Ito et al., 2004,
2011; Assana et al., 2013).
In order to estimate the health impact (or burden) of (neuro)cysticercosis and a number
of other parasitic zoonoses (e.g. echinococcosis, fasciolosis and schistosomiasis) the World
Health Organisation’s (WHO) preferred metric is the “disability adjusted life year” (DALY)
(Torgerson and Macpherson, 2011). DALYs are calculated by summarising the years of
life lost due to premature death (YLL) and the healthy life years lost due to living with
disability (YLD). Ideally, DALYs should facilitate comparisons between diseases, countries
and regions. However, accurate data regarding these parameters is often scarce which, if
left uncorrected, can result in an underestimation of the true burden. In regions where the
data is available, the total number of DALYs related to neglected tropical diseases (which
include neglected zoonotic diseases like cysticercosis) can be on a par with other major
infectious diseases like malaria and HIV/AIDS, as is the case in Nepal (Devleesschauwer
et al., 2014). To assess the health impact on a global scale, Murray et al. (2012) presented
the Global Burden of Diseases, Injuries, and Risk Factors Study 2010 DALY calculations
for 291 diseases and injuries in 21 regions and estimated that for cysticercosis, 503,000
DALYs were lost (all ages). In a recent publication, Torgerson et al. (2014) argued that it
is likely to be considerably higher, since there is a lack of clarity over the proportion of
epilepsy DALYs that was ascribed to cysticercosis. Torgerson et al. further stated that the
Foodborne Disease Burden Epidemiology Reference Group (FERG) that was established
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by WHO in 2006, will undertake its own DALY calculation.
The economic impact associated with T. solium cysticercosis is equally hard to estimate,
since accurate information (especially for porcine cysticercosis) is also relatively scarce
(Carabin et al., 2005; Schantz, 2006). Nonetheless, the figures that have been published
indicate significant economic losses. For example, in West Cameroon, the total annual
costs due to T. solium cysticercosis were estimated at over EUR 10 million. Losses in pig
husbandry accounted for 4.7% of that amount while the remaining 95.3% was taken up by
losses directly or indirectly due to human cysticercosis (Praet et al., 2009). Even higher
numbers were reported in Eastern Cape Province (South Africa) where the overall cost
was estimated to vary from USD 18.6 million to USD 34.2 million.
These figures illustrate the massive impact of the disease and the need to control, eliminate
and, if possible, eradicate it. This need was also recognised by the WHO and cysticercosis
was included in the “Neglected Zoonotic Disease” list (WHO, 2006) and in the “Global
Plan to Combat Neglected Tropical Diseases (2008-2015)” which aims to prevent, control,
eliminate and eradicate neglected tropical diseases and zoonoses (WHO, 2007). More
recently, the commitment to prevention, control, elimination and eradication programmes
was further recognised and confirmed by the World Health Assembly with the adoption of
resolution WHA66.12 on May 23, 2013 (WHO, 2013).
2.4 Eradication, elimination, control and prevention
T. solium cysticercosis is considered a potentially eradicable disease (Schantz et al., 1993).
Indeed, T. solium was successfully eliminated in most European countries by improving
hygienic and sanitary conditions, controlled (indoor) pig husbandry and rigorous meat
inspection (Garc´ıa et al., 2003b; Schantz, 2006). In developing countries, however, the
situation is more complicated. These countries are often endemic regions and lack the
necessary financial resources and political, social and economic structures to set up and
maintain an elimination program. Nonetheless, even in endemic countries, it is possible to
implement a number of measures in an attempt to control the disease (Garc´ıa et al., 2007).
Treatment of human tapeworm carriers is probably the most logical and obvious control
measure. The drugs currently used for this are niclosamide and praziquantel (PZQ).
Niclosamide became available in 1960 and was the first safe, synthetic taeniacide (Pearson
and Hewlett, 1985; Ditzel and Schwartz, 1967). Its efficacy is about 85% with a single oral
dose of 2 g (Murrell, 2005), often given in combination with a purgative (Jeri et al., 2004;
Rajshekhar, 2004). Later, in 1972, PZQ was introduced and quickly proved very effective
against a wide range of cestodes and trematodes (Katz et al., 1979; Andrews et al., 1983).
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For human taeniasis, the efficacy is around 95% with one oral dose of 5-10 mg/kg. The use
of PZQ does require an extra degree of caution. Unlike niclosamide, PZQ is absorbed from
the intestine and is also used for the treatment of human (neuro)cysticercosis (Garc´ıa et al.,
2002). Although there is a report of neurological symptoms after a single taeniacidal dose
of PZQ (Flisser et al., 1993), the low dose makes it unlikely that this will be a common
occurrence. It may however be more relevant in regions where schistosomiasis (treated
with PZQ at 40 mg/kg) occurs together with cysticercosis. Furthermore, niclosamide
has little to no side effects, while the use of PZQ can result in headaches and nausea
(WHO, 1995). On the other hand, PZQ is cheaper1 and more widely available than
niclosamide and is therefore the drug of choice from an economic point of view (Allan
et al., 1997; Murrell, 2005; Pawlowski et al., 2005). Another issue to consider is whether
to opt for identification and treatment of individual carriers (selective treatment) or for
mass treatment of an entire population (mass drug administration or MDA). Individual
identification and treatment has the advantage of being more controlled. The obvious
downside is the amount of community involvement, resources and field visits necessary for
the identification, treatment and follow-up. Interventions like this require blood and/or
stool samples from each individual and when found positive, the individual needs to report
back (or be tracked down), treated and be available for follow-up (Gilman et al., 2012).
The alternative is mass treatment, where the entire community is treated at the same time.
This has several advantages compared to the previous method and although it was once
claimed that the massive expulsion of proglottids and eggs into the environment could
potentially cause an increase in porcine cysticercosis (Keilbach et al., 1989), recent expert
opinions tend to disagree, because the proglottids would be expelled anyway and the rest
of the tapeworm is not infectious.
Finally, treatment of taeniasis without implementation of other control measure(s) leaves
the possibility of reinfection by consumption of infected pork. To prevent this, treatment
would have to be repeated at regular intervals for at least as long as the life span of the
infected pigs. Therefore, combined treatment of human taeniasis and porcine cysticercosis
is a logical next step (Gonzalez, 1997; Gonzalez et al., 2003; Garc´ıa et al., 2006).
Treatment of porcine cysticercosis was initially tried with flubendazole, praziquantel and
albendazole, but this was rather impractical due to the need for multiple doses (and a
subsequent higher cost) and a number of side effects including death, lethargy, anorexia
and the fact that, although dead, the cysts remained intact and made the meat appear
unsuitable for human consumption (Telle´z-Giro´n et al., 1981; Flisser et al., 1990; Torres
et al., 1992; Gonzalez et al., 1995). This changed with the introduction of oxfendazole. A
single dose of 30 mg/kg oxfendazole was shown to kill all cysts (except some in the brain)
after 12 weeks (Gonzalez et al., 1996, 1997, 1998). Furthermore, pigs did not get re-infected
1Praziquantel costs about USD 0.01 per cure (Pawlowski et al., 2005)
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for at least three months post treatment (Gonzalez et al., 2001), but, unfortunately, it also
takes 3 to 6 months for the cysts to resolve and the meat to become aesthetically suitable
for human consumption (Gonzalez et al., 1998; Sikasunge et al., 2008). The aesthetic
aspect aside, there is also a withdrawal period of 17 days before which the meat is not
suitable for human consumption because of drug residues (Moreno et al., 2012). The use
of oxfendazole in pregnant sows is considered safe at a dose of 13.5 mg/kg (Morgan, 1982).
However, the effect of the recommended dose of 30 mg/kg on pregnant sows and the piglets
still requires further study. Additional limitations to the use of oxfendazole are the scarce
availability in many endemic regions and the fact that the drug is not currently registered
for use in pigs (Mkupasi et al., 2013a). Despite these limitations, oxfendazole is generally
considered safe, inexpensive, very effective against muscle cysts (although less against
brain cysts), easy to administer in suspension and as an added bonus, the drug was found
to be highly effective against Ascaris suum, strongyles and Trichuris suis (Mkupasi et al.,
2013a,b). In hyperendemic regions, re-infection is likely to occur. To prevent this from
happening, treatment can be combined with vaccination.
Vaccination of pigs was first tried by Molinari et al. (1983) with a total extract from
T. solium cysticerci. The following years, a number of purified fractions of Taenia spp.
metacestode proteins were evaluated under experimental conditions i.e. with well nourished
pigs of similar age, gender and genetic background and with a single infection with limited
numbers of eggs, often from the same tapeworm. However, to date, only two vaccines
have been successfully used in field trials where circumstances often differ greatly from
experimental conditions e.g. in the field, pigs can be genetically (very) heterogeneous,
malnourished, stressed and exposed to multiple T. solium infections with varying amounts
of eggs, possibly from different tapeworms, as well as various other diseases (Sciutto et al.,
2007c).
The first vaccine, S3Pvac, is a combination of three synthetic peptides (GK1, KETc1
and KETc12) that were identified by using Taenia crassiceps murine cysticercosis as
an experimental model (Manoutcharian et al., 1996; Toledo et al., 1999, 2001; de Aluja
et al., 2005; Sciutto et al., 2007b,c, 2013). S3Pvac was evaluated under field conditions on
two separate occasions in rural Mexico. The first trial showed that S3Pvac reduced the
prevalence of cysticercosis in pigs from 15.8% to 7.5% and caused a 97.9% reduction of the
total parasite load (Huerta et al., 2001). In a follow-up paper, Sciutto et al. (2003) hinted
at the possible involvement of the pigs’ genetic background when it comes to resistance
to naturally transmitted T. solium cysticercosis. During the second trial, Sciutto et al.
(2007b) observed a reduction in porcine cysticercosis from 10% to 4% (with one dose) and
to 3% (with two doses). However, statistical analysis revealed no significant difference
between the values. This was likely due to the difference in sample sizes. In a recent
review, Sciutto et al. (2013) commented further on the cysticidal effect of the vaccine on
Page 13
Taenia solium: An Introduction
2
early established cysticerci in experimentally lightly infected young pigs. The vaccinated
pigs harboured 11-84% damaged cysts, while the control animals had 0.4-40% damaged
parasites. The importance of this observation lies mostly in the fact that a damaged cyst
is less likely to develop into a tapeworm as evidenced by a reduction in in vitro cysticercus
evagination from 70% to 38% and a reduced in vivo transformation into tapeworms
when fed to immunologically uncompromised golden hamsters (from 59% to 18%). In
contrast, S3Pvac was found to be ineffective in damaging fully developed muscle cysticerci
of naturally, heavily infected adult pigs (de Aluja et al., 2011).
The second vaccine, TSOL18, is derived from the T. solium oncosphere larval stage and has
been successful in experimental vaccine trials (Lightowlers, 2003; Gonzalez et al., 2005a;
Lightowlers, 2006) and, more recently, in field studies as well. In a first study conducted
by Assana et al. (2010) in Cameroun, 2-3 month old piglets were given three vaccinations
along with a single oxfendazole treatment (at the time of the second immunisation). At 12
months of age, necropsy revealed a prevalence of 20% in the control group, while no cysts
were found in any of the vaccinated animals. A second study in Peru, where a combination
of two recombinant antigens, TSOL16 and TSOL18, was given twice, but without any
anthelmintic treatment, the number of viable cysts in the vaccinated group was found to
be significantly different from the number of viable cysts in the control group (3 versus
33,416, respectively) (Jayashi et al., 2012). Of the three viable cysts, two were found
in the brain and since consumption of raw brain is a rare practice in Peru, these cysts
would not have posed much risk to human health (Gonzalez et al., 1998). The number of
observed degenerated cysts was 80 and 665 for the vaccinated group and the control group,
respectively. Despite initial thoughts that vaccination had no effect on established cysts
(Lightowlers, 2010), results from the study in Peru suggest that the protection provided by
the TSOL16 and TSOL18 antigens led to an increase in the number of non-viable cysticerci
in the vaccinated animals. These promising results notwithstanding, a major disadvantage
of TSOL18 vaccination is the need to give animals more than one immunisation (often two
or three are given). This adds to the cost and limits feasibility, especially in traditional pig
husbandry systems (free roaming pigs and no breed control). Further factors to consider
when attempting vaccination are the immunological immaturity of neonatal piglets, which
may prevent very young piglets from being properly immunised and the possibility that
maternally-derived antibodies might interfere with the immunisation (Lightowlers, 2013).
Gonzalez et al. (1999) showed that passively transferred antibodies can persist for months
in piglets born to T. solium infected sows. However, these antibodies are likely to be
directed against the cysticerci and since TSOL18 is an oncosphere-derived protein and
anti-TSOL18 antibodies are almost undetectable in pigs harbouring mature cysticerci,
there is little chance that the maternal antibodies will interfere with the immune response
to the TSOL18 vaccine. However, this may not be the case if the sow was vaccinated
during pregnancy (Lightowlers, 2013).
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Health education has also been shown to be effective and generally includes education of the
community on T. solium transmission, disease prevention, pig-management and sanitation
knowledge (Sarti et al., 1997; Ngowi et al., 2008). A slightly different initiative is the
community-led total sanitation (CLTS) approach, where the aim is not so much to educate
the community about the diseases etc., but to make the communities critically question
their own open defecation behaviour (Kar and Chambers, 2008). This is done through
a process of social awakening, stimulated by local facilitators who publicly analyse open
defecation in order to shock, disgust and shame the community members. The end-goal is
to achieve and sustain an “open defecation free” status. This type of interventions come
with an initial cost (training, posters, travel, etc.), but in the long run, no further costs are
required, since the communities take over. Costs are of course higher if these initiatives
are followed-up by or combined with infrastructure improvements such as the construction
of latrines and pigpens (Sarti and Rajshekhar, 2003).
As a control measure, carcass inspection at official slaughterhouses is rather ineffective
(Gilman et al., 2012). One of the main reasons for this is the lack of official slaughterhouses
(and meat inspection) in rural areas. Furthermore, when cysts are found, the carcass is
confiscated with little to no compensation for the farmer (Gonzalez et al., 2003). To avoid
confiscation, farmers and/or traders often inspect the base of the tongue for the presence
of cysticerci to identify the heavily infected animals and slaughter these for their own
consumption (“backyard slaughter”) or sell them illegally (Praet et al., 2010a). Also, many
pigs harbour only a few viable cysts which are easily missed by meat inspection (Sciutto
et al., 1998b; Dorny et al., 2004b; Gilman et al., 2012) .
Finally, freezing of meat at −24℃ or −15℃ for 1 or 3 days, respectively (Sotelo et al.,
1986) and the use of gamma-radiation (Verster et al., 1976) have also been proposed, but
the feasibility of both these methods is limited at best in the poor, rural areas where the
disease is mostly occurring. Salting, where 2.5 kg pieces of pork are covered with ordinary
salt and pickled for 20 days, has also been suggested, but perhaps the most realistic option
to make meat suitable for consumption is heating, since it can be included in the daily
food preparation routine. In general, meat is considered safe for consumption when an
internal temperature of 80℃ is reached (Murrell, 2005).
2.5 Diagnosis of Taenia solium
Depending on the host and the life cycle stage of the parasite, different diagnostic tools
are currently in use. There is no ideal test for all purposes and deciding which tool to use
for which purpose is not trivial. Even in the case where the most optimal tool is obvious,
it may still not be feasible to use it due to limited local infrastructure, availability, the
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number and nature of the samples and the price tag of the assay.
The intended purpose is the first thing to establish and this can vary from the identification
of an individual tapeworm carrier to confirmation of the aetiology of the cysts, the screening
of a population (human or porcine) to determine the prevalence of T. solium infection
in an epidemiological study, the assessment of the efficacy of control measures and the
evaluation of a newly developed tool. Furthermore, the “best tool” need not necessarily
be one tool. Multiple tools can be combined in support of an individual diagnosis or
for prevalence estimations based on Bayesian analysis of imperfect tests (i.e. not 100%
sensitive and specific) and in the absence of a “gold standard” (Dorny et al., 2004b).
Table 2.1 provides an overview of the tools and techniques that are commonly utilised for
the detection of (neuro)cysticercosis and taenisasis. In the following sections, the different
tools and their respective advantages and disadvantages will be discussed in more detail.
2.5.1 Cysticercosis
Human (neuro)cysticercosis
Diagnosis of human NCC is ideally done by combining clinical evaluation, neuroimaging
techniques and immunological methods. Neuroimaging techniques like computed tomogra-
phy (CT) or magnetic resonance imaging (MRI) offer information regarding the location,
the number and the involutionary stage of the cysts (Figure 2.3).
(a) MRI of viable cysts. (b) MRI of degenerating cysts. (c) CT of calcified cysts.
Figure 2.3: Neuroimaging examples of magnetic resonance imaging (MRI) (a-b) and computed
tomography (CT) (c).
Reprinted from The Lancet, volume 362, number 9383, Garc´ıa, H. H., Gonzalez, A. E., Evans,
C. A. W., Gilman, R. H., and Cysticercosis Working Group in Peru., Taenia solium cysticercosis,
547–556, Copyright (2003), with permission from Elsevier.
Although MRI is the most accurate technique and can visualise the different stages of
the cysts, inflammation around the cysts and even forms of the disease which are difficult
to detect with CT (e.g. intraventricular cysticercosis and brainstem cysts), it is scarcely
available in endemic regions and comes with a hefty price tag (Suss et al., 1986; Garc´ıa
et al., 2003b). CT on the other hand, offers better detection of calcified cysts [a common
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Table 2.1: Overview of the commonly used diagnostic tools and techniques for the detection of
Taenia solium, grouped according to the lifecycle stage and the host.
Human (neuro)cysticercosis: detection of the metacestode larval stage
- Clinical evaluation: seizures, headaches, subcutaneous nodules, patient
history (travel/stay in endemic areas), ...
- (Neuro)imaging techniques: MRI1 and CT2
- Immunological tools:
→ Antibody detection: immunoblot (EITB)3 and various ELISAs4
→ Antigen detection: HP10 and B158/B60 ELISA
- Molecular tools: PCR5 (+ enzymatic digestion)
(used mainly as confirmatory tool)
Porcine cysticercosis: detection of the metacestode larval stage
- Post-mortem diagnosis: carcass inspection
- Ante-mortem diagnosis
→ Tongue palpation and eyelid examination
→ Immunological tools:
*Antibody detection: immunoblot (EITB) and various ELISAs
*Antigen detection: HP10 and B158/B60 ELISA
→ Molecular tools: PCR (+ enzymatic digestion)
(used mainly as confirmatory tool)
Taeniasis: detection of the adult stage
- Stool sample examination: proglottids and/or eggs
- Coproantigen detection ELISA on stool samples
- Molecular diagnosis (copro-PCR) on stool samples
- Antibody detection: immunoblot assay on serum
1 magnetic resonance imaging
2 computed tomography
3 enzyme-linked immunoelectrotransfer blot
4 enzyme-linked immunosorbent assay
5 polymerase chain reaction
occurrence in NCC patients from endemic regions, accounting for over 95% of the general
population and up to 30% of symptomatic cases (Zea-Vera et al., 2013)], but CT images
are rarely characteristic for the disease (Garc´ıa et al., 1994).
Immunological methods should complement the neuroimaging to confirm the aetiology of
the cysts i.e help differentiate the T. solium lesions from tuberculomas, mycotic granu-
lomas and primary or metastatic brain tumours which may present with similar lesions
on neuroimaging (Del Brutto et al., 2001). These methods focus either on (i) detecting
parasite antigens or (ii) detecting host antibodies directed against the parasite. The
different techniques and their respective advantages/disadvantages have, in recent years,
been reviewed in great detail by a number of experts (Dorny et al., 2003, 2004a; Deckers
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and Dorny, 2010; Esquivel-Vela´zquez et al., 2011b; Rodriguez et al., 2012; Giri and Parija,
2012). The next paragraphs will offer a summary of the most important characteristics
and considerations relevant to this thesis.
Antibody detection has been in use since the early 1900s (Weinberg, 1909; Moses, 1911)
in a wide variety of assays (e.g. complement fixation) (Flisser et al., 1979), but the real
breakthrough came in 1971, when Engvall and Perlmann described the enzyme-linked
immunosorbent assay (ELISA). This assay enabled the analysis of multiple samples at the
same time and was generally better than any other test before it. Initially, the antigens
that were used in ELISA were crude soluble whole metacestode extracts or cyst fluids,
not necessarily derived from T. solium. Due to the fact that the metacestodes were easy
to maintain in laboratory conditions, T. crassiceps cysts were often used as a source of
antigen (Pardini et al., 2002). These crude antigens had moderate sensitivity and rather
poor specificity (Schantz and Sarti-Gutierrez, 1989), but fortunately, advancements in
protein purification made it possible to develop assays with more refined antigens (Ito et al.,
1998; Ferrer et al., 2005a). Progress in purification methods also lead to the development
of the enzyme-linked immunoelectrotransfer blot (EITB) (Tsang et al., 1989), a Western
blot assay that is currently considered the test of choice for serodiagnosis of cysticercosis
(Rodriguez et al., 2012). This assay uses lentil lectin purified glycoproteins (LLGP) from
homogenised T. solium metacestodes and had an initial sensitivity and specificity of 98%
and 100%, respectively. However, later reports indicated that the sensitivity was lower
in cases with few or single cysts or when cerebrospinal fluid was used instead of serum
(Wilson et al., 1991). Reaction with one or more of the seven diagnostic proteins (at 13,
14, 18, 21, 24, 39-42, and 50 kDa) is considered a positive result (Figure 2.4). The need for
parasite material limits the large scale production of the EITB, resulting in the evaluation
and use of recombinant proteins and synthetic peptides in the EITB format, the Falcon
assay screening test-enzyme-linked immunosorbent assay (FAST-ELISA) format and the
QuickELISA™ format (Hancock et al., 2004, 2006, 2003; Greene et al., 2000; Scheel et al.,
2005; Bueno et al., 2005; Handali et al., 2004; Lee et al., 2011).
Regardless of the format, antibody detection generally struggles to distinguish an active in-
fection from a past infection or exposure (without infection), as antibodies can linger for up
to a year and more after the infection was cleared or treated (Garc´ıa et al., 1997; Ito et al.,
1999; Garc´ıa et al., 2001). Despite this characteristic, several assays have been proposed
for a stage-specific diagnosis i.e. distinguish between viable and degrading metacestodes.
IgG4 antibodies have been linked with active infection (Chung et al., 2002) and were
suggested as a marker in NCC follow-up in saliva (Malla et al., 2005). Also, a recombinant
10-kDa metacestode protein, called CyDA, looked promising in the diagnosis of active
NCC with no cross reaction with chronic inactive NCC or other parasitic infections (Chung
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Figure 2.4: The seven diagnostic bands in the enzyme-linked immunoelectrotransfer blot (EITB)
recognised by human sera.
Image (adapted): Centres for Disease Control and Prevention Image Library (http://www.dpd.
cdc.gov/dpdx/HTML/Image_Library.htm).
et al., 1999). Later studies involving deletion mutants revealed that amino acid residues
30-34 (Asn-Met-Thr-Val-Met) reacted only with sera from active cysticercosis cases and
that these residues were almost exclusively recognised by IgG4 antibodies (Chung et al.,
2002). Recently, sequence alignment analysis located the peptide within a variable region
of the 8 kDa antigen family, further emphasising the diagnostic importance of this antigen
family (Ferrer et al., 2012).
Notwithstanding promising results, antibody assays for a stage-specific diagnosis are not
widely used [e.g. due to major limitations like the need for cerebrospinal fluid (Barcelos
et al., 2007)] and require further validation in both clinical and field settings.
A better detection of viable cysticerci can be achieved with antigen detection assays. Since
the production of (circulating) antigens is directly related to the viability of the cysts,
dead cysts will not register in these assays.
The antigen composition of helminths can be roughy divided into surface, excretory/se-
cretory and somatic antigens. Excretory/secretory proteins (ESPs) are released by the
parasite as either “waste” proteins (excretion) or as “functional” molecules (secretion)
(Harnett, 2014). Secretory proteins are often identifiable by a specific N-terminal signal
peptide although leaderless secretion (a non-conventional/non-classical secretory pathway)
has also been described (Kuchler et al., 1997).
ESPs are at the interface of interaction between host and parasite and can represent
8-20% of the proteome of an organism (Nagaraj et al., 2008). Specifically for T. solium,
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ESPs help the parasite to (i) penetrate the host, (ii) establish and maintain an infection,
while being attacked by the host immune system, and (iii) provide for its own nutrition
by incorporating metabolites from the host. Perhaps the most important function is the
evasion of the host immune system. T. solium metacestodes have developed various
strategies to deal with both the innate and the adaptive immune system of its host and
many of them are shared with other helminths or helminth stages e.g. the production of
proteases and protease inhibitors, inhibition of complement formation and the directing of
the host immune response towards a Th2 non-inflammatory response. A large number of
experts have reviewed these strategies and proteins in great detail e.g. White et al. (1992,
1997b); Rigano` et al. (2001); Sciutto et al. (2007a); Siracusano et al. (2008a); Maizels
et al. (2009); Hewitson et al. (2009); Siracusano et al. (2012) and McSorley et al. (2013).
Evading the immune system is however not the only function of ESPs. Obtaining nutrients
is equally important. Recent evaluation of four cestode genomes (including T. solium) has
revealed a reduction in overall metabolism capability and an increased ability to absorb
nutrients (Tsai et al., 2013). This is evidenced by e.g. a large number of hydrophobic
ligand binding proteins found in parasite ESPs (Hancock et al., 2003; Lee et al., 2007).
Aside from the above mentioned functions, ESPs are also involved in signalling, defence
against oxygen-mediated killing mechanisms and various binding processes (Kim et al.,
2000; Guillou et al., 2007; Siles-Lucas et al., 2008). Furthermore, many ESPs can have
multiple functions.
Since ESPs are so vital to the survival of the parasites, they have been extensively studied
with diagnosis, vaccination and development of antiparasitic drugs in mind (Nagaraj et al.,
2008). Furthermore, ESPs are used as an indicator of parasite viability i.e. contrary to
antibody levels, ESP levels decrease relatively quickly when the metacestodes enter a
degenerative/calcified stage.
Currently, two antigen detection assays are being used. The first one, the HP10 ELISA
(Harrison et al., 1989), where HP10 is the circulating antigen detected in this assay, has a
sensitivity of 72% in cerebrospinal fluid of NCC confirmed patients (Correa et al., 1989).
The second assay, the B158/B60 ELISA (Brandt et al., 1992; Van Kerckhoven et al., 1998;
Dorny et al., 2000), where B158 and B60 are the monoclonal antibodies used to capture the
circulating antigens, has a reported sensitivity and specificity of 90% and 98%, respectively
(Praet et al., 2010b). Both assays were originally designed to detect antigens produced
by T. saginata metacestodes in cattle. The fact that they are used in the detection of T.
solium (neuro)cysticercosis is due to a (convenient) cross reaction between Taenia species.
For clinical case management, antigen detection has proven to be very valuable in a number
of ways. Since a positive test is directly linked to the viability of the cysts, it is a well
suited follow-up tool for treatment, with circulating antigen levels decreasing in parallel
with parasite resolution on brain imaging (Garc´ıa et al., 2000, 2010). Furthermore, antigen
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levels not only correlate with severity of the infection (Zea-Vera et al., 2013), but also
with the type of NCC. In the case of intraparenchymal NCC, both antigen assays showed
reduced sensitivity, but test results still scaled well with the number of cysts (Rodriguez
et al., 2009; Bobes et al., 2006). Extraparenchymal NCC, which carries a poorer prognosis,
shows much higher antigen levels, particularly in patients with basal subarachnoid NCC
(Garc´ıa et al., 2010). Very high antigen levels can thus indicate extraparenchymal NCC or
massive intraparenchymal NCC (Rodriguez et al., 2012).
In 2001, Del Brutto et al. presented four diagnostic criteria for neurocysticercosis stratified
on the basis of their diagnostic strength. These criteria were revisited in 2012 with notes on
recent advances in neuroimaging and immunodiagnostic techniques (Table 2.2) (Del Brutto,
2012).
Table 2.2: Four diagnostic criteria for neurocysticercosis. Interpretation of these criteria permits two
degrees of diagnostic certainty (Del Brutto, 2012).
Diagnostic criteria
Absolute
- Histological demonstration of the parasite from biopsy of a brain or spinal cord lesion
- Evidence of cystic lesions showing the scolex on neuroimaging studies
- Direct visualisation of subretinal parasites by fundoscopic examination
Major
- Evidence of lesions highly suggestive of neurocysticercosis on neuroimaging studies
- Positive serum immunoblot for the detection of anticysticercal antibodies
- Resolution of intracranial cystic lesions after therapy with albendazole or praziquantel
- Spontaneous resolution of small single enhancing lesions
Minor
- Evidence of lesions compatible with neurocysticercosis on neuroimaging studies
- Presence of clinical manifestations suggestive of neurocysticercosis
- Positive CSF1 ELISA2 for detection of anticysticercal antibodies or cysticercal antigens
- Evidence of cysticercosis outside the central nervous system
Epidemiological
- Individuals coming from or living in an area where cysticercosis is endemic
- History of travel to disease-endemic areas
- Evidence of a household contact with T. solium infection
Degrees of diagnostic certainty
Definitive
- Presence of one absolute criterion
- Presence of two major plus one minor and one epidemiological criteria
Probable
- Presence of one major plus two minor criteria
- Presence of one major plus one minor and one epidemiological criteria
- Presence of three minor plus one epidemiological criteria
1 cerebrospinal fluid
2 enzyme-linked immunosorbent assay
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However, the criteria (still) depend heavily on neuroimaging and the EITB assay, while
antigen detection is not thoroughly considered. Recently, the criteria have been questioned
in resource-poor settings where imaging is not feasible and the suggestion to include the
B158/B60 ELISA as a major criterion was put forward by Gabrie¨l et al. (2012). Del Brutto
commented on this in his revisited paper by suggesting minor adaptations to the criteria
according to the most common patterns of disease expression in a given region. To further
illustrate the added value of antigen detection, it was demonstrated that a positive antigen
ELISA in serum can predict undetected viable brain metacestodes, thereby selecting a
group of high-risk patients who would benefit from more advanced imaging techniques
and possibly antiparasitic treatment or even surgery (Zea-Vera et al., 2013). The authors
also suggested to investigate whether antigen ELISA could be routinely recommended in
patients with a diagnosis of calcified NCC on CT.
In some peculiar cases, NCC presents itself as a single parenchymal brain enhancing lesion
(or single cysticercus granuloma; SCG), which accounts for up to 60% of NCC cases in
the Indian subcontinent (Rajshekhar, 1991; Kumar Garg et al., 2000; Prabhakaran et al.,
2007) and has also been reported in Latin America and a number of non-endemic countries
(Del Brutto et al., 2012). Although the diagnosis of neurocysticercosis can be established
with a sensitivity of 99.5% and a specificity of 98.9% when those lesions fulfil a rigid set of
clinical and radiologic criteria (Rajshekhar and Chandy, 1997), it is generally observed
that immunodiagnostic tools (i.e. both antigen and antibody detection assays) show
low sensitivity in those cases (Proan˜o-Narvaez et al., 2002), especially when the cyst is
starting to degenerate. To remedy this drop in sensitivity, the six most recognised EITB
glycoproteins in Indian patients [50, 38, 24, 18, 14 and 13 kDa according to Prabhakaran
et al. (2004)] were unfolded with 5 M urea to expose more/other epitopes. In Western
blot format, sera from SCG patients that were negative in the “native” EITB, were
tested with these unfolded proteins, resulting in an increase in sensitivity from 0% to 46%.
When repeating the analysis in the ELISA format, the sensitivity went from 13% to 42%
(Prabhakaran et al., 2007).
Overall, antibody detection (with the EITB as best example) has a higher diagnostic
sensitivity and specificity than antigen detection, but it tends to overestimate the true
prevalence (especially in the endemic regions), due to its inability to discriminate between
active and past infections or contact. The use of the EITB as a screening tool to refer
seropositive patients to more specialised health centres has been suggested. However,
seropositive patients with neurological symptoms will most likely not be treated differently
(or more urgently) than seronegative patients with seizures and/or (surgery requiring)
intracranial hypertension (Garc´ıa et al., 2012). Therefore, the role of antibody detection
is more towards confirmation of the aetiology of the cysts and identifying individuals at
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higher risk of disease progression (e.g. early stages of extraparenchymal NCC and patients
with multiple viable cysts who will likely encounter problems in later years). Since antigen
detection provides insights in the viability of the (brain) cysts and is therefore an important
tool in the follow-up of treated cases, it can also be used to support (early) detection of
the above mentioned cases, especially because extraparenchymal NCC presents itself with
very high levels of circulating antigens.
Porcine cysticercosis
Porcine cysticercosis is diagnosed post-mortem by carcass inspection, or ante-mortem by
inspection or palpation of the tongue or by using a variety of immunodiagnostic tools.
A complete necropsy of the carcass (i.e. complete slicing of the muscle tissues and organs in
3-5 mm slices) is the only true “gold standard”. However, this procedure is detrimental to
the commercial value of the meat and is very labour intensive. Therefore, it is never used
for routine meat inspection. Nonetheless, it does have its use in the validation of (new)
immunodiagnostic tools (Dorny et al., 2003). Routine meat inspection at slaughterhouses
is limited to a number of incisions in the T. solium cysticerci predilection sites e.g. the mas-
seter muscles, triceps brachii muscle, tongue and heart (Dorny et al., 2004b). This method
requires trained staff and while being 100% specific, it lacks sensitivity. In two studies in
Zambia, one using a Bayesian approach to estimate test characteristics and another to
validate those findings, the reported sensitivity of the carcass inspection varied from 22.1%
(estimated) to 38.7% (validated) with no detection of light infections (1-100 cysts) (Dorny
et al., 2004b). In addition to the low sensitivity, lots of pigs are not slaughtered at the “offi-
cial” abattoirs, so even heavily infected carcasses can enter the food chain without detection.
Tongue palpation (inspection of the base of the tongue for the presence of nodules) is
often used by “middlemen” who purchase pigs in the villages and at the markets and
(unofficial) slaughterslabs, since it is quick, requires no infrastructure and does not damage
the meat. However, although 100% specific when performed by trained staff, it is even
less sensitive than carcass inspection for moderate to heavy infections and also misses all
light infections (Dorny et al., 2004b). Eyelid examination has also been suggested and
compared with tongue palpation (Singh et al., 2013b). Specificity was determined at 100%
for both tongue palpation and eyelid examination, while the sensitivity was determined
at 70% and 25%, respectively. Although the 70% sensitivity is in line with a previous
report by Gonzalez et al. (1990), the available information in both reports suggests that
the animals harboured moderate to high infections, hinting at the possibility that the 70%
sensitivity of the tongue palpation is applicable to heavier infections only.
Clinical signs of porcine neurocysticercosis (excessive salivation, excessive blinking and
tearing, and subconjunctival nodules) have also been proposed as a means to identify
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infected pigs (Prasad et al., 2006), however, most authors report no clinical signs at all,
except for the presence of subconjunctival nodules in massive infections.
Apart from a complete necropsy, all the methods described above lack sensitivity. Despite
this, their use (in slaughterhouses) remains vital as they help keep (heavily) infected
carcasses out of the food chain. However, in large-scale epidemiological studies or in
assessments of control measures, those tools are impractical and immunological tools are a
better choice.
Immunodiagnostic assays offer increased sensitivity and, as is also the case for human
(neuro)cysticercosis, the assays can be divided into antibody detection and antigen detec-
tion. Antibody detection assays using a wide range of antigens (from crude Taenia spp.
extracts to purified fractions) have been described (and reviewed) with variable sensitivities
and specificities, mainly depending on how severe the infection is (de Aluja et al., 1996;
Biondi et al., 1996; Vaz et al., 1996; Sciutto et al., 1998a; Ko and Ng, 1998; Sciutto
et al., 1998b; D’Souza and Hafeez, 1999; Pinto et al., 2000; Nunes et al., 2000; Dorny
et al., 2003; Sato et al., 2003). In short, there is no “go-to” antibody assay for porcine
cysticercosis. That being said, the EITB (Tsang et al., 1989), the assay of choice for human
(neuro)cysticercosis, has also been evaluated for the detection of porcine cysticercosis.
In 1991, evaluation of the EITB assay reported 100% sensitivity and specificity in a control
group of 137 animals. Additionally, four pigs were experimentally infected and their
immune response was quantified by EITB. All four animals harboured 12-74 cysts after
full necropsy and showed IgG activity directed mainly towards the 42 kDa and 50 kDa
bands (Tsang et al., 1991). A year before, identical results were obtained by Gonzalez
et al. (1990). Since then, the EITB assay has been used throughout the world on pig serum
samples (Sakai et al., 1998; Garc´ıa et al., 1999, 2003a; Rodriguez-Hidalgo et al., 2006;
Gomes et al., 2007; Krecek et al., 2008, 2011; Devleesschauwer et al., 2013). Despite the
initially promising results, later reports have indicated that pigs can have a seropositive
result on EITB while being negative at full necropsy. Various reasons have been proposed
with maternal antibodies (Gonzalez et al., 1999) and secondary transmission (Gonzalez
et al., 2005b) being amongst the most plausible explanations. Further research into the
correlation between antibodies detected with the EITB and the number of cysts found
after a full necropsy revealed that there are two important factors to be considered when
estimating the actual infection status: (i) the age of the pig (i.e. the older pigs have
a higher probability of being infected) and (ii) the number of EITB bands (i.e. the
probability of having (many) cysts is higher for pigs that react with 3 or 4+ diagnostic
bands than for pigs reacting with only one or two bands) (Gavidia et al., 2013).
A similar age relation was shown in e.g. Mozambique (Pondja et al., 2010) and Peru
(Garc´ıa et al., 2003a), while Jayashi et al. (2013) made similar observations about the
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number of identified EITB bands. Furthermore, their evidence suggests that the more
cysts in an animal, the more consistent the EITB results will be. Jayashi et al. go on to
propose a modification of the EITB cut-off point from one to ≥ 3 bands, based on receiver
operating characteristic (ROC) curve analysis. This cut-off point modification changed
the EITB characteristics from a sensitivity of 88.9% and a specificity of 48.3% (for one or
more bands) to a sensitivity of 77.8% and a specificity of 76.4% (for three or more bands).
The ≥ 3 bands cut-off point offered the best trade-off in sensitivity and specificity and
more closely resembled the prevalence of porcine cysticercosis determined by necropsy
(16.8% versus 57.9% for one band and 32.7% for three or more bands). Coincidentally,
the second best cut-off point, four or more bands, resulted in a prevalence of 16.8% (i.e.
identical to the one found by necropsy)! However, the individual animals did not match
between the two. A further observation was that a relatively high proportion of animals
that were negative at necropsy still reacted to ≥ 3 bands in the EITB assay. This could
be due to antibodies triggered by exposure and/or aborted infections (the Achilles’ heel of
any antibody assay), but also to non-specific reactions. Indeed, although the EITB for
human NCC has been well studied in that regard, there is a need for thorough specificity
studies involving non-T. solium (helminth) infections.
In conclusion, the use of the EITB for porcine cysticercosis is possible, though not ideal.
The EITB remains a complex, expensive and labour intensive test with potentially un-
known cross reactions. Also, its use may require resetting the cut-off point to better suit
the conditions (field or experimental) and the objective of the study e.g. ≥ 1 band to
“rule out” the disease and ≥ 3 bands to “rule in” the disease.
Antibody detection assays are not the only tool available. The two antigen detection assays
that were described for human NCC can also be used to diagnose porcine cysticercosis and
here too, they only detect viable cysticerci. The B158/B60 ELISA characteristics were
evaluated in Zambia using a Bayesian approach and resulted in 87.6% sensitivity and 94.7%
specificity. A follow-up study to validate these findings resulted in 64.5% sensitivity and
91.2% specificity (Dorny et al., 2004b). Although most assays display lower sensitivities
and specificities in medium to light infections, the B158/B60 ELISA was able to detect
a single viable cyst in the brain of a pig (Nguekam et al., 2003). A later study in South
Africa also used a Bayesian approach to evaluate the prevalence [56.7%, close to the one
found in Zambia (64.2%) (Dorny et al., 2004b)] and test characteristics of the B158/B60
ELISA as well as the HP10 ELISA (Krecek et al., 2008, 2011). The study revealed a
slightly lower sensitivity for the B158/B60 ELISA compared to the HP10 ELISA (63.3%
versus 70.4%, respectively) and a specificity of 87.0% for the B158/B60 ELISA versus a
66.1% specificity for the HP10 ELISA.
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As is evidenced by the above mentioned specificities, there is an important drawback to
using antigen detection in pigs: there is strong evidence of cross reaction with metaces-
todes of Taenia hydatigena, a non-zoonotic Taenia species that is transmitted between
dogs (the final host) and small ruminants (the intermediate hosts) (Dorny et al., 2003,
2004a). Pigs may also act as intermediate hosts for T. hydatigena, although there are
regional variations in their role in the life cycle i.e. T. hydatigena infections in pigs are
rare in Africa, but they are a common observation in Asia and Latin America (Conlan
et al., 2012). Furthermore, in many Asian countries [e.g. Nepal, Korea, China, Taiwan,
Thailand, Indonesia, Vietnam, Japan, and the Philippines as reported by Eom et al.
(2009)] the metacestodes of a third Taenia species, T. asiatica, are found in pig viscera
(Eom, 2006; Eom and Rim, 1993) and given the known cross reactions between T. solium,
T. saginata and T. hydatigena, it is logical to expect a cross reaction with T. asiatica as well.
All this considered, antigen detection is seriously compromised in regions where these
parasites coexist in the pig. In Laos, maximum-likelihood adjusted prevalence of T. solium
and T. hydatigena in pigs was 4.2% and 55.9%, illustrating the potential error that can be
made in these regions (Conlan et al., 2012).
A number of attempts have been made to address the need for a T. solium-specific
(antigen detection) assay. Deckers et al. (2009) developed nanobodies (camelid-derived
single-domain antibody fragments) that did not cross react with T. hydatigena, T. saginata,
T. crassiceps or Trichinella spiralis (cross reaction with T. asiatica could not be assessed).
Unfortunately, attempts to detect antigens in serum from naturally infected pigs with
ELISA resulted in a high background signal, preventing assessment of the real reactivity.
A different approach towards a more sensitive and more specific assay was reported by
Diaz-Masmela et al. (2013). They used two-dimensional polyacrylamide gel electrophoresis
blots in combination with liquid chromatography and tandem mass spectrometry to identify
seven antigens that were specific for porcine cysticercosis: tropomyosin 2, alpha-1 tubulin,
beta-tubulin 2, annexin B1, small heat-shock protein, 14-3-3 protein, and cAMP-dependent
protein kinase. None of these proteins cross reacted with serum pools of pig infected with
Ascaris suum, cysticerci of T. hydatigena and hydatid cysts of Echinococcus spp. or with
a serum sample from a cow infected with T. saginata.
Despite this progress, there is currently no T. solium-specific antigen detection assay
available.
2.5.2 Taeniasis
Diagnosis of the adult tapeworm in the intestine of its final host, humans, can be done
with a number of techniques, ranging from stool examinations to molecular biology.
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The first and most obvious way to detect a tapeworm is a stool sample examination. This
can be macroscopic or microscopic. The former can detect (gravid) proglottids, while the
latter is used to detect eggs and can be preceded by some form of concentration method
(e.g. sedimentation and formalin-ether concentration) (Murrell, 2005). These techniques
all have low sensitivity due to the intermitted release of eggs/proglottids and the relatively
small size of the sample. Specificity of stool examination depends on the tapeworm tissue
found in the sample. When eggs are found, specificity is limited to the genus level, since T.
solium eggs cannot be distinguished from other Taenia that are known to infect humans (T.
saginata and T. asiatica). When scolices and gravid or mature proglottids are recovered
(e.g. after treatment), it is theoretically possible to distinguish between the three Taenia
species (Table 2.3) (Murrell, 2005). Unfortunately, even with optimised purges, recovery
rates are low: 25-33% and 53-69% for scolices and gravid proglottids, respectively (Jeri
et al., 2004).
Table 2.3: Morphological differences between Taenia solium, Taenia saginata and Taenia asiatica.
Taenia solium Taenia saginata Taenia asiatica
Scolex
Rostellum Present Absent Present
Hooks 22-32 Absent Absent
Mature proglottids1
No. of testes 375-575 800-1,200 324-1,216
Ovary 3 lobes 2 lobes 2 lobes
Vaginal sphincter Absent Present Present
Gravid proglottids1
Unilateral uterine branches 7-16 14-32 11-32
Branching pattern Dendritic Dichotomous Dichotomous
Expulsion from host Passively2 Actively3 Actively3
(in groups) (single) (single)
1 Comparison of the internal structures can be facilitated by a simple hematoxylin-eosin staining (Mayta
et al., 2000).
2 Usually with faeces.
3 Outside defecation.
Adapted from “WHO/FAO/OIE Guidelines for the surveillance, prevention and control of taeniasis/cysticer-
cosis” (Murrell, 2005).
More complex methods like electrophoresis assays using mobility of glucose phosphate
isomerase (Le Riche and Sewell, 1977, 1978) or total protein (Bursey et al., 1980) to
distinguish between species were evaluated in the late seventies and early eighties. Since
these assays often required very fresh material without additives (to preserve enzyme
activity), their use was limited.
An ELISA that could detect Taenia antigens in faecal material made its appearance in the
early nineties (Allan et al., 1990, 1992). This coproantigen detection ELISA uses polyclonal
rabbit antibodies directed against whole worm extract of T. solium and is able to detect
2.6 times as many confirmed cases of taeniasis compared to a stool examination. Sensitivity
was determined at 98% and specificity at 99%, but on the genus level, meaning that the
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test is unable to distinguish between Taenia species (Allan et al., 1996). To solve this issue,
new IgG capture antibodies were produced against T. solium whole worm extract while
new IgG detecting antibodies were produced against T. solium adult excretion/secretion
proteins (both in rabbits) (Guezala et al., 2009). The authors calculated 100% specificity
and 96% sensitivity for T. solium tapeworm carriers. Apart from an increase in sensi-
tivity, coproantigen ELISAs have other advantages as well: they can detect tapeworms
in their immature, prepatent stage [even after one week in animal models (Avila et al.,
2003)] and can be used as an early indicator of cure or treatment failure (Bustos et al., 2012).
In an ongoing search for increased sensitivity and specificity, researchers started looking
into DNA for the development of a diagnostic tool. Small differences in the genomic
or mitochondrial DNA were exploited and made into tools to differentiate between T.
solium and T. saginata/T. asiatica. Initially, DNA probes were used (Harrison et al.,
1990), while later efforts employed (multiplex) polymerase chain reactions (PCR) and PCR
followed by enzymatic digestion or single-strand conformation polymorphism (Gasser and
Chilton, 1995; Gasser et al., 1999; Gonza´lez et al., 2000b, 2002, 2004; Montero et al., 2003;
Rodriguez-Hidalgo et al., 2002). Close scrutiny of T. solium mitochondrial DNA enabled
the distinction between a genotype restricted to Asia and a genotype in Africa and Latin
America (Nakao et al., 2002, 2003), while a range of highly polymorphic markers (such
as microsatellites) made it possible to analyse genetic variation at the community level
(Campbell et al., 2006). As with coproantigen detection, DNA analysis also allows for
the detection of immature worms (Yamasaki et al., 2004) and, although many extraction
protocols require pure and clean samples (e.g. proglottids and/or eggs), it is possible to
extract DNA from faecal material directly with a lower detection limit of 40 eggs/g faecal
matter (Mayta et al., 2008). Additionally, since DNA is the same for all stages of the life
cycle, DNA based assays can serve double duty as as confirmation tool for cysticercosis
lesions as well (Geysen et al., 2007).
A recent study by Praet et al. (2013) in Zambia compared for the first time the perfor-
mances of stool examination, coproantigen ELISA and real-time copro-PCR and used
Bayesian modelling to estimate test characteristics and prevalence. They found high
specificities for all three tests: 99.9%, 92% and 99% for stool examination, coproantigen
ELISA and copro-PCR, respectively, although the 92% was lower than previously reported.
Sensitivities for stool examination, coproantigen ELISA and copro-PCR were 52.5%, 84.5%
and 82.7%, respectively. Given the observed genus specificity of the coproantigen ELISA
and low sensitivity of the stool examination, Praet et al. argued that a more widespread
use of copro-PCR would enable better detection of tapeworm carriers, a key factor in T.
solium control.
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The above discussed tests share a dependance on parasite material. Collecting and handling
stool samples and/or tapeworm segments not only carries with it the risk of exposure to
infective Taenia eggs, but also to bacteria, protozoa and other helminth eggs. Furthermore,
collection of faecal material is not always “acceptable” for social or cultural reasons, nor is
it practical i.e. a container has to be given to the individual for collection of the sample and
this person has to return it as well. For those reasons, an immunoblot assay that can detect
specific antibodies in serum was developed (Wilkins et al., 1999). The assay is based on
the identification of two protein groups in T. solium excretion/secretion proteins (32.7 and
37.8 kDa) by specific antibodies in the serum of T. solium tapeworm carriers. Sensitivity
and specificity were determined at 95% and 100%, respectively. In later modifications,
the native proteins were replaced by two baculovirus expressed recombinant antigens to
eliminate the need for fresh parasite material (Levine et al., 2004, 2007). A drawback of
this assay is that antibodies may persist, even though the patient no longer harbours the
adult Taenia (Deckers and Dorny, 2010).
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3CHAPTER 3
The Hitchhiker’s Guide to Proteomics1
3.1 Proteomics: what’s in a name?
The term proteome was coined in 1994 by Marc Wilkins in a symposium on two-dimensional
gel electrophoresis in Siena, Italy, and appeared in print one year later (Wilkins et al., 1995).
A proteome was defined as the entire PROTEin complement expressed by a genOME. Soon
thereafter, the study of a proteome was referred to as proteomics. Nowadays, proteomics is
a mature post-genomic research field that not only aims to study the proteins in a given cell,
but also their isoforms, modifications, structures and interactions (Martins-de Souza, 2014).
The relationship between DNA, mRNA and proteins is not necessarily straightforward.
A significant change in mRNA abundance is not necessarily followed by a correspond-
ing change in protein abundance. Gygi et al. (1999b) examined 106 yeast genes with
corresponding information on mRNA and protein levels. When calculating a Pearson
product moment correlation coefficient with only the low abundant 40 to 95 proteins,
correlation between protein levels and mRNA levels was bad (consistently between 0.1
and 0.4). If the 11 most abundant proteins were included, the correlation increased to
0.94. They then estimated the correlation for all yeast proteins to be less than 0.4. Two
years earlier, Anderson and Seilhamer (1997) came to similar conclusions when studying
mRNA and protein abundances in human liver. Similarly, studies of parasitic protozoa,
like Plasmodium falciparum showed discrepancies between transcriptomic and proteomic
data, albeit with a higher correlation of up to 0.59 (Le Roch et al., 2004).
Only 30-40% of the variance in protein abundance is explained purely by mRNA abun-
1Title adapted from the novel “The Hitchhiker’s Guide to the Galaxy”, written by Douglas Adams
and published by Pan Books in 1979.
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dance. Mainly it is due to extensive regulatory processes occurring after mRNA is made i.e.
post-transcriptional regulation, translation efficiency, and protein half-life and degradation
(Varshavsky, 1996; Vogel and Marcotte, 2012).
A further interesting observation in this regard was made by Schrimpf et al. (2009) and Lau-
rent et al. (2010) and involves that fact that the abundances of orthologous proteins across
divers taxa (bacteria: Escherichia coli, Pseudomonas aeruginosa, fungi: Saccharomyces
cerevisiae, rice: Oryza sativa, fruit fly: Drosophila melanogaster, nematode: Caenorhab-
ditis elegans and humans) correlate remarkably well. Much better in fact than protein
abundance versus transcript abundance within each organism or transcript abundances
across organisms. This lead the authors to conclude that there is also an evolutionary
component involved and changes in mRNA expression could be offset by opposite changes
in translation rate or protein half-life, and vice versa. Over evolutionary time scales, such
small changes may accumulate, resulting in appreciable changes of mRNA abundance,
whereas protein abundance would remain roughly constant.
Examples like this highlight how many of the common “omics” sciences (like genomics,
transcriptomics, proteomics and metabolomics) complement each other (Figure 3.1).
genomics transcriptomics PROTEOMICS metabolomics
what can
happen
what will
happen
what is
happening
what has
happened
Figure 3.1: The common “omics” sciences complement each other.
In genomics, one studies the genome, which is the complete set of DNA in a cell or
organism. Simply put, genomics tries to sequence and assemble the DNA and study
the function and structure of the genome. To better understand the functional elements
of the genome, researchers started looking at gene transcripts (mRNA). The complete
set of transcripts in a cell at a given time, development stage or condition is called the
transcriptome. The field of transcriptomics studies these transcripts to determine the
transcriptional structure of genes (5’ and 3’ ends, splicing patterns, ...) and to quantify
the changing expression levels of each transcript under various conditions and development
stages (Wang et al., 2009b). The translation of mRNA leads towards proteins, proteomes
and proteomics. Proteins are often considered the workhorses who carry out the majority
of cellular processes. Furthermore, they have received a large amount of attention by
researchers looking to develop diagnostic assays, since, for example in the case of T. solium
cysticercosis, circulating antigens are likely to be easier to detect than circulating DNA
(Ramahefarisoa et al., 2010). In order to get the whole story of what happens in a cell, the
field of metabolomics studies the substances produced in or by biological/cellular processes.
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These metabolites are usually smaller than 1.5 kDa and reflect the sum of all up-stream
regulatory events, as well as direct inputs from the external environment.
3.2 Tandem mass spectrometry-based proteomics
This section describes a generic proteomics workflow. Since it is impossible to cover all
the currently available tools, techniques and equipment, the text is limited to those most
relevant to this thesis.
3.2.1 Sample preparation and separation
The sample of interest can be just about anything that contains proteins or peptides:
eukaryotic tissue and derived extracts, cells and organelles, biological fluids (e.g. plasma
or serum, urine, cerebrospinal fluid, saliva, tears, nasal mucus, milk, amniotic fluid, semen
or snake venom), prokaryotic organisms, seeds, vegetal matter and plants (Carrette et al.,
2006). In cases where endogenous protease activity is to be expected (e.g. after cell
lysis), the addition of protease inhibitors is recommended. Further sample preparation
often includes concentration steps and general sample clean-up (from centrifugation for
the removal of insoluble particles to dedicated clean-up kits to separate proteins from
detergents, salts, lipids and nucleic acids).
At this stage, it is of the utmost importance to realise that most if not all of the down-
stream manipulations and/or analyses operate by the “garbage in, garbage out” principle,
meaning that no good results can come from a bad sample preparation (Lidwell et al., 2010).
Currently, no method or instrument is capable of identifying and quantifying the com-
ponents of a complex sample in a single-step operation (Abdallah et al., 2012). Hence,
several separation methods are employed prior to mass spectrometry in order to reduce the
complexity of the sample and to increase the identification rate of less abundant proteins.
One of the most common protein separation methods is one-dimensional polyacrylamide
gel electrophoresis (1D-PAGE; Figure 3.2b) (Laemmli, 1970) which separates the proteins
based on size. Throughout the years, numerous optimisations like neutral pH conditions
instead of alkaline, pre-cast gels and ready made reagents have made this a very robust and
highly reproducible technique. At around the same time, another separation technique,
called isoelectric focussing (IEF; Figure 3.2a), which relied on a separation based on the
isoelectric point (pI) of a protein (instead of the size), was also being developed (Svensson,
1961; Vesterberg and Svensson, 1966). A few years later, the two techniques were combined
into two-dimensional (2D) PAGE (Figure 3.2c) (MacGillivray and Rickwood, 1974; Klose,
1975; O’Farrell, 1975).
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Figure 3.2: Schematic representation of isoelectric focussing (IEF), where proteins are separated
based on their isoelectric point (pI; a), one-dimensional polyacrylamide gel electrophoresis (1D-
PAGE), where proteins are separated based on their size (b) and two-dimensional polyacrylamide
gel electrophoresis (2D-PAGE; c). 2D-PAGE combines IEF as a first dimension of separation and
1D-PAGE as a second dimension.
The advantages of 2D-PAGE are numerous. The high resolving power and large sample
loading capacities allow for the simultaneous display of hundreds of proteins on a single
gel (Carrette et al., 2006). Furthermore, 2D-PAGE can detect protein isoforms and
posttranslational modifications and can demonstrate changes in relative abundance of
visualised proteins. These characteristics have made 2D-PAGE a very popular choice for
proteomic research (Rabilloud, 2002; Go¨rg et al., 2004; Carrette et al., 2006; Rabilloud
and Lelong, 2011).
The benefits of 2D-PAGE notwithstanding, its use has been declining over the past few
years. The reasons for this trend lie with the many limitations of the technique: (i)
2D-PAGE tends to identify only the most abundant proteins due to the limited dynamic
range of the staining methods compared to the large dynamic range of protein levels in
a proteome, (ii) proteins with extreme masses (< 10 kDa or > 150 kDa) and extreme
isoelectric point (pI) values (pI < pH 3 or pI > pH 10) are poorly resolved, (iii) poorly
soluble proteins (e.g. membrane proteins) are often lost or underrepresented, (iv) different
posttranslational modifications (PTMs) can alter the behaviour of a protein during elec-
trophoresis, (v) poor reproducibility, (vi) co-migration of multiple proteins in a single spot,
and (vii) the difficulty to automate (Gygi et al., 1999b, 2000; Rabilloud, 2002; Wu and
MacCoss, 2002; Lilley et al., 2002; Carrette et al., 2006; Abdallah et al., 2012). The 2D
difference gel electrophoresis technique (2D DIGE) addresses some of these shortcomings
by enabling the comparison of two different protein samples simultaneously on the same
gel (Unlu¨ et al., 1997; Viswanathan et al., 2006; Timms and Cramer, 2008; Minden et al.,
2009; Beckett, 2012). Before running the gel, the proteins in each sample are labelled
with fluorescent cyanine dyes [Cy3 = sample 1, Cy5 = sample 2 and Cy2 = equal amount
of each sample as internal standard as proposed by Alban et al. (2003)]. Cyanine dyes
have both a high fluorescent extinction coefficient (i.e. they are bright) and they each
possess unique absorption and emission spectra (i.e. they each have a different colour).
Once labelled, the protein samples can be mixed and separated as a normal 2D-PAGE
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sample. During development of the gel, sophisticated imaging equipment scans each dye
individually and makes a gel image. Then, the gel images are analysed with appropriate
software to detect common proteins (or a change in abundance) as well as proteins unique
to any one of the samples. Unfortunately, the software is not without issues and often
requires user intervention, especially during spot matching across different gels (Abdallah
et al., 2012).
Due to the limitations mentioned above, 2D-PAGE is being phased out by advancements
in mass spectrometry, especially for quantitative proteomics. Labelling methods like
stable isotopic labelling with amino acids in cell culture (SILAC) (Ong et al., 2002) are
designed around the fact that both the labelled and unlabelled peptides have the same
chromatographic and ionisation properties, but can be distinguished by their specific
mass-shift. However, these labelling methods are often expensive and require large sample
volumes and many preparation steps. Therefore, label-free methods have provided a
reliable, versatile, and cost-effective alternative to labelled quantitation (Neilson et al.,
2011). The specific details about the labelling and label-free methods have been discussed
and reviewed by several experts in the field (Gygi et al., 1999a; Ong et al., 2002; Ross
et al., 2004; Mann, 2006; Choi et al., 2008a; Lundgren et al., 2010; Neilson et al., 2011).
The use of shotgun proteomics combined with multi-dimensional liquid chromatography
separation techniques has also provided an alternative to gel-based separation (Wu and
MacCoss, 2002; Motoyama and Yates, 2008; Gilmore and Washburn, 2010).
In a technique often referred to as multidimensional protein identification technology
(MudPIT), a protein sample is fully digested with a protease and the resulting peptides are
separated based on several characteristics before being analysed by the mass spectrometer
(Link et al., 1999). This shotgun approach effectively eliminates many of the disadvantages
of gel-based separations as well as any loss related to incomplete sample extraction for the
gel (Rabilloud, 2002).
Whether or not proteins were separated first, they still need to be processed before they
can be analysed with a mass spectrometer. This generally implies (i) the addition of
dithiothreitol (DTT) to reduce the cystines, (ii) the addition of iodoacetamide to alkylate
the cysteines, (iii) the addition of a protease, commonly trypsin, to digest the proteins
(Olsen et al., 2004) and, when using PAGE, (iv), an elution of the resulting peptides from
the gel piece (Shevchenko et al., 1996, 2006).
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3.2.2 Liquid chromatography and tandem mass spectrometry
Liquid chromatography
Protein sample complexity may have been reduced by a first separation step (e.g. 1D-
PAGE), but the subsequent tryptic digest again adds complexity. Therefore, another
separation step is required, this time on the peptide level. Frequently, the method of choice
is reversed-phase liquid chromatography (RPLC). Peptides are loaded onto a stationary
phase made out of C18 chains bound to a silica base material. A gradual increase of organic
solvent (e.g. acetonitrile) in the mobile phase will elute the peptides based on the strength
of their hydrophobic interaction with the stationary phase. The eluted peptides can either
be collected in fractions (off-line) or can be directly loaded onto the ionisation source of the
mass spectrometer (on-line). Although RPLC is much used, it is often overlooked when
optimising the experimental set-up. Peterson et al. (2009) found that a slight decrease
(from 5% to 2%) in the concentration of acetonitrile during the desalting step, resulted in
a 26% increase in peptide identifications. Logically, most of these peptides were hydrophilic.
When the protein sample is digested without prior separation, the resulting sample com-
plexity often requires multidimensional liquid chromatography before sufficient separation
is achieved (Motoyama and Yates, 2008). One of the most widely used combinations is ion
exchange chromatography (e.g. strong cation exchange or SCX) and subsequent RPLC
(Wolters et al., 2001).
Sample ionisation
In short, mass spectrometry is the measurement of the mass-to-charge ratio (m/z) of
gas-phase ions. Hence, peptides need to be ionised and transferred to the gas phase before
they can be analysed. The two most used ways to achieve this are matrix-assisted laser
desorption/ionisation (MALDI) and electrospray ionisation (ESI).
The MALDI technique (as it was introduced by Karas et al. in 1987) uses a nitrogen
laser (at 337 nm) to shoot at a matrix/analyte mixture that is fixed on a target plate
(Figure 3.3). The ultraviolet energy from the laser is absorbed by the matrix material and
transferred to the analytes, causing both to transfer to the gas phase. Ionisation of the
analytes is believed to happen during or shortly after the laser pulse as well as during
secondary reactions in the expanding plume of desorbed material (Knochenmuss, 2006).
Combining (reversed-phase) liquid chromatography and MALDI is possible in an off-line
format i.e. the liquid chromatography outlet is not directly coupled to the ionisation
source. Instead, the LC eluent has to be mixed with MALDI matrix first and then spotted
onto target plates (Pereira et al., 2013). Although not as convenient as a direct coupling
(on-line), it does offer a big advantage: preservation of the chromatographic separation on a
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MALDI target plate yields as much time as desired to obtain (tandem) mass spectrometry
spectra, without risk of missing ions as they elute from the LC column (Zhen et al., 2004).
laser beam
matrix/analyte mixture
target
plate
to mass spectrometer
charged
analytes
focussing lenses
Figure 3.3: Principle of matrix-assisted laser desorption/ionisation (MALDI).
ESI also became popular in the 1980s (Yamashita and Fenn, 1984; Fenn et al., 1989)
and, like MALDI, it is a soft ionisation method, meaning it does not fragment (larger)
molecules. The ESI principle involves a flow of liquid analytes, a thin conducting needle at
3-4 kV and a potential difference between the needle and the inlet of the mass spectrometer
(Figure 3.4). Positively charged analytes accumulate at the liquid surface, while negatively
flow of liquid analytes (from the RPLC)
drying gas (N2)
to mass spectrometer
+ −
conducting needle
nebuliser gas (N2)
Taylor cone
spray of droplets
Figure 3.4: Principle of electrospray ionisation (ESI).
charged particles will be drawn to the positive wall of the needle. This accumulation
of positive charges in the liquid leads to a Taylor cone (Taylor, 1964), which under the
influence of the high electric field and Coulomb’s law, ends in a fine spray of droplets
containing positively charged analytes. A flow of (warm) N2 nebuliser and drying gas
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helps evaporate the liquid in the droplets, until they are so small that the Coulomb forces
between the like charges exceed the surface tension and the droplet breaks up into smaller
droplets. This process continues until the radius of the droplet is less than 10 nm at which
point direct emission of an ion into the gas phase takes place (ion evaporation model)
(Iribarne and Thomson, 1976; Nguyen and Fenn, 2007). The outlet of the RPLC can
easily be coupled to the inlet of the ESI source (on-line). The mobile phase of the RPLC
contains organic solvents which evaporate easily and the addition of acid (e.g. formic acid)
lowers the pH to assist protonation of the analytes.
Unlike MALDI, where mostly singly charged ions are produced, ESI produces multiply
charged ions. This results in a shorter m/z range.
Mass analysers
Once the charged analytes are transferred to the gas phase, they enter the heart of the
mass spectrometer, called the mass analyser, where they are separated based on their
m/z ratio. Nowadays, there is a wide range of mass analysers available with the most
popular being the time-of-flight (TOF) analysers (Wiley and McLaren, 1955), quadrupole
mass filters (Paul and Steinwedel, 1953), quadrupole ion traps (Paul and Steinwedel, 1960;
March, 1997; Jonscher and Yates, 1997), orbitraps (Makarov, 2000; Zubarev and Makarov,
2013) and Fourier-transform ion cyclotron resonance (FTICR) mass analysers (Comisarow
and Marshall, 1974). In some cases, multiple mass analysers are combined to form a hybrid
mass spectrometer.
The performance of mass spectrometers is often assessed by a number of properties
(de Hoffmann and Stroobant, 2007):
Mass range: The m/z range over which a mass analyser can measure ions with sufficient
sensitivity to be practically useful.
Analysis speed: The rate at which the analyser measures over a particular mass range,
the number of spectra per unit of time.
Transmission: The ratio of the number of ions reaching the detector and the number of
ions entering the mass analyser.
Mass accuracy: The accuracy of the m/z provided by the mass analyser. It is the
difference that is observed between the theoretical m/z and the measured m/z.
Resolution or resolving power: The ability to distinguish two peaks of slightly differ-
ent m/z.
Linear dynamic range: The range over which the ion signal is linear with the analyte
concentration.
Detailed explanations about and comparisons between mass analysers would be (i) beyond
the scope of this thesis and (ii) quickly outdated, since technical advancements in the field
of mass spectrometry (both software and hardware) are fast and numerous. That being
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said, since a Bruker Daltonics amaZon ETD ion trap mass spectrometer (www.Bruker.com)
was used for the analyses described in this thesis, further explanations will use the 3D ion
trap mass spectrometer as example.
All things considered, there is no “ideal” mass spectrometer that does everything perfectly
and one should select the most optimal mass spectrometer for the envisioned task.
Tandem mass spectrometry
In general, tandem mass spectrometry (MS/MS) is the practice of carrying out one mass
analysis after another. The first mass-selective operation is meant to isolate an ion, called
the parent or precursor ion, while the second mass-selective operation will determine the
m/z ratios of the fragment ions formed by fragmentation of the precursor ion (March, 1997).
The core of a 3D ion trap mass spectrometer is roughly the size of a tennis ball and
consists of three hyperbolic electrodes: a ring and two endcaps (Figure 3.5) (Jonscher and
Yates, 1997). In this chamber –the actual ion trap– ions with different m/z ratios are
accumulated and trapped using constant DC and radio frequency (RF) oscillating AC
electric fields. Once trapped, ions are sequentially ejected from low m/z to high m/z by
ramping up the RF voltage. The ejected ions are detected by an electron multiplier to
produce a mass spectrum (Stafford, 2002).
ESI needle
ion guide ions are sequentially
ejected from the trap
end caps
ring electrode
Figure 3.5: Schematic representation of an ion trap. Ions are guided from the electrospray ionisation
(ESI) source to the ion trap. They enter through an opening in the end cap and are accumulated
in the centre of the trap. Once accumulated/trapped, the ions are sequentially ejected from low
m/z to high m/z by ramping up the radio frequency amplitude.
If an ion of interest (parent ion or precursor ion) is observed in this MS spectrum, the ion
trap chamber is filled again with ions, but this time, all ions with an m/z ratio higher or
lower than the parent ion are ejected, so that only the parent ions remain in the chamber.
These precursor ions are then allowed to collide with the He buffer gas in the chamber. This
collision-induced dissociation (CID) results in a fragmentation of the peptide backbone and,
in the case of singly charged precursor ions, in the formation of b ions, when the charge
is retained at the N-terminal or y ions, when the charge is retained at the C-terminal
(Figure 3.6) (Roepstorff and Fohlman, 1984; Biemann, 1990; Paizs and Suhai, 2005). The
presence of basic residues in the fragments greatly influences the formation of the b and y
ions i.e. the fragment containing the most basic site is most likely to retain the charge.
Since trypsin is the enzyme of choice in many proteomics experiments, and trypsin yields
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peptides that terminate in basic arginine and lysine residues, fragmentation of these
peptides tends to favour prominent y series (Tabb et al., 2004; Olsen et al., 2004). Doubly
charged precursor ions can produce both a b ion and a y ion, but fragment ions that
contain two basic residues may accept both protons during fragmentation, which, in turn,
leads to a doubly charged fragment ion (Tabb et al., 2004).
H2N C
R1
H
C
O
NH C
R2
H
C
O
NH C
R3
H
C
O
NH C
R4
H
C
O
OH
x3 y3 z3 x2 y2 z2 x1 y1 z1
a1 b1 c1 a2 b2 c2 a3 b3 c3
2H+
Figure 3.6: Theoretical fragmentation of a doubly charged parent ion. Charges can be mobile
as illustrated by the square brackets around the ion. Collision-induced dissociation leads to
fragmentation of the peptide backbone in b ions (charge retained at the N-terminal) and/or y
ions (charge retained at the C-terminal). The presence of basic residues in the fragments greatly
influences the formation of the b and y ions and fragments that contain two basic residues may
even accept both protons during fragmentation.
All aspects of this procedure are controlled by software and many of them can be modified
by the user to optimise the quality of the data e.g. one could set the mass spectrometer
to select the 10 most intense peaks of each MS scan for MS/MS analysis, but to exclude
them if they were already selected during the past 15 seconds. This would force the
mass spectrometer to skip the most abundant precursors and to select less abundant ones
instead.
At the end of the mass spectrometry experiment, the user has MS spectra (with precursors
mass information) and, for a number of precursors, MS/MS spectra (with fragmentation
information).
3.2.3 Data analysis
The next step in the process is to assign peptide sequences to the experimental spectra.
Generally speaking, there are three ways to go about this: de novo analysis, spectral
library searching and protein database searching.
It is possible to derive the peptide sequence directly from the fragmentation spectrum,
without the assistance of a protein databases. This is called de novo analysis and the idea
behind it is that the mass difference between e.g. fragment ions b3 and b2 is the mass of
an amino acid residue. By overlapping all b ions and matching the mass differences to
amino acids, the amino acids sequence can be determined (Figure 3.7). The same can be
done with the y ions and, if done correctly, the sequence should be the same.
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Figure 3.7: De novo analysis of the collision-induced fragmentation spectrum of the DARWIN
peptide. The difference between each b or y ion is one amino acid residue e.g. b3 and b4 differ
by the amino acid Tryptophan (W), which corresponds to a mass difference of 186.07931 Da.
Likewise, y2 and y3 also differ by 186.07931 Da. Calculating the differences between the b and y
peaks eventually reveals a (partial) peptide sequence.
Although de novo analysis sounds straightforward, the spectra have to be of excellent
quality and there are a number of extra difficulties, like mass shifts due to loss of water
or ammonia and incomplete b or y series. Furthermore, evergrowing datasets have made
manual annotation of spectra increasingly difficult. Fortunately, specialised computer
algorithms have been developed to cope with many of these issues (Ma et al., 2003; Frank
and Pevzner, 2005; Seidler et al., 2010).
The spectral library searching approach takes experimental MS/MS spectra and compares
them against a spectral library which is compiled from a large collection of experimentally
observed MS/MS spectra identified in previous experiments (Yates et al., 1998; Craig
et al., 2006b; Frewen et al., 2006). Spectral library search tools like SpectraST (Lam et al.,
2008) use a set of user defined parameters (e.g. mass tolerance windows) to compare each
experimental spectrum to a limited list of candidate spectra from the library (Figure 3.8).
The best match is then retained.
DARWIN
best match
ARCHIMEDES
EINSTEIN
Figure 3.8: Spectral library searching approach. An experimental spectrum is compared to a
subsection of identified spectra from the spectral library. Each match is scored and the best match
is retained.
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Although spectral library matching outperforms protein database searching in terms
of speed, error rates, and sensitivity of peptide identification (Lam et al., 2007), the
technique is still underused. The most notable limitation is with the spectral libraries.
Only previously identified peptides whose experimental spectra are uploaded to a library
can be identified. Furthermore, spectra that were generated under specific conditions
(modifications, mass spectrometer, ...) can not always be matched to spectra generated
under other conditions. Finally, spectra from lower abundant peptides are often scarce.
In the mid-1990s, an almost revolutionary breakthrough in protein identification was
made with the development of computer algorithms that converted the character-based
representations of amino acid sequences in a protein database to a fragmentation pattern
that could then be used to match fragment ions in a MS/MS spectrum. One of the widely
used early algorithms was SEQUEST, first described by Eng et al. in 1994.
It should be made clear that the (almost simultaneous) development of these algorithms
did not happen by chance at that particular time. On the contrary, since these tools relied
heavily on the availability of protein databases and since protein sequences are encoded
in DNA, it comes as no surprise that the development of these database search tools
coincided with the enormous efforts to sequence the genomes of several model organisms
such as Haemophilus influenzae, the first bacterial genome, by Fleischmann et al. (1995),
the Escherichia coli K12 genome by Blattner et al. (1997), the first eukaryotic genome
(Saccharomyces cerevisiae) by Goffeau et al. (1996) and the Human Genome Project,
which was initiated in 1990 (Watson, 1990). This is a perfect illustration of the strong
link between the “omics” sciences: the huge leap forward in the field of genomics enabled
major progress in protein identification strategies.
The above mentioned algorithms marked the beginning of the protein database searching
approach and since then, a large number of computational tools have been developed, with
Mascot (Perkins et al., 1999), X!Tandem (Craig and Beavis, 2004) and OMSSA (Geer et al.,
2004) being amongst the most popular. They all share the same basic idea (Figure 3.9):
the search program takes experimental MS/MS spectra and compares them to a subset
of theoretical MS/MS spectra that were created in silico from a protein database, using
a number of user defined parameters (e.g. mass tolerances of parent and fragment ions,
allowing for tryptic peptides only and fixed and variable posttranslational modifications)
(Nesvizhskii, 2010, 2007).
The degree of similarity between the experimental spectrum and a theoretical in silico
spectrum is scored by the search program and all theoretical spectra are then ranked
according to their score. Most search tools consider only the top scoring peptide spectrum
match (PSM) for each experimental MS/MS spectrum as the potential peptide identifica-
tion.
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Figure 3.9: Protein database searching approach. The amino acid sequence of a peptide in the
database is translated to a theoretical fragmentation spectrum. The experimental spectrum is
then compared to a subset of the computer generated spectra and each peptide spectrum match
is scored. Finally, the best match is retained.
It is important to realise that the protein database search tool will produce a PSM for nearly
all experimental spectra, but that the majority of these PSMs are incorrect (especially
when the dataset was created on low mass accuracy instruments or when peptide sequences
are not in the protein database) (Choi et al., 2008b; Nesvizhskii, 2010). It is therefore
necessary to assess the confidence of the PSMs and to estimate error rates associated with
filtering the data using various thresholds (Carr et al., 2004; Choi and Nesvizhskii, 2008b).
Assessing the confidence of PSMs can be roughly divided into single-spectrum and global
(whole dataset) modelling approaches. The expectation value (E-value) is the most
used single-spectrum statistical confidence measure and refers to the expected number
of peptides with scores equal to or better than the observed best match score under
the assumption that peptides are matching the acquired MS/MS spectrum by random
chance (Fenyo¨ and Beavis, 2003; Choi and Nesvizhskii, 2008a). It is achieved by modelling
the distribution of the search tool score(s) constructed separately for each individual
experimental spectrum from all candidate peptides in the searched protein database that
were scored against it (Choi and Nesvizhskii, 2008b). However, the conversion of a search
tool score into an E-value does not control the overall identification error rates, since its
construction does not specifically involve steps for multiple testing correction and, although
a necessity when the analysis involves simultaneous processing of multiple MS/MS spectra,
classical multiple testing corrections like the Bonferroni correction were never designed for
such large datasets and give overly conservative results (Choi and Nesvizhskii, 2008a; Choi
et al., 2008b; Nesvizhskii, 2010). Therefore, additional analysis and modelling is required
to obtain statistical measures more suitable for filtering of very large PSM datasets (Choi
et al., 2008b; Nesvizhskii, 2010).
When dealing with large datasets, the most reported statistical measure is the false dis-
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covery rate (FDR) (Benjamini and Hochberg, 1995). The FDR, which deals with the
PSM dataset at a global level, can be defined as the expected number of incorrect PSMs
amongst all PSMs that pass a certain search score threshold (Choi and Nesvizhskii, 2008a;
Ka¨ll et al., 2008).
The most popular way to estimate the global FDR is to use a target/decoy database
approach (Figure 3.10). Here, the number of incorrect PSMs against the original, target
protein database is estimated by searching a decoy database, which contains “fake” proteins
sequences (e.g. reversed, scrambled or randomised protein sequences from the target
database). This decoy database is searched separately or simultaneously as a concatenated
target+decoy database. The number of decoy PSMs above the threshold score can then
be used as a measure of the number of incorrect target PSMs and the desired FDR can be
achieved by selecting a different threshold score. The most simple FDR estimation can
thus be defined as Ndecoy/Ntarget where Ndecoy and Ntarget are the number of hits above
the search score threshold Ts in the decoy database and the target database, respectively
(Jeong et al., 2012). Depending on the way the search is performed (separate or as a
composite database) and the way the decoy database is constructed [reversed, scrambled
or randomised (Elias and Gygi, 2010)] the use of a correction factor (Ka¨ll et al., 2008),
an alternative formula (Elias and Gygi, 2007; Navarro and Va´zquez, 2009; Wang et al.,
2009a), an optimal decoy construction and search strategy (Bianco et al., 2009) and a
form of FDR quality control (Vaudel et al., 2011b) have been suggested.
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Figure 3.10: Global false discovery rate (FDR) estimation by using a concatenated target+decoy
database database searching approach. Once the peptide spectrum matches are ranked by score,
the FDR is estimated by taking the number of hits in the decoy database (reversed sequences)
that pass the threshold score Ts divided by the number of hits in the target database (normal
sequences) that pass the same threshold score. The desired FDR can be achieved by adjusting Ts.
An alternative way to estimate the global FDR is to calculate the posterior probability
of correct identification for each individual PSM by means of a mixture model-based
approach (Efron et al., 2001) and to use those probabilities to derive global FDR estimates
(Figure 3.11). This approach is implemented in the PeptideProphet (Keller et al., 2002)
and was later updated with three modifications (Ma et al., 2012): (i) the optional use of a
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decoy database to assist the expectation-maximisation (EM) algorithm (Dempster et al.,
1977) in establishing a more reliable distribution of incorrect PSMs (Choi and Nesvizhskii,
2008b), (ii) a non-parametric option that allows accurate fitting of the models without
prior selection of the optimal distribution models to best fit the data (Choi et al., 2008b)
and (iii), the implementation of an adaptive method in which a new discriminant function
is learned from the data, instead of using fixed weighting coefficients (Ding et al., 2008).
To improve the discrimination between correct and incorrect PSMs, the calculation of the
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Figure 3.11: Global false discovery rate (FDR) estimation by calculating posterior probabilities P for
each peptide spectrum match. A discriminant score S (calculated from the search tool scores) is
plotted and two distributions (dashed lines) are fitted to the observed data. Posterior probabilities
are computed using this data along with auxiliary information (e.g. mass accuracy). A global FDR
can then be derived from these probabilities. The desired FDR can be achieved by moving the
threshold probability PT up or down. The use of a decoy database is optional with this approach.
posterior probabilities not only takes into account the search tools score(s) (recalculated
into a discriminant score S), but also auxiliary information like the number of missed
cleavages (NMC), the number of tryptic termini (NTT) and the mass accuracy (∆M; the
difference between the measured and calculated mass of the peptide in the first MS step)
(Nesvizhskii, 2010).
Much research has gone into the identification of correct PSMs and the estimation of
a FDR at that level, but ultimately, the main purpose of most proteomic analyses is
the identification of proteins. This final step of the data analysis basically involves the
assembly of the identified peptides into (a list of) proteins. As was the case at the PSM
level, a FDR is also estimated at the proteins level. Here, however, a common observation
is that correct PSMs tend to identify a relatively small group of (abundant) proteins,
while each incorrect PSM tends to (randomly) match a new (incorrect) protein. This
results in a higher FDR at the protein level, even when the PSM FDR was low. To further
complicate matters, the same peptide sequence can be present in multiple proteins (e.g.
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isoforms, homologous proteins, redundant entries in the database). This is often referred
to as the “protein inference problem”. These shared (degenerate) peptides can lead to
ambiguities in identifying sample proteins (Nesvizhskii and Aebersold, 2005; Li et al., 2009).
Different approaches have been described to estimate the FDR at the protein level. The
target+decoy strategy (popular for FDR estimations at the PSM level), can be extended
to the protein level. In its simplest form, this is done by estimating the number of incorrect
protein identifications by counting the decoy proteins. Considering that a decoy protein
is by definition wrong, but a target protein is considered correct if identified by at least
one true positive PSM (regardless of the number of decoy PSM that match as well), the
Ndecoy/Ntarget estimation tends to be overly pessimistic as the number of decoy proteins is
often higher than the number of incorrect target proteins. A tool called MAYU (Reiter
et al., 2009) also uses the target+decoy approach but combines it with a hypergeometric
distribution to estimate more reliable FDRs, even for very large (multi-replicate) datasets.
Although an improvement, MAYU still requires preprocessing of the data to solve the
protein inference problem.
ProteinProphet (Nesvizhskii et al., 2003) builds on the posterior probabilities that were
calculated for PSMs by PeptideProphet (Keller et al., 2002) and uses them to calculate
protein posterior probabilities which, in turn, can be used to filter the data to a desired
FDR. Although there are a number of ways to assign a probability to a protein (e.g. take
the highest PSM probability or assign probability 1 if the protein is identified by at least
two good peptides), the method implemented in ProteinProphet uses a cumulative score
(Feng et al., 2007; Li et al., 2009). Equation (3.1) illustrates the calculation of the protein
posterior probability based on the PSM posterior probabilities of the peptides that are
associated with that protein.
Where p
′
is the NSP modified PSM posterior probability:
protein posterior probability = 1−
∏
i
(1− p′i) (3.1)
In Equation (3.1), p
′
is a modification of the original PSM posterior probability, since
using the original probabilities would overestimate the probability for a number of proteins,
notably those proteins identified by only one (incorrect) peptide. To deal with this problem,
ProteinProphet will re-evaluate the PSM posterior probabilities based on the number of
sibling peptides (NSP). Practically, for proteins that are recognised by multiple different
peptides, this will lead to an increase in the PSM posterior probabilities, while for proteins
that are only recognised by a single peptide, this will result in a decrease of the peptide
posterior probability. Logically, NSP correction of the PSM posterior probability will
penalise all proteins that are identified by a single peptide. However, since this would
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be overly negative for correct single peptide identifications [which can be 20-60% of all
correctly identified proteins (Higdon and Kolker, 2007; Nesvizhskii, 2010)], ProteinProphet
will also take into account the quality of the peptide i.e. if the PSM posterior probability is
very high, the penalisation will be less severe. This goes somewhat against the established
“two peptide rule”, but recent research showed that one very good peptide is often better
than two or more not-so-good ones (Gupta and Pevzner, 2009). Once the protein posterior
probabilities have been calculated, the FDR is estimated much like it was at the peptide
level, as shown by Equation (3.2), and as was also the case with the PeptideProphet, FDRs
can be estimated without the use of decoy databases.
Where Px is the protein posterior probability above a certain probability threshold PT :
protein FDR =
∑
x|Px≥PT
(1− Px)∑
x|Px≥PT
1
(3.2)
A final issue to address is the protein inference problem. The drastic decision to omit all
shared peptides and only accept non-shared peptides would be much too conservative.
ProteinProphet employs a number of algorithms that look at the proteins that have a
particular degenerate peptide in common and, based on additional evidence like the number
of non-degenerate peptides that match to a protein, a weight (0 to 1) is given to that
peptide (Figure 3.12).
These assigned weights, combined with the NSP information and empirically determined
minimum thresholds for weight and PSM posterior probability (0.5 and 0.2, respectively)
are then taken into account when calculating the protein posterior probability (Nesvizhskii
et al., 2003).
Protein A
Protein B
Peptide 1 Peptide 2 Peptide 3
1 a. Prob Protein A = 1
Peptide 1 → w = 1
Peptide 2 → w = 1
Peptide 3 → w = 1
1 b. Prob Protein B = 0
Peptide 2 → w = 0
Peptide 3 → w = 0
Figure 3.12: Illustration of shared peptides – the protein inference problem. Proteins A and B
share peptides 2 and 3, but only Protein A contains Peptide 1. Peptides 1, 2 and 3 combine to
support the presence of Protein A, as is reflected by the weight assigned to these peptides (w
= 1). Similarly, the lack of conclusive evidence for Protein B is reflected in the weight (w = 0)
assigned to Peptides 2 and 3.
All this combined, results in the smallest possible list of protein groups and subgroups that
can account for all the observed peptides. This is the parsimony principle, also referred to
as Occam’s (or Ockham’s) razor (Ockham, 1495; Nesvizhskii and Aebersold, 2005). This
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complete list can then be shortened by setting a probability threshold that corresponds to
the desired FDR.
X!Tandem, PeptideProphet and ProteinProphet are combined (along with a number of
other tools) in the Trans-Proteomic Pipeline (TPP) (Keller et al., 2005; Deutsch et al.,
2010). Although the TPP is convenient and widely used, a number of research groups have
developed tools and pipelines that are equally good or better at various aspects of the
data analysis e.g. MS-GFDB (Kim et al., 2010), MAYU (Reiter et al., 2009), SearchGUI
(Vaudel et al., 2011a), PeptideShaker (https://code.google.com/p/peptide-shaker/)
(Barsnes et al., 2011) and a feedback framework that outputs a list of proteins and a list
of corresponding peptides at the same time by iteratively updating the two lists with
a feedback from the inferred proteins to the selection of correct peptides (Shi and Wu, 2012).
Since computational power is vital to the efficient processing of (very) large datasets and
many desktop computers simply can no longer process data as fast as it is produced,
advancements in the field of scientific workflow design and cloud computing have also
made their entry into the field of proteomics. Contrary to pipelines, which allow for
sequential processing of one dataset at a time, these advanced workflows, combined with
cloud computing, allow for parallel processing, making the data analysis much faster and
(if desired) fully automated (Oinn et al., 2004; de Bruin et al., 2012; Mohammed et al.,
2012).
3.3 Helminth proteomics
In comparison to human and, to a lesser extent, Escherichia and Saccharomyces, (large
scale) proteomic studies on helminths (and especially cestodes) have not received much
attention (Figure 3.13a). A comparison of the number of reviewed proteins per genus
reveals similar results, only here, Escherichia proteins are very well represented, mainly due
to the large number of different strains (Figure 3.13b). These two figures help illustrate
how research in the field of proteomics is currently dominated by a small number of
organisms.
A major bottleneck for proteomic experiments involving helminths (and cestodes like
Taenia in particular) has been the incompleteness of protein databases due to the lack of
genomic information and comprehensive expressed sequence tag (EST) libraries.
In 2006, researchers at the Universidad Nacional Autonoma de Mexico started “The genome
project of Taenia solium” (Aguilar-Dı´az et al., 2006) and although there was mention of
an advanced draft status in 2012 (Olson et al., 2012), the genome was not presented until
April 2013, when the high quality reference genome of Echinococcus multilocularis was
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Taenia (3)
Caenorhabditis (14)
Saccharomyces (36)
Echinococcus (5)
Escherichia (66)
Trichinella (5)
Human (965)
Schistosoma (20)
(a) Illustration of the limited amount of proteomic studies done on helminths compared to hu-
man, Escherichia and Saccharomyces. Results obtained with a search on PubMed (http:
//www.ncbi.nlm.nih.gov/pubmed) on December 7, 2013 using the query ’(proteomic[Title])
AND (genus[Title])’. The number of hits for each query is shown within parentheses.
Taenia [6202] (14)
Caenorhabditis [6237] (4039)
Schistosoma [6181] (143)
Saccharomyces [4930] (7865)
Echinococcus [6209] (39)
Escherichia [561] (23668)
Trichinella [6333] (6)
Homo [9605] (20274)
(b) Illustration of the number of reviewed proteins per genus. Results obtained with a search on
UniProtKB (http://www.uniprot.org) on December 17, 2013 using the query ’taxonomy:”genus
[taxonomy code]”’. The number of reviewed proteins (UniProtKB/Swiss-Prot) for each query is
shown within parentheses, while the taxonomy code is shown within square brackets.
Figure 3.13: Two illustrations of the underrepresentation of proteomic studies on helminths (a) and
the number of reviewed helminth proteins (b) compared to some of the “big players” in the field
e.g. Homo sapiens, Escherichia and Saccharomyces.
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presented, along with the E. granulosus, T. solium and Hymenolepis microstoma genomes
for comparison (Tsai et al., 2013). Until then, Cestoda (tapeworms) were the only class for
which no genome sequence had been available so far. Trematoda (flukes) and Nematoda
(round worms) all had members of their respective class sequenced (Berriman et al., 2009;
Young et al., 2012; C. elegans Sequencing Consortium, 1998).
Cestode proteomics is currently in its infancy and hopefully, the field will quickly see a
major boost now that cestode genomics have made such promising progress.
In the case of T. solium, most studies have focussed on characterising one (or very few)
protein(s), mostly due to their importance as vaccine candidates or diagnostic antigens
in antibody detecting assays (Deckers and Dorny, 2010) e.g. diagnostic antigen GP50
(Hancock et al., 2004), T24 (Hancock et al., 2006) and the 8 kDa protein family (Hancock
et al., 2003; Ferrer et al., 2007), which are the three protein groups that represent the
seven diagnostic bands in the EITB (Tsang et al., 1989). In recent years, advancements in
technologies and data analysis have facilitated the study of larger groups of proteins e.g. in
relationship to immunological significance (Salazar-Anton and Lindh, 2011; Diaz-Masmela
et al., 2013) or related to a specific parasite stage like activated T. solium oncospheres
(Santivan˜ez et al., 2010) or T. solium metacestode excretion/secretion proteins [Chapters 6
and 7 and Victor et al. (2012b, 2013)]. Echinococcus, the other genus in the Taeniidae
family, has received a bit more attention, especially E. granulosus (Monteiro et al., 2010;
Aziz et al., 2011; Virginio et al., 2012; Parkinson et al., 2012). Furthermore, a number
of papers that present an overview of Echinococcus related molecular cross talk and
host-parasite interactions have been published (Siracusano et al., 2008a,b; Brehm, 2010;
Siracusano et al., 2012). Since the Taenia and Echinococcus genera are so closely related,
it is reasonable to assume that a (large) number of proteins will be homologous in sequence
and function [e.g. Gonza´lez et al. (2007)] and that much of the molecular cross talk
described for Echinococcus will also be applicable to Taenia. This concept of homology is
even likely to be expandable to other studied helminths like Schistosoma (Mutapi, 2012;
Hong et al., 2011; Liu et al., 2009, 2007, 2006).
Incomplete protein databases can never offer full proteome coverage, which limits the
number of identifiable proteins. In the absence of a (reference) genome, this limitation
can be (partially) circumvented by relying on the sequence homology between related
species and genera and by using ESTs (Nagaraj et al., 2007; Parkinson and Blaxter, 2009).
ESTs have the advantage of already being closer to proteins than genomic DNA, but
their generation was not overly efficient and fast. Fortunately, the same “next generation
sequencing” technologies that have replaced Sanger sequencing (Sanger et al., 1977) in
whole genome analyses, have also made it possible to sequence cDNA libraries in a high
throughput manner [RNA-Seq (Nagalakshmi et al., 2008)]. This technology was rapidly
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embraced by the proteomics field and new tools to generate customised protein databases
from RNA-Seq data are being developed e.g. customProDB (Wang and Zhang, 2013),
enabling an increased proteome coverage for non-sequenced organisms without the cost
and difficulties of sequencing and analysing a whole genome.
A number of websites and repositories have attempted to group relevant information about
the current state of helminth genome, transcriptome and proteome publications2:
• 959 Nematode Genomes:
http://www.nematodes.org/nematodegenomes/index.php/Main_Page
• Wellcome Trust Sanger Institute – Helminth genomes:
http://www.sanger.ac.uk/resources/downloads/helminths/
• HelmDB – An integrative database of curated transcriptomes of key nematodes and
trematodes for functional annotation-improvement:
http://www.helmdb.org
• HelmCoP – An Online Resource for Helminth Functional Genomics and Drug and
Vaccine Targets Prioritisation:
http://www.nematode.net/helmcop.html
• Helminth Secretome database:
http://www.biolinfo.org/hsd/
• The National Centre for Biotechnology Information (NCBI):
http://www.ncbi.nlm.nih.gov/
While proteomic analyses with state-of-the-art mass spectrometers and software can be a
very powerful tool in biological research, the above section illustrates that their use is not
so straightforward when it comes to studying one of the many organisms whose genomes
have not yet been sequenced. There are significant difficulties and most of them are not
easily bypassed and will likely involve a number of compromises.
It is important to realise that proteomic studies often fail to identify every single protein
in a sample, even when it is a sequenced organism. This will unfortunately be even more
the case when one of the main requisites, a complete protein library, is not even available.
2This list is not a complete overview of all helminth data repositories. All website links are functional
in January 2014.
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Rationale and Objectives
The previous chapters have highlighted the shortcomings of many of the diagnostic tools
currently used for the diagnosis of T. solium as well as the difficulties related to the
study and characterisation of proteins that are produced by a non-sequenced organism.
Specifically related to the detection of T. solium porcine cysticercosis, studying the proteins
that are excreted and secreted by the metacestode larval stages (cysticerci) is nonetheless
a vital step in the direction of a more specific assay, one that does not cross react with
other Taenia spp. that may co-exist in the pig.
Studying protein samples like excretion/secretion proteins can be performed with the
tools discussed in Chapter 3. However, the biggest bottleneck is the fact that the Taenia
protein databases are incomplete due to a lack of genomic information. This, in turn, may
have an effect on the number of identified proteins and the false discovery rate, the metric
that estimates the number of incorrect identifications.
The main objective of this thesis is to analyse T. solium excretion/secretion
proteins with the aim of identifying species-specific diagnostic antigens.
To achieve this, the main objective was divided into three sub-objectives:
1. To investigate whether false discovery rate estimations (a quality metric which
estimates the number of incorrect identifications) are also applicable in the case of
partially sequenced organisms, like T. solium, where many high-quality spectra fail
to identify the correct peptides, simply because these peptides are not present in the
searched protein database (Chapter 5).
2. To use protein sequences from other (closely related) helminths and expressed
sequence tags to increase the proteome coverage of the incomplete protein database
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and identify T. solium excretion/secretion proteins (Chapters 6 and 7).
3. To identify T. solium-specific peptides/proteins by exploring different options to
compare the T. solium excretion/secretion proteome with proteomes of other Taenia
spp. (Chapter 8).
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Partially Sequenced Organisms, Decoy Searches and False
Discovery Rates
Abstract: Tandem mass spectrometry is commonly used to identify peptides,
typically by comparing the experimental spectra with those predicted from
a protein sequence database and scoring these matches. The most reported
quality metric for a set of peptide identifications is the false discovery rate
(FDR), the fraction of expected false identifications in the set. This metric has
so far only been used for completely sequenced organisms or known protein
mixtures. It is worthwhile to investigate whether FDR estimations are also
applicable in the case of partially sequenced organisms, where many high-
quality spectra fail to identify the correct peptides because the latter are
not present in the searched sequence database. Using real data from human
plasma and simulated partial sequence databases derived from two complete
human sequence databases with different levels of redundancy, the mixture
model-based approach in PeptideProphet was found to be robust for partial
databases, particularly if used in combination with decoy sequences, regardless
of how these decoy sequences were created (reversed, scrambled or randomised).
It is therefore recommended to use this method when estimating the FDR
from incompletely sequenced organisms.
Adapted from:
Victor, B., Gabrie¨l, S., Kanobana, K., Mostovenko, E., Polman, K., Dorny, P., Deelder, A.
M., and Palmblad, M. Partially Sequenced Organisms, Decoy Searches and False Discovery
Rates. Journal of Proteome Research 11, 3 (2012), 1991–1995.
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5.1 Introduction
While most published work in proteomics has been on humans and extensively sequenced
model organisms, only limited sequence information is available for the remainder of the
millions of extant biological species. Researchers studying one of the non- or partially
sequenced organisms are faced with a number of difficulties, including the use of incomplete
protein databases and robustly estimating global false discovery rates.
The problem of the incomplete databases can be addressed to some degree by adding protein
sequences from other species of the same genus which are likely to be highly homologous
e.g. one can study Taenia saginata (166 entries in NCBInr) and supplement the sequences
from this species with the 401 entries for Taenia solium and the 119 entries for Taenia
hydatigena. Given the known homology between proteins [like the TEG-Tsag protein and
EG10 (Gonza´lez et al., 2007)], one could even opt to add the 1,498 Echinococcus granulosus
protein sequences. This inevitably creates a degree of redundancy in the database, but
increases the chances of finding an exact match to a peptide in one of the homologous
sequences searched. Similar approaches can be taken when studying many other organisms.
Global false discovery rates (FDRs), in the field of proteomics, can be defined as the
expected number of incorrect peptide spectrum matches (PSMs) amongst all PSMs that
pass a certain search score threshold (Choi and Nesvizhskii, 2008a; Ka¨ll et al., 2008). The
number of incorrect PSMs against the original, target database can be estimated by using
a target-decoy strategy where a decoy database is searched separately or simultaneously
as a composite target+decoy database. The number of decoy PSMs above the threshold
score can be used as a measure of the number of incorrect target PSMs. The most
simple FDR estimation can thus be defined as Ndecoy/Ntarget where Ndecoy and Ntarget
are the number of hits above the search score threshold in the decoy database and the
target database, respectively. Depending on the way the search is performed (separate
or as a composite database) and the way the decoy database is constructed (reversed,
scrambled or randomised) the use of a correction factor (Ka¨ll et al., 2008), an alternative
formula (Elias and Gygi, 2007; Navarro and Va´zquez, 2009; Wang et al., 2009a), an
optimal decoy construction and search strategy (Bianco et al., 2009) and a form of FDR
quality control (Vaudel et al., 2011b) have been suggested. A different way to estimate
the FDR is a mixture model-based approach that calculates posterior probabilities for
each PSM and uses those probabilities to derive global FDR estimates. This approach is
implemented in the PeptideProphet (Keller et al., 2002) and was later updated with the
optional use of a decoy database to assist the expectation-maximisation (EM) algorithm
in establishing a more reliable distribution of incorrect PSMs (Choi and Nesvizhskii, 2008b).
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Nearly all published work on FDR estimations has been done using complete protein
databases from fully sequenced organisms, or known well-defined protein mixtures. When
working with incomplete databases (from partially sequenced organisms), FDR estima-
tion may be more challenging. It is reasonable to assume that a significant number
of high-quality spectra coming from the studied organism will not find a match in the
target database, simply because the protein is not in that database. A fraction of these
high-quality spectra will instead match a decoy sequence (or another peptide in the target
database). It is not a trivial assumption that this larger fraction of falsely matched high
quality spectra will not have any influence on FDR estimations, whether counting decoy
hits or using a mixture model method.
In this study, the PeptideProphet FDR estimation using incomplete databases with or
without the use of different decoy database designs was investigated.
5.2 Materials and methods
5.2.1 Databases
Two target databases with varying redundancy were used in this study, both down-
loaded from UniProt (http://www.uniprot.org/) on July 20th 2011 using “Homo sapi-
ens reviewed:yes” as query. The first database contained 25,800 canonical Swiss-Prot
protein sequences. The second database contained 41,551 canonical and isoform Swiss-
Prot protein sequences. To model the effect of incomplete target databases, partial
databases approximately covering 1 to 99% of both databases were constructed by scan-
ning the full database and including each sequence with a probability ranging between
0.01 and 0.99. Reversed decoy databases were constructed using the decoyfasta script
included with the Trans-Proteomic Pipeline (TPP) version 4.4 rev 1 (Keller et al., 2005).
Scrambled decoy databases were created with Perl scripts and the randomised decoy
databases were constructed using the make random Markov chain sequence generator
(http://www.ms-utils.org/make_random.html) based on transitional probabilities from
both target databases. Each partial target database was searched (i) as a composite
database with an equally sized reversed (n = 1), scrambled (n = 10) and randomised
decoy database (n = 10) and (ii) without the use of any decoy databases.
5.2.2 Sample preparation
As a representative complex proteomics sample with a few abundant and many less
abundant proteins, a human plasma sample was prepared. Human plasma from a healthy
individual was separated on a 4-12% NuPAGE Novex Bis-Tris gel (Invitrogen, Carlsbad,
CA) and stained overnight with the Colloidal Blue Staining Kit (Invitrogen). The gel
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lane was cut in 47 identical slices using a custom designed gel cutter (Gel Company Inc.,
San Francisco, CA) and all slices were transferred to a 96-well plate (Greiner Bio-One,
Frickenhausen, Germany; one slice/well). Gel slices were washed three times: first with
100 µL 25 mM ammonium bicarbonate (ABC; Sigma-Aldrich Corp.), then with 100 µL
30% acetonitrile (Biosolve, Valkenswaard, The Netherlands) in ABC and finally with 100
µL 100% acetonitrile. Cystines were reduced in 75 µL 10 mM DTT in ABC for 30 minutes
at 56℃ and cysteines were alkylated in 75 µL 50 mM iodoacetamide (Sigma-Aldrich Corp.)
in ABC for 20 minutes (in the dark) at ambient temperature. Gel slices were washed as
above and proteins were digested with sequencing grade porcine trypsin (5 ng/µL 25 mM
ABC; Promega, Southampton, UK; 30 µL/well) at 37℃ for 6h. Supernatant from every
two wells was combined and transferred to a new plate (first well was left single, resulting
in 24 fractions). Digestions were quenched with the addition of 4 µL 5% trifluoroacetic
acid (TFA). Gel slices were incubated for another hour at 37℃ in 0.1% TFA and the
second supernatant was added to the first. The plate was stored at −20℃ pending further
analysis.
5.2.3 Liquid chromatography – tandem mass spectrometry
All fractions were analysed by LC-MS/MS using a splitless NanoLC-Ultra 2D plus (Eksigent,
Dublin, CA) for parallel ultra-high pressure liquid chromatography (UHPLC) with an
additional loading pump for fast sample loading and desalting. The UHPLC system was
configured with 300 µm-i.d. 5-mm PepMap C18 trap columns (Dionex, Sunnyvale, CA),
15-cm 300 µm-i.d. ChromXP C18 columns supplied by Eksigent and running 45 min.
linear gradients from 4 to 33% acetonitrile in 0.05% formic acid. The UHPLC system
was coupled on-line to an amaZon ETD high-capacity 3D ion trap (Bruker Daltonics,
Bremen, Germany). After each MS scan, up to 10 abundant multiply charged species in
m/z 300-1,300 were automatically selected for MS/MS but excluded for one minute after
being selected twice. The modes of resolution were “Enhanced mode” and “UltraScan”
for MS and MS/MS, respectively. The UHPLC system was controlled using the HyStar
3.4 (Bruker) with a plug-in from Eksigent and the amaZon ion trap by trapControl 7.0
(Bruker). DataAnalysis (Bruker) converted 1,000 MS/MS spectra with the highest signal
intensity from each of the 24 raw files to MGF format. The resulting MGF files were
merged and converted to mzXML with msconvert.
5.2.4 Analysis pipeline
The human plasma dataset was searched against the different databases with X!Tandem
(2009.10.01.1) (Craig and Beavis, 2004) using the following parameters: precursor mass
tolerance window was set between −2.0 and 4.0 Da, while fragment tolerance was set
to 0.4 Da, modifications were set for carbamidomethylation of cysteine and oxidation of
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methionine, k-scoring was enabled, maximum missed cleavages was set to two and scoring
was done for b and y ions. The X!Tandem output files were translated to the pepXML file
format with the tandem2xml converter. Posterior probabilities and FDRs were estimated
using PeptideProphet with all parameters at their default values except the -d decoy option
was used when including decoys to provide an initial discriminant score distribution for
the false matches. These tools are included in version 4.4 rev 1 of the Trans-Proteomic
Pipeline.
5.3 Results and discussion
5.3.1 Dataset
After searching the plasma dataset against the Swiss-Prot database containing only
canonical sequences with X!Tandem, PeptideProphet estimated a total of 2,525 correct
peptide assignments amongst 367 spectra from a singly charged precursor; 12,557 spectra
from a doubly charged precursor; 12,618 spectra from a triply charged precursor and 1,066
spectra from a quadruply charged precursor. At FDR = 1%, PeptideProphet predicts
1,752 correct PSMs resulting in 1,703 unique peptides. This dataset represents a complex
sample with a number of abundant proteins, that are also redundantly represented in the
database.
5.3.2 PeptideProphet false discovery rate estimations for com-
posite databases
Figure 5.1 shows the deviations in estimated FDRs (∆FDR) calculated relative to the
(median) FDR estimation of the full database. The ∆FDR is plotted for composite databases
consisting of target databases (1-100% of the total size) without redundancy (Figures 5.1a
to 5.1c) or with (limited) redundancy (Figures 5.1d to 5.1f) and an equally sized decoy
database (reversed, scrambled or randomised) and at three different probability thresholds
(p > 0.90, p > 0.95 and p > 0.99, respectively). An alternative presentation of the data is
available in the supporting information (Figure A.1).
From the data, it is clear that mixture model-based FDR estimations for partial databases
are stable, reproducible and very similar to the FDR of the full database, irrespective of the
manner in which the decoy database was constructed, until the databases become so small
that the mixture models can no longer be correctly fitted to the observed distributions.
Appending the initial (partial) target database with protein sequences from closely related
species to increase the proteome coverage and, consequently, the number of correct PSMs
has no negative effect on the fitting of the mixture models or the subsequent estimation of
posterior probabilities and FDRs.
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Figure 5.1: Deviations in estimated false discovery rates (∆FDR) calculated relative to the (median)
FDR estimation of the full database at three different probability thresholds. The composite
databases consisted of a target database with only canonical sequences (a-c) or canonical sequences
and isoforms (d-f) and an equally sized reversed (n = 1), scrambled (n = 10) or randomised (n =
10) decoy database. The boxes in figures b, c, e and f show the median, the 25th and the 75th
percentile, while the error bars show the minimum and maximum values. Values within parentheses
are the FDR estimations (a and d) or the median FDR estimations (b, c, e and f) for the complete
databases.
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Figure 5.2: Deviations in estimated false discovery rates (∆FDR) calculated relative to the median
FDR estimation of the full database at three different probability thresholds for target databases
with only canonical sequences (a) or canonical sequences and isoforms (b) without any decoy
database. Values within parentheses are the FDR estimations for the complete databases.
5.3.3 PeptideProphet false discovery rate estimations without
decoy databases
The original implementation of PeptideProphet did not use decoy databases and their use is
still optional. We therefore also investigated the use of PeptideProphet mixture modelling
in the context of partially sequenced organisms without the use of decoy databases.
Figure 5.2 shows the deviations in estimated false discovery rates (∆FDR) calculated
relative to the FDR estimation of the full database. The ∆FDR is plotted for target
databases (1-100% of the total size) without redundancy (Figure 5.2a) or with (limited)
redundancy (Figure 5.2b) and at three different probability thresholds (p > 0.90, p > 0.95
and p > 0.99, respectively). An alternative presentation of the data is available in the
supporting information (Figure A.2).
The results are largely similar to when using a decoy database, which again demonstrates
the robustness of the approach. However, in cases where the dataset is challenging or
when working with very limited partial target databases, it is recommended to use of a
decoy database to assist the EM algorithm in establishing a more reliable fitting of the
mixture models (Choi and Nesvizhskii, 2008b).
5.4 Conclusions
When describing results from a proteomics experiment, an estimate of the FDR is always
recommended and often required by the scientific journal or data repository. If the database
search was done with a complete sequence database (i.e. a database assumed to represent
all proteins that can possibly be found in the sample) and the FDR estimated using
established tools, the estimation is generally accepted without further discussion. In
this short paper, it was demonstrated that mixture model-based FDR estimations using
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incomplete databases from partially sequenced organisms are stable, highly reproducible
and comparable to the estimations based on complete databases.
Based on this, it is recommended to use of PeptideProphet mixture model FDR estimations
in combination with a decoy database strategy when studying organisms whose genome is
not yet (completely) known.
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6CHAPTER 6
Proteomic Analysis of Taenia solium Metacestode
Excretion/Secretion Proteins
Abstract: In order to improve the current diagnostic tools and to get a
better understanding of the interaction between Taenia solium metacestodes
and their host, there is a need for more information about the proteins that
are released (excreted and secreted) by the parasite. However, the lack of a
complete protein database for T. solium is an important limitation in mass
spectrometry-based proteomics experiments. To increase the proteome coverage
of the T. solium database, protein sequences from other (closely related)
helminths were added. This composite database, along with one-dimensional
polyacrylamide gel electrophoresis, reversed-phase liquid chromatography and
tandem mass spectrometry were utilised to analyse the excretion/secretion
proteins produced by cysticerci from infected pigs. A total of 76 proteins
including 27 already described T. solium proteins, 17 host proteins and 32
proteins likely to be of T. solium origin, but identified using sequences from
other helminths were identified. This is the first report of the T. solium
metacestode excretion/secretion proteome.
Adapted from:
Victor, B., Kanobana, K., Gabrie¨l, S., Polman, K., Deckers, N., Dorny, P., Deelder, A. M.,
and Palmblad, M. Proteomic Analysis of Taenia solium Metacestode Excretion/Secretion
Proteins. Proteomics 12, 11 (2012), 1860–1869.
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6.1 Introduction
Taenia solium metacestodes (and many other helminths/helminth stages) are able to
establish and maintain an infection in the host, while being attacked by the host immune
system. Helminths have therefore developed diverse mechanisms to protect themselves
in this hostile environment. These mechanisms often depend on the production of excre-
tion/secretion proteins (ESPs) (Hewitson et al., 2009). Parasite defence mechanisms and
ESPs have been studied and described for other helminths of public health importance
such as Echinococcus (Siracusano et al., 2008b; Monteiro et al., 2010) and Schistosoma
(Guillou et al., 2007; Liu et al., 2009), but the excretion/secretion proteome of T. solium
has not been well characterised so far. A recent proteomic study investigated T. solium
oncospheres, as this is the stage that determines the success or failure of the infection
(Santivan˜ez et al., 2010). From a diagnostic point of view, ESPs are of specific interest.
Furthermore, given the importance of the ESPs for the survival of the parasite, they might
also be good vaccine candidates or anthelmintic drug targets.
In the case of T. solium, a few specific ESPs [e.g. diagnostic antigen GP50 (Hancock
et al., 2004)] have been extensively studied and successfully used in antibody detecting
enzyme-linked immunoelectrotransfer blots (EITB) and ELISAs. The drawback is that
antibody detection does not allow the differentiation between an active infection and a
past infection or contact with oncospheres (Garc´ıa et al., 2001). Other methods, such as
monoclonal antibody-based antigen detection ELISAs demonstrate the presence of viable
T. solium metacestodes by detecting circulating ESPs in the blood, cerebrospinal fluid and
urine (Deckers and Dorny, 2010), but current tests for porcine cysticercosis are not able
to differentiate between different Taenia spp. A more thorough knowledge of T. solium
ESPs would be an important step in improving current diagnostic techniques.
At the time of publication, a complete proteomic analysis of many parasite ESPs was
still hampered by incomplete protein databases due to the lack of genomic information.
Although a T. solium genome project had been initiated in 2006 (Aguilar-Dı´az et al.,
2006), no data were yet in the public domain. To get around this limitation, our approach
relied on homology to other helminth species and supplemented the T. solium database
with protein sequences from other helminths. Furthermore, our study took full advantage
of the recent advancements in reversed-phase liquid chromatography and tandem mass
spectrometry (LC-MS/MS) that have enabled high throughput analysis of large sample
numbers.
This study presented the first proteomic analysis of the T. solium metacestode ESPs using
one-dimensional polyacrylamide gel electrophoresis (1D-PAGE) and LC-MS/MS.
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6.2 Materials and methods
6.2.1 Parasite material and excretion/secretion proteins
Taenia solium metacestodes were obtained from naturally infected pigs in Zambia and
Peru. In each country, five pigs were selected based on positive tongue palpation. The
animals were humanely euthanised and at least 200 cysts were dissected from the muscle
tissues of each pig. Cysts were washed three times in sterile phosphate-buffered saline
(PBS), two times in sterile PBS containing penicillin (100 units/mL), streptomycin (100
µg/mL) and amphotericin B (0.25 µg/mL) (Invitrogen, Carlsbad, CA) and incubated in
culture dishes (BD, Franklin Lakes, NJ) at a concentration of 50 cysts/20 mL of culture
medium (RPMI-1640 with L-glutamine and 25 mM HEPES (Invitrogen) supplemented
with penicillin (100 units/mL), streptomycin (100 µg/mL) and amphotericin B (0.25
µg/mL)) for 6h at 37℃ in an atmosphere of 5% CO2. Because it was likely to contain
high amounts of host proteins, the culture medium was discarded after 6h, replaced with
fresh medium and incubated for another 18h. Culture media from 200 cysts and from
the same animal were pooled, centrifuged for 15 minutes at 3000×g , supplemented with
Complete Protease Inhibitor Cocktail Tablets (Roche, Indianapolis, IN) and stored at
−80℃ pending further processing (ESP 24h). After removal of the 24h culture medium,
cysts were washed three times in culture medium and incubated for another 24h at 50
cysts/20 mL. The collection of the 48h fraction was done as described above (ESP 48h).
Each fraction (per pig, country and time point) was concentrated to a final volume of
2 mL with an Amicon Stirr Cell (Millipore, Billerica, MA) using a 1 kDa ultrafiltration
membrane (Millipore) and Macrosep 1K UF Spin Filters (Pall, Port Washington, NY).
Concentrated fractions were aliquoted (100 µL) and stored at −20℃. Cyst viability was
assessed by incubating 20 cysts/pig in 10% porcine bile in culture medium and subsequent
evaluation of cyst evagination.
6.2.2 One-dimensional polyacrylamide gel electrophoresis
Aliquots were precipitated and washed in ice-cold acetone and resuspended in half the
original volume with 10 mM DTT (Sigma-Aldrich Corp., St. Louis, MO) and 3% sodium
dodecyl sulfate (SDS). When fully resuspended, samples were mixed with NuPAGE LDS
Sample Buffer (4x) and separated on a 4-12% NuPAGE Novex Bis-Tris gel (Invitrogen).
Gels were stained overnight with the Colloidal Blue Staining Kit (Invitrogen).
6.2.3 In-gel trypsin digest
Each gel lane was cut in 48 identical slices using a custom designed gel cutter (Gel Company
Inc., San Francisco, CA) and all slices were transferred to a 96-well plate (Greiner Bio-One,
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Frickenhausen, Germany; one slice/well). Gel slices were washed three times: first with
100 µL 25 mM ammonium bicarbonate (ABC; Sigma-Aldrich Corp.), then with 100 µL
50% acetonitrile (Biosolve, Valkenswaard, The Netherlands) in ABC and finally with 100
µL 100% acetonitrile. Cystines were reduced by adding 75 µL 10 mM DTT in ABC for 30
minutes at 56℃. Gel slices were shrunk with 100 µL of 100% acetonitrile and cysteines
were alkylated with the addition of 75 µL 50 mM iodoacetamide (Sigma-Aldrich Corp.)
in ABC for 20 minutes (in the dark) at ambient temperature. Gel slices were washed
and shrunk again with the addition of 100 µL 25 mM ABC followed by 100 µL 100%
acetonitrile. Proteins were digested with sequencing grade porcine trypsin (0.125 µg in 25
µL 25 mM ABC; Promega, Southampton, UK; 25 µL/well) at 37℃ for 6h. From each well,
20 µL of supernatant was extracted and 15 µL of Milli-Q water (Millipore) was added
for another incubation of 30 minutes at 37℃. A second supernatant sample of 15 µL was
extracted and the two supernatants were pooled. TFA (Sigma-Aldrich Corp.) was added
to a final concentration of 1% to each well to quench the reaction. The total volume per
well was reduced to around 15 µL with a vacuum centrifuge and plates were stored at
−20℃ pending further analysis.
6.2.4 Liquid chromatography – tandem mass spectrometry
Peptides were analysed on an amaZon ETD ion trap mass spectrometer (Bruker Daltonics,
Bremen, Germany) equipped with an Apollo II ESI source and coupled on-line with a
NanoLC-Ultra 2D plus LC (Eksigent, Dublin, CA, USA). A total volume of 10 µL was first
desalted on a C18 PepMap300 trap column (5 µm, 300 µm × 5 mm; Dionex, Sunnyvale,
CA) and then separated on a 15 cm C18 ChromXP analytical column (3 µm, 150 × 0.3
mm; Eksigent) by a 45-minute linear gradient from 4% to 35% acetonitrile, 0.05% formic
acid (Sigma-Aldrich Corp.) with a flow rate of 4 µL/minute. Mass spectra were acquired
in m/z 300-1,300 with the ion charge control (ICC) set to 200,000 and the maximum
accumulation time set to 200 ms. The 10 most abundant precursors were selected for CID
MS/MS in m/z 100-2,000 with the ICC and maximum accumulation time set to 200,000
and 50 ms respectively, but were excluded for 0.5 minutes after having been selected once.
Singly charged ions were excluded for MS/MS. The LC system was controlled by HyStar
3.2 and the ion trap by trapControl 7.0.
6.2.5 Data analysis
Raw LC-MS/MS data were converted to line spectra mzXML files1 with the Bruker
compassXport tool version 3.0.3. All further data processing was done with the Trans-
Proteomic Pipeline (TPP) 4.4 rev 1 (Keller et al., 2005). Database searching was performed
1The datasets supporting the results of this article are available in the PRIDE repository at http:
//www.ebi.ac.uk/pride with accession numbers 19232 – 19267.
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with X!Tandem (2009.10.01.1) (Craig and Beavis, 2004) using the following parameters:
precursor mass tolerance window was set between −2.0 and 4.0 Da, while fragment
tolerance was set to 0.4 Da, modifications were set for carbamidomethylation of cysteine
and oxidation of methionine, k-scoring was enabled, maximum missed cleavages was set to
two and scoring was done for b and y ions. The X!Tandem output files were converted to
the pepXML file format with tandem2xml (no cut-off was set on X!Tandem hyperscore or
E-value). X!Tandem pepXML files from different pigs but corresponding to the same time
point and country were merged into PeptideProphet (Keller et al., 2002) and analysed
with the decoy option enabled (Choi and Nesvizhskii, 2008b). The resulting posterior
probabilities for the peptide spectrum matches (PSMs) were further refined by iProphet
(Shteynberg et al., 2011). Finally, ProteinProphet (Nesvizhskii et al., 2003) was used to
compute a probability that each protein was present in the sample and to estimate a
global false discovery rate (FDR). ProteinProphet output was filtered using the probability
threshold that corresponded to an FDR < 1% and proteins with an individual probability
of zero were discarded. Filtered protein lists were combined and proteins were organised
based on homology using a rough tree (MAFFT; v6.857b) (Katoh and Toh, 2008). Further
classification was based on Gene Ontology biological process and molecular function
information available from the UniProt database (http://www.uniprot.org/). SignalP
3.0 server (Bendtsen et al., 2004b) and SecretomeP 2.0 Server (Bendtsen et al., 2004a)
were used to predict classical (signal peptide triggered) and non-classical protein secretions,
respectively. The number of spectrum IDs calculated by ProteinProphet was used to
estimate the relative protein abundance.
6.2.6 Databases
The target database used in this study was constructed from three separate databases.
The first database (48,245 protein sequences) contained protein sequences from all Taenia
species as well as protein sequences from the more studied Echinococcus and Schis-
tosoma helminths. Trichinella spp. protein sequences were also included because it
is a common parasite in pigs. This database was extracted from the National Cen-
tre for Biotechnology Information non-redundant (NCBInr) database on June 15 2011
with a Perl script that (i) looks up the species identification number for all Taenia,
Echinococcus, Schistosoma and Trichinella species in the names.dmp file (ftp://ftp.
ncbi.nih.gov/pub/taxonomy/taxdump.tar.gz), (ii) finds the matching GenInfo Identi-
fiers in the gi taxid prot.dmp file (ftp://ftp.ncbi.nih.gov/pub/taxonomy/gi_taxid_
prot.dmp.gz) and (iii) extracts the corresponding protein sequences from the NCBInr
database (ftp://ftp.ncbi.nih.gov/blast/db/FASTA/nr.gz). The second database was
a Sus scrofa database downloaded from the UniProt website (http://www.uniprot.org/)
on June 15 2011 that contained 1,388 SwissProt protein sequences. The third database,
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the common Repository of Adventitious Proteins database (112 protein sequences; ftp:
//ftp.thegpm.org/fasta/cRAP/crap.fasta) was included to detect common and/or
accidental contaminations in the protein samples. A decoy database with 49,745 reversed
sequences was created using decoyfasta and target and decoy databases were concatenated
into one final database.
6.3 Results and discussion
6.3.1 Taenia solium metacestodes and in vitro excretion/secre-
tion protein production
On carcass inspection, Zambian pigs were found to be more massively infected than
Peruvian pigs. Cyst viability was 72% and 100% for Peru and Zambia, respectively. After
each incubation step, plates were checked. Dead cysts were observed and removed in the
Peruvian cultures only. The 24h fractions from two Zambian pigs were lost due to a failed
ammonium sulphate precipitation. This method was abandoned and all remaining samples
were concentrated with filters.
6.3.2 One-dimensional polyacrylamide gel electrophoresis
Figure 6.1a shows a protein profile of ESP 24h and ESP 48h obtained from cysts coming
from two Peruvian pigs. ESP fractions from all Peruvian pigs showed almost identical
profiles, irrespective of the incubation time. Figure 6.1b illustrates the variation in protein
profiles which was observed between ESP 24h and ESP 48h fractions obtained from the
Zambian pigs.
The discrepancies between profiles from Zambia and Peru could be attributed to differences
in ESP production, as well as to proteins leaking from dead/damaged metacestodes or
differences in concentration. The aim of the study was to be as complete as possible, not to
draw a direct comparison between fractions or countries. Therefore, the differences are not
interpreted as erroneous or problematic, but are considered beneficial to the completeness
of the study.
6.3.3 Data analysis
X!Tandem pepXML files from five pigs/ESP 24h Peru, five pigs/ESP 48h Peru, five
pigs/ESP 48h Zambia and three pigs/ESP 24h Zambia were merged into PeptideProphet,
refined with iProphet and further analysed with ProteinProphet. The ProteinProphet
output with FDR < 1% is available in Tables 3-6 in the supporting information2). Table 6.1
2http://onlinelibrary.wiley.com/doi/10.1002/pmic.201100496/suppinfo
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(a) Lane 1: protein size marker; lanes 2 and 3:
24h and 48h ESP fractions from pig 4; lanes 4
and 5: 24h and 48h ESP fractions from pig 5.
(b) Lane 1: protein size marker; lane 2: 48h ESP
fraction from pig 1; lane 3: 48h ESP fraction
from pig 2; lanes 4 and 5: 24h and 48h ESP
fractions from pig 5.
Figure 6.1: Two examples of one-dimensional polyacrylamide gel electrophoresis illustrating (a) the
similarities between different excretion/secretion protein (ESP) fractions from cysts obtained from
Peruvian pigs and (b) the differences in protein profiles observed between excretion/secretion
protein fractions obtained from cysts from Zambian pigs.
summarises the probability thresholds used to filter the output, the estimated FDRs and
the estimated number of correct protein groups, as reported by ProteinProphet. The
mixture model in PeptideProphet failed for charge (1+) and (for ESP 24h Zambia) also
for charge (3+).
Table 6.1: The ProteinProphet estimations for the four merged fractions.
Merged Probability Estimated false Estimated number of
fraction threshold discovery rate (%) correct protein groups
ESP 24h Peru 0.90 0.5 82
ESP 48h Peru 0.90 0.4 85
ESP 24h Zambia 0.80 0.8 30
ESP 48h Zambia 0.90 0.5 49
The combined, filtered and organised output resulted in 76 protein groups containing
one or more (homologous) proteins from T. solium and/or other organisms (Table 7 in
the supporting information3). Keratin contaminations were omitted from the list. The
inclusions of multiple homologous proteins in a protein group is a consequence of the
way the database was constructed. However, it does not imply independent evidence for
multiple isoforms of the proteins, although, in the case of the 8 kDa protein family, it is
highly likely that multiple proteins from this family were present in the samples. SignalP
and SecretomeP analyses were done on all proteins. The former reports yes (Y) or no (N)
3http://onlinelibrary.wiley.com/doi/10.1002/pmic.201100496/suppinfo
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for both the neural networks (NN) and hidden Markov models (HMM), while the latter
interprets a NN-score above 0.5 as possible secretion (Y).
6.3.4 Proteins identified in Taenia solium excretion/secretion
proteins
Table 6.2 lists the 76 protein groups that were found in the T. solium ESPs, organised by
Gene Ontology annotations for biological process and molecular function. For simplicity,
the protein groups are represented by one protein.
The objective of this study was not to compare different time points and/or geographical
locations, but to provide a broader coverage and identify ubiquitous components of the ES
proteome. Therefore, time points and geographical locations of the proteins were added to
Table 6.2 for completeness only. The results of SignalP and SecretomeP show a number of
proteins that are negative for both analyses. These proteins are mostly found in Peruvian
ESPs and may be a result of leakage due to cyst damage/death, since dead cysts were
observed in Peruvian cultures.
Gene Ontology group 1 includes proteins with little information on molecular function
or biological processes in the UniProtKB. However, this group includes proteins that are
widely used in immunodiagnostic assays. Group 2 contains proteins related to muscle
(paramyosin), microtubule-based processes (dynein light chain), protein polymerisation
(tubulin) and tegument/cytoskeleton (H17g protein and actin). Group 3 are the stress
response/chaperone proteins and group 4 lists proteins involved in various metabolic
activities e.g. glycolysis (phosphoglycerate kinase, fructose-bisphosphate aldolase, eno-
lase, glucose phosphate isomerase, GADPH) and gluconeogenesis (phosphoenolpyruvate
carboxykinase) as well as biosynthetic processes/protein synthesis (Na+/K+-transporting
ATPase, nucleoside diphosphate kinase, elongation factor 1 alpha). Group 5 entails
signal transduction, group 6 presents protein folding and group 7 contains transport
proteins. Group 8 contains the enzymatic antioxidant system of Taeniidae (cytosolic
Cu/Zn-superoxide dismutase, glutathione S-transferase, 2-cys peroxiredoxin) and proteins
with oxidoreductase activity (ferritin, aldo-keto reductase). Group 9 holds proteolysis
related proteins with serine-type (trypsin-like protein, trypsin), cysteine-type (cathepsin
L-like cysteine proteinase) and threonine-type (proteasome subunit alpha) endopeptidase
activity. Trypsin was introduced during the protein digestion step. Group 10 contains
proteins with cysteine-type (alpha-2-HS-glycoprotein (Fragment), immunogenic protein
Ts11) and serine-type endopeptidase inhibitor activity (alpha-1-antitrypsin, leukocyte
elastase inhibitor, inter-alpha-trypsin inhibitor). Group 11 are binding proteins e.g. fatty
acid (fatty acid binding protein), calcium (annexin, calcium binding protein), actin (actin
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Table 6.2: Proteins (n = 76) identified in Taenia solium metacestode excretion/secretion proteins
organised by Gene Ontology annotations for biological process and molecular function.
Gene Ontology classification Closest organism gi/sp code
Perua) Zambiaa)
SigP/SecPb)
Protein 24h 48h 24h 48h
1) No Gene Ontology information
Hypothetical protein T. solium 21726976 - - - + N/Y
Antigen EM/EG13 Echinococcus spp. multiple + - - - N/N
8 kDa protein family c) T. solium multiple -/+ -/+ + -/+ -/-
Antigen T. solium 29893185 + + - - N/Y
P27 T. solium 333101790 + + - + N/Y
Apolipoprotein AI binding protein E. multilocularis 223640019 - + - - N/Y
Immunogenic protein T. solium multiple + + - - Y/Y
T24 T. solium 37786712 + + + + -/N
Hypothetical protein T. solium 21912540 + + - - N/N
Diagnostic antigen GP50 T. solium multiple + + + + -/-
Small heat-shock protein T. solium 21665905 + + - - N/Y
2) Microtubule-based movement/motor activity/tegument-cytoskeleton
Paramyosin T. solium multiple - - - + N/-
H17g protein T. solium 34368418 + + + - N/Y
Actin multiple generac) multiple -/+ -/+ -/+ -/+ -/-
Dynein light chain multiple genera multiple -/+ + - -/+ N/-
Tubulin multiple genera multiple -/+ -/+ - -/+ -/-
3) Response to stress/chaperone
Heat shock protein 70 multiple genera multiple + + - -/+ N/N
Heat shock protein 90 alpha T. asiatica 124783119 + + - + N/N
Heat shock protein 90 T. asiatica 124783236 + + - + N/Y
4) Metabolism/biosynthetic processes
Phosphoglycerate kinase multiple genera multiple + -/+ - + N/-
Fructose-bisphosphate aldolase multiple genera multiple -/+ + -/+ -/+ N/N
Enolase multiple genera multiple -/+ -/+ -/+ -/+ N/-
Cytosolic malate dehydrogenase T. solium 323361126 + + + + N/N
Glucose phosphate isomerase Echinococcus spp. multiple + -/+ - + N/Y
Glycogen phosphorylase T. spiralis 316972087 - + - - N/N
GAPDHd) T. solium 149364041 + + - + N/Y
Triosephosphate isomerase T. solium 38258647 + + + + N/N
Phosphoenolpyruvate carboxykinase T. solium 283466482 + + + + N/N
Glucosidase multiple genera multiple + + - - Y/-
Adenosylhomocysteinase S. scrofa Q710C4 - + - - N/N
Cell polarity protein S. mansoni 256075333 - + - - N/N
Carbonic anhydrase 3 S. scrofa Q5S1S4 + + - - N/N
Creatine kinase M-type S. scrofa Q5XLD3 + + - - N/N
Na+/K+-transporting ATPase T. solium 74794482 + + - + N/Y
subunit alpha
Nucleoside diphosphate kinase Schistosoma spp. multiple + + - - N/N
Elongation factor 1 alpha T. solium multiple - + - - N/N
5) Signal transduction
GTPase multiple genera multiple -/+ -/+ - - N/Y
ADP-ribosylation factor multiple genera multiple + -/+ - - N/-
Multiple pdz domain protein S. mansoni 256082156 - - - + N/N
CAMP-dependent protein kinase S. japonicum multiple + + - - N/Y
regulatory subunit
14-3-3 protein Echinococcus spp. multiple + + -/+ + N/-
6) Protein folding
Cyclophilin multiple genera multiple + + -/+ + N/N
Calreticulin T. solium 14029538 + - - - Y/N
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Table 6.2: Continued.
Gene Ontology classification Closest organism gi/sp code
Perua) Zambiaa)
SigP/SecPb)
Protein 24h 48h 24h 48h
7) Transport
Glucose transporter TGTP2 T. solium 1480799 + - - - Y/N
Apolipoprotein A-I S. scrofa P18648 + - - - Y/Y
Transthyretin S. scrofa P50390 + - - - Y/Y
Hemopexin S. scrofa P50828 + + - - Y/Y
Serum albumin S. scrofa P08835 + + + + Y/Y
Transferrin S. scrofa multiple + + -/+ -/+ -/-
8) Cell redox homeostasis/detoxification/oxidoreductase activity
Thioredoxin E. granulosus 29337032 + + - + N/N
2-Cys peroxiredoxin T. solium multiple -/+ -/+ + -/+ N/Y
Cytosolic Cu/Zn-superoxide dismutase T. solium 18252397 + + - + N/N
Glutathione S-transferase T. solium multiple + + -/+ -/+ N/-
Ferritin T. saginata 1297064 + + - + N/N
Aldo-keto reductase Schistosoma spp. multiple + + - - N/-
9) Proteolysis/endopeptidase activity
Trypsin-like protein T. solium 311335041 + + + + Y/Y
Cathepsin L-like cysteine proteinase T. solium multiple + + - - Y/Y
Proteasome subunit alpha 2 (T01 family) S. mansoni 256083548 - + - + N/N
Haptoglobin S. scrofa Q8SPS7 + + + - Y/Y
Trypsin S. scrofa P00761 + + + + N/Y
10) Endopeptidase inhibitor activity
Immunogenic protein Ts11 T. solium 7339849 + + - - Y/Y
Alpha-1-antitrypsin S. scrofa P50447 + + - - Y/Y
Leukocyte elastase inhibitor S. scrofa P80229 + - - - N/Y
Inter-alpha-trypsin inhibitor heavy chain S. scrofa P79263 + + - - Y/Y
Alpha-2-HS-glycoprotein (Fragment) S. scrofa P29700 + + - - Y/Y
11) Binding (miscellaneous)
Cytosolic fatty acid binding protein T. solium 82412213 + + + + N/N
Calcium binding protein Schistosoma spp. multiple - + - - N/Y
Annexin T. solium multiple + -/+ -/+ + N/-
Actin-binding protein multiple genera multiple + + - - -/-
Tuftelin interacting protein S. mansoni 256076696 + - - - N/N
Hemoglobin subunit beta S. scrofa P02067 + + - - N/N
Ig lambda chain C region S. scrofa P01846 + + + + N/Y
12) Translation
Ubiquitin multiple genera multiple + + - -/+ N/Y
13) Cell division
Cell division control protein S. mansoni multiple - + - - N/N
14) Defence response to bacterium
Protegrin (and related) S. scrofa multiple - - + - -/-
15) Catalytic activity
Transketolase E. multilocularis 27526313 + + - - N/Y
a) Proteins present in Peru/Zambia in the 24h/48h fraction are described as + while - indicates absence. -/+ indicates
there were multiple entries for this protein with variable presence in the fractions.
b) SignalP and SecretomeP (SigP/SecP) results are described as yes (Y) or no (N). SignalP is Y when both the neural
network and the hidden Markov models agree. (-) is reported when not all individual proteins in that groups have the
same result.
c) For simplicity, the 8 kDa protein family is presented as one protein although it is highly likely that multiple proteins
from this family were present in the samples.
d) GAPDH: glyceraldehyde-3-phosphate dehydrogenase.
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binding protein), DNA (tuftelin interacting protein), oxygen (hemoglobin) and antigen
binding proteins (Ig lambda chain C region). Group 12, 13, 14 and 15 contain proteins
involved in translation, cell division, defence response and catalytic activity, respectively.
6.3.5 Relative protein abundance
Protein abundance showed similar patterns in Peru ESP 24h and 48h: porcine albumin and
phosphoenolpyruvate carboxykinase were most abundant followed by members of the 8 kDa
protein family, immunogenic protein, trypsin-like protein, enolase, 2-cys peroxiredoxin and
14-3-3 protein. Host proteins (serotransferrin, Ig) were present in both ESPs although more
abundant in the 24h fraction. Zambia ESP 24h showed high abundance for members of
the 8 kDa protein family and porcine albumin, followed by immunogenic protein, trypsin-
like protein, cyclophilin, porcine Ig, phosphoenolpyruvate carboxykinase and porcine
serotransferrin. Zambia ESP 48h showed highest abundance for members of the 8 kDa
protein family and phosphoenolpyruvate carboxykinase, followed by immunogenic protein,
porcine albumin, glutathione S-transferase, enolase and 2-cys peroxiredoxin.
The abundance of albumin in the ESPs can be explained by its abundance in blood (despite
multiple washings) and possibly because it was secreted by the cysts. Secretion of host
albumin has been described in Taenia crassiceps metacestodes where it may be involved
in osmoregulation (Aldridge et al., 2006).
6.3.6 Taenia solium proteins
Of the 76 proteins listed in Table 6.2, 27 have been described in literature specifically for
T. solium. Many of these proteins have been studied due to their importance as diagnostic
antigens in antibody detecting assays (Deckers and Dorny, 2010) e.g. diagnostic antigen
GP50 (Hancock et al., 2004), T24 (Hancock et al., 2006) and the 8 kDa protein family
(Hancock et al., 2003; Ferrer et al., 2007), which are the three protein groups that represent
the 7 diagnostic bands in the EITB (Tsang et al., 1989). Members of the 8 kDa protein
family are believed to be hydrophobic ligand binding proteins (Hancock et al., 2003) and
a similarity to the related E. granulosus AgB might indicate an immunoregulatory role,
enabling the parasite to reduce an inflammatory response (Shepherd et al., 1991) and
manipulate the Th1-Th2 balance (Rigano` et al., 2001). Paramyosin (Vargas-Parada and
Laclette, 2003), 14-3-3 protein (Santivan˜ez et al., 2010), actin (Campos et al., 1990), P27,
small heat-shock protein (Ferrer et al., 2005b) and phosphoenolpyruvate carboxykinase
have been described as immunoreactive proteins recognised by NCC-positive human sera
(Salazar-Anton and Lindh, 2011). Paramyosin in particular is also reported to inhibit
complement formation (Laclette et al., 1992). P27 is homologous to P-29 (E. granulosus)
and Antigen 6 (E. multilocularis). Several studies have shown similarities between sequences
and epitopes of P-29, Antigen S, Antigen 6 and even Antigen 5, which possesses similar
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protease activity as the T. solium trypsin-like protein (Lorenzo et al., 2003; Siles-Lucas
et al., 1998; Gonza´lez et al., 2000a; Ben Nouir et al., 2009). The enzymatic antioxidant
system of Taeniidae involves Cu/Zn-superoxide dismutase (Castellanos-Gonza´lez et al.,
2002), glutathione S-transferase (Vibanco-Pe´rez et al., 2002; Plancarte et al., 2004; Torres-
Rivera and Landa, 2008; Nguyen et al., 2010) and 2-cys peroxiredoxin (Vaca-Paniagua
et al., 2009). These proteins have been considered as targets for drugs and vaccines
(Vaca-Paniagua et al., 2008). Cysteine proteases help the parasite to evade the host
immune system in multiple ways: they possess the ability to lyse host immunoglobulins
(White et al., 1997a) and in vitro tests have proven their capability to deplete CD4+
lymphocytes by inducing apoptosis (Molinari et al., 2000; Tato et al., 2004). Furthermore,
cathepsin L-like cysteine peptidase has been used for differential diagnosis of infections
with Taenia species with a loop-mediated isothermal amplification assay (Nkouawa et al.,
2009). Annexin B2 is known to be associated with inflammatory reaction (Gao et al.,
2007). Other studies have shown anticoagulant activity (Lu et al., 2010). Furthermore,
secreted annexin B1 [antigen cC1 (Hongli et al., 2002)] was shown to induce apoptosis
in eosinophils, a novel strategy to prevent the host’s immune attack (Yan et al., 2008),
and was suggested as a candidate for the development of a vaccine against T. solium
cysticercosis (Guo et al., 2004). Calreticulin controls intracellular Ca2+ homeostasis, but
can also assist in secretion, protein synthesis and control of protein folding (Mendlovic
et al., 2004). Cytosolic malate dehydrogenase is involved in the citric acid metabolism
and has recently been studied because it might potentially serve as a target for drugs
(Nava et al., 2011). Glucose transporter TGTP2 is believed to mediate sugar uptake and
is predominantly localised on the surface of the cyst (Rodr´ıguez-Contreras et al., 1998). It
is however not recognised by the host immune system (Rodr´ıguez-Contreras et al., 2002).
6.3.7 Proteins matching sequences from other species
The interpretation of the 49 proteins that are not identified by T. solium requires careful
consideration to assess if they are likely to be of helminth or host origin.
In most cases, spectra matching proteins from other helminths (n = 32) can be assumed
to derive from T. solium proteins not present in the T. solium database. A number of
proteomic studies have been carried out on other helminth parasites like Schistosoma
spp. (Guillou et al., 2007; Pe´rez-Sa´nchez et al., 2008; Liu et al., 2009) and E. granulosus
metacestodes (Monteiro et al., 2010). Many of those proteins are identified in this study as
well and it is reasonable to assume that the proposed function is similar. Although a few
of these proteins (e.g. enolase, tubulin and phosphoglycerate kinase) are identified also by
S. scrofa, the proteins are unlikely to be of host origin due to their nature or function and
presence in other helminths.
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A total of 17 proteins were identified only by S. scrofa and because most of them are
commonly found in blood (e.g. Ig, hemoglobin, endopeptidase inhibitors and transport
proteins), they are almost certainly of host origin. They may be considered as contamina-
tion, although importantly, some host proteins (e.g. albumin) are also known to be taken
up and secreted by cysts (Aldridge et al., 2006).
6.4 Conclusions
This study presented the first report of the T. solium metacestode excretion/secretion
proteome. Since the genome of T. solium was not yet available at the time of publication,
and only 401 protein entries were found in the NCBInr database, our approach relied on
homology to other helminths to increase the proteome coverage. The 76 reported proteins
included 27 already described T. solium proteins, 17 host proteins and 32 proteins likely
to be of T. solium origin, but identified using sequences from other helminths, effectively
demonstrating the value of this approach. However, until a reference genome for T. solium
becomes available, it is likely that several proteins in the ESPs remained unidentified. The
fact that many of the proteins found in this study are involved in parasite survival strategies
and have been described in other helminths as well indicates that the excretion/secretion
proteome is not all that different between species or even related genera. Therefore, it
is reasonable to assume that the proposed protein functions are similar. Albeit the close
homology to another protein may limit the specificity of diagnostic tests based on that
protein, it also has the potential to widen the usable range of a vaccine or drug.
Page 75

7CHAPTER 7
Use of Expressed Sequence Tags for the Identification of Taenia
solium Metacestode Excretion/Secretion Proteins
Abstract: In the previous study, a custom protein database containing pro-
tein sequences from related helminths was used to identify Taenia solium
metacestode excretion/secretion proteins. An alternative or complementary
approach would be to use expressed sequence tags combined with BLAST and
protein mapping to supercontigs of Echinococcus granulosus, a closely related
cestode. In this study, this approach is evaluated and the results are compared
to those obtained in the previous study. A total of 297 proteins organised in 106
protein groups were identified. Of the 106 protein groups, 58 groups were newly
identified, while 48 groups confirmed previous findings. Blast2GO analysis
revealed that the majority of the proteins were involved in catalytic activities
and binding. Comparable findings were obtained in recent studies on other
helminth genera like Echinococcus, Schistosoma and Clonorchis, indicating
similarities between helminth excretion/secretion proteomes.
Adapted from:
Victor, B., Dorny, P., Kanobana, K., Polman, K., Lindh, J., Deelder, A. M., Palmblad,
M., and Gabrie¨l, S. Use of Expressed Sequence Tags as an Alternative Approach for the
Identification of Taenia solium Metacestode Excretion/Secretion Proteins. BMC Research
Notes 6, 1 (2013), 224.
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7.1 Introduction
Proteomic experiments involving liquid chromatography and tandem mass spectrometry
(LC-MS/MS) typically attempt to match the generated experimental spectra to in silico
spectra from a (target) protein database. Ideally, this database contains every protein likely
to be in the sample, but obtaining such an all-including protein database proves difficult
when there is little to no genomic information available, as was the case for T. solium until
recently (Tsai et al., 2013). In the previous study, we bypassed this limitation by using
a custom database with known proteins from related helminths (Taenia, Echinococcus,
Schistosoma and Trichinella) as a target database in the LC-MS/MS experiments [Chap-
ter 6 and Victor et al. (2012b)]. In that study, translated expressed sequence tags (ESTs)
were deliberately not used, because the aim there was to investigate to usefulness of a
target database made up of protein sequences originating mostly from (closely) related
helminths.
The usefulness of ESTs for the identification of helminth proteins has already been de-
scribed for e.g. Haemonchus contortus (Yatsuda et al., 2003; Millares et al., 2012) and
Echinococcus granulosus (Monteiro et al., 2010). In the case of T. solium, ESTs from
different parasite stages have been made available by different research groups, both
published (Almeida et al., 2009; Lundstro¨m et al., 2010) and unpublished (Huang J. et al.,
Analysis of Taenia solium and Taenia saginata adult gene expression profile, 2009 and
Aguilar-Diaz H. et al., Taenia solium larva/adult ESTs, 2007).
In this study, T. solium ESTs combined with the Basic Local Alignment Search Tool
(BLAST) and protein mapping to supercontigs of E. granulosus (a member of the Taeniidae
family) were used to investigate whether this would increase the number of T. solium
metacestode excretion/secretion protein identifications compared to the previous study.
7.2 Materials and methods
7.2.1 Generation of the dataset
The in vitro production of the T. solium metacestode excretion/secretion proteins from
Peru and Zambia at 24h and 48h and the generation of line spectra mzXML files1 have
been described in Chapter 6 and Victor et al. (2012b).
1The datasets supporting the results of this article are available in the PRIDE repository at http:
//www.ebi.ac.uk/pride with accession numbers 19232 – 19267.
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7.2.2 Database design and data analysis
To construct the target database, 30,700 expressed sequence tags were downloaded from
the National Centre for Biotechnology Information (NCBI) website in April 2012 and
a six frame translation was performed using transeq (Rice et al., 2000). A Sus scrofa
database with 1,388 Swiss-Prot sequences (http://www.uniprot.org/) and the common
Repository of Adventitious Proteins database (112 protein sequences; ftp://ftp.thegpm.
org/fasta/cRAP/crap.fasta) were also included to assist detection of host proteins
and accidental contaminations, respectively. A decoy database with 185,700 reversed
sequences was created using decoyfasta. These databases were fused into one final database.
Database searching with X!Tandem (2010.10.01.1) (Craig and Beavis, 2004) and subsequent
analyses with PeptideProphet (Keller et al., 2002; Choi and Nesvizhskii, 2008b), iProphet
(Shteynberg et al., 2011) and ProteinProphet (Nesvizhskii et al., 2003) were also performed
as previously described [Chapter 6 and Victor et al. (2012b)]. All above mentioned tools,
except transeq, are included with the Trans-Proteomic Pipeline v4.5 RAPTURE rev 2
(Keller et al., 2005). The identified translated ESTs were further filtered to a false discovery
rate of < 1% and ESTs with an individual probability of zero were discarded. The remaining
ESTs were blasted against the NCBI nonredundant database (E-value < 1e-10) and for
each recognised EST, the best matching protein was retained. The resulting proteins
were then screened by mapping the proteins to the E. granulosus supercontigs using
TBLASTN (http://www.sanger.ac.uk/cgi-bin/blast/submitblast/Echinococcus).
Identifications with a Score > 200 were considered valid. Identifications with a lower score
were manually evaluated and proteins originating from T. solium were retained. This
step also helped to filter out host contaminations. Finally, proteins were grouped based
on homology. All proteins that could not be grouped and were identified by only one
EST were also discarded. SignalP 4.1 server (Petersen et al., 2011) and SecretomeP 2.0
Server (Bendtsen et al., 2004a) were used to predict classical (signal peptide triggered)
and non-classical protein secretions, respectively. Finally, Blast2GO was used for Gene
Ontology (GO) annotations (biological process, molecular function and cellular component)
and the construction of level 2 pie charts (Conesa et al., 2005). In order to gain more
specific information, the largest categories were analysed to levels 3 and 4.
7.3 Results and discussion
7.3.1 Identified proteins and Gene Ontology annotation
In this study, 297 proteins (from 1,787 translated ESTs) were identified and organised in
106 protein groups based on homology (Additional file 12). For simplicity, each protein
2http://www.biomedcentral.com/content/supplementary/1756-0500-6-224-s1.pdf
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group is represented by one protein. The groups were further organised by Gene Ontology
annotation information on biological process and molecular function. A total of 48 protein
groups are labelled with an asterisk, indicating that they were also identified in the previous
study (Additional file 23) [Chapter 6 and Victor et al. (2012b)]. For brevity, Table 7.1
shows only the 58 newly identified protein groups along with the SignalP and SecretomeP
analysis result. The former reports yes (Y) or no (N) for both the neural networks (NN)
and hidden Markov models (HMM), while the latter interprets a NN-score above 0.5
as possible secretion (Y). For a number of proteins/protein groups, no Gene Ontology
information was available. Nonetheless, many of them, like the 8 kDa protein family
(Hancock et al., 2003), have been extensively studied and used in diagnostic assays.
Most of the identified protein groups could be categorised in miscellaneous binding activities
(e.g. actin binding, calcium binding and metal ion binding), various metabolic processes,
gluconeogenesis (triosephosphate isomerase, enolase, phosphoenolpyruvate carboxykinase
and phosphoglucose isomerase), glycolysis (glyceraldehyde-3-phosphate dehydrogenase,
phosphoglycerate kinase, phosphoglycerate mutase and fructose-bisphosphate aldolase)
and proteins with (endo) peptidase activity, including cysteine-type (calpain, UDP-glucose
4-epimerase and cathepsin), threonine-type (proteasome subunits) and serine-type en-
dopeptidase activity (trypsin-like protein). Endopeptidase inhibitors with both serine-type
(kunitz protein 8 and leukocyte elastase inhibitor) and cysteine-type endopeptidase in-
hibitor activity (immunogenic protein Ts11) and components of the enzymatic antioxidant
system of Taeniidae (Cu/Zn superoxide dismutase, glutathione S-transferase and peroxire-
doxin) were also identified (Vaca-Paniagua et al., 2009).
Gene Ontology level 2 pie charts were created for biological process (Figure 7.1a), molecular
function (Figure 7.1b) and cellular component (Figure 7.1c). To avoid overly busy charts,
the sequence filter was set to 10. The two largest categories of the biological process chart
were cellular and metabolic processes. Others included biological regulation, response
to stimulus, multicellular organismal processes and cellular component organisation or
biogenesis. Further investigation of the general cellular and metabolic processes revealed
primary and cellular metabolic processes at level 3 and protein, cellular macromolecule
and cellular nitrogen compound metabolic processes at level 4 (Additional file 3, tab 14).
Molecular function was clearly divided between binding and catalytic activity. GO level
3 showed protein binding and hydrolase activity while level 4 entailed mostly nucleotide
binding, hydrolase activity (acting on acid anhydrides), cation binding, peptidase activity,
cytoskeletal and identical protein binding (Additional file 3, tab 24). The level 2 pie chart
for the cellular component indicated cell and organelle as the largest categories. Further
3http://www.biomedcentral.com/content/supplementary/1756-0500-6-224-s2.pdf
4http://www.biomedcentral.com/content/supplementary/1756-0500-6-224-s3.xls
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Table 7.1: Protein groups (n = 58) newly identified in Taenia solium metacestode excretion/secretion
proteins, organised by Gene Ontology annotation information on biological processes and molecular
functions. For simplicity, all protein groups are represented by one protein.
Gene Ontology classification
Closest organism GI code Proteinsa) ESTsb) SigP/SecPc)
Protein group
1) No Gene Ontology classification
Major egg antigen Clonorchis sinensis 358336515 1 2 N/Y
ES1 protein homolog Multipled) - 3 5 N/Y
Phosphoglyceride transfer protein Taenia asiatica 124782980 1 7 N/Y
Alpha-2-macroglobulin-like protein 1 Clonorchis sinensis 358333571 1 5 Y/Y
Aldose 1-epimerase Clonorchis sinensis 358334888 1 2 N/Y
SJCHGC02626 protein Schistosoma japonicum - 3 7 N/Y
Hypothetical protein Schistosoma mansoni 256079415 1 4 Y/N
TSP1 Echinococcus multilocu-
laris
209967595 1 4 N/Y
Putative major vault protein Echinococcus granulosus 62178032 1 2 N/Y
2) Binding (miscellaneous)
Filamin Multiple - 3 7 -/-
Methionyl-tRNA synthetase Clonorchis sinensis 358255967 1 5 N/N
cytoplasmic
SJCHGC09631 protein Schistosoma spp. - 2 2 N/-
four and a half LIM domains protein 3 Clonorchis sinensis 358341124 1 7 N/Y
Alpha-actinin isoform B Taenia asiatica 124783372 1 3 N/Y
Calumenin Taenia asiatica 124784033 1 2 N/Y
Calcium-binding protein Schistosoma mansoni 256071353 1 2 N/Y
Lysyl oxidase-like Schistosoma mansoni 256072781 1 2 N/Y
Porphobilinogen synthase Multiple - 3 3 N/-
Phosphoglucomutase-1 Clonorchis sinensis 358337844 1 2 N/N
Fibrillar collagen Multiple - 9 16 -/-
3) Glycolysis/Metabolic processes (miscellaneous)
Adenylosuccinate synthetase Schistosoma mansoni 387912858 1 4 N/Y
Adenylate kinase Multiple - 2 4 N/Y
UDP-glucose pyrophosphorylase 2 Schistosoma spp. - 2 2 N/-
Hypothetical protein SINV 09109 Solenopsis invicta 322793762 1 2 N/Y
Aspartate aminotransferase Multiple - 3 5 N/-
Lactate dehydrogenase A Taenia solium 318054471 1 6 N/Y
SJCHGC05968 protein Multiple - 2 2 N/Y
Methylthioadenosine phosphorylase Multiple - 2 2 N/-
Ornithine aminotransferase Multiple - 3 3 N/-
Endoglycoceramidase Multiple - 3 3 -/Y
Aminoacylase Multiple - 2 2 N/N
Glucose-6-phosphate 1-dehydrogenase- Sus scrofa 350595984 1 2 N/N
like
Phosphoglycerate mutase Multiple - 3 7 N/N
4) (Endo)peptidase activity
Calpain Multiple - 5 5 N/-
UDP-glucose 4-epimerase Multiple - 2 2 N/-
Dipeptidyl-peptidase Multiple - 2 3 N/-
Glutamate carboxypeptidase 2 Clonorchis sinensis 358331956 1 3 N/Y
5) Endopeptidase inhibitor activity
Kunitz protein 8 Multiple - 2 3 -/Y
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Table 7.1: Continued.
Gene Ontology classification
Closest organism GI code Proteinsa) ESTsb) SigP/SecPc)
Protein group
6) Cell redox homeostasis/Oxidation-reduction related
Carbonyl reductase Schistosoma spp. - 3 3 N/N
Methionine sulfoxide reductase Multipled) - 2 4 N/Y
procollagen-lysine, 2-oxoglutarate Multiple - 3 6 -/-
5-dioxygenase 3
7) Transport
Charged multivesicular body protein Multiple - 3 4 N/N
SJCHGC06082 protein Multiple - 2 8 N/-
Glycolipid transfer protein-like protein Taenia asiatica 124782916 1 2 N/N
Gamma-soluble NSF attachment Multiple - 4 10 N/-
protein
Sodium/glucose cotransporter Multiple - 2 7 N/N
8) Motor activity/Cytoskeleton and Microtubule related
Tubulin polymerization-promoting Multiple - 2 2 N/-
protein
Myophilin Multiple - 2 19 N/-
9) Miscellaneous Gene Ontology classification
Translation initiation factor 5A Multiple - 2 4 N/N
Ubiquitin-conjugating enzyme Multiple - 4 10 N/Y
Protein-l-isoaspartate Schistosoma mansoni 256081696 1 2 N/Y
o-methyltransferase
Protein DJ-1-like Multiple - 2 4 N/Y
6-phosphogluconolactonase Multiple - 2 4 N/Y
SJCHGC02435 protein Schistosoma japonicum 56756018 1 5 Y/Y
Family T2 unassigned peptidase Schistosoma mansoni 256088374 1 4 Y/Y
3’(2’), 5’-bisphosphate nucleotidase Multiple - 2 2 -/Y
RAB GDP dissociation inhibitor alpha Multiple - 2 3 N/N
Laminin Multiple - 2 2 -/N
a) The number of proteins in each protein group.
b) The number of expressed sequence tags that were matched to proteins in this protein group.
c) SignalP and SecretomeP (SigP/SecP) results are described as yes (Y) or no (N). SignalP is Y when both the
neural network and the hidden Markov models agree. (-) is reported when not all individual proteins in that
groups have the same result.
d) ’Multiple’ indicates that different (helminth) genera have identified proteins in that protein group.
analyses showed mostly cell part and membrane-bound organelle, and intracellular (part)
GO terms at levels 3 and 4, respectively (Additional file 3, tab 34).
Human keratin and porcine trypsin were identified in all samples. As keratin is a common
contamination and trypsin was deliberately added during the LC-MS/MS experiments,
both were omitted from the final results.
The presence of intracellular/non-secreted proteins in the ESPs is interesting and has
been observed in other ESP studies before (Mulvenna et al., 2010; Virginio et al., 2012).
Although it is highly likely that the majority of those proteins are indeed excreted or
secreted by the parasite, the possibility that they are the result of leakage due to cyst
damage or death should not be excluded.
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(a) Gene Ontology level 2 pie chart – biological processes.
A
B
C
(b) Gene Ontology level 2 pie chart – molecular functions.
A
B
C
(c) Gene Ontology level 2 pie chart – cellular components.
Figure 7.1: Gene Ontology level 2 pie charts displaying the biological processes (a), the molecular
functions (b) and the cellular components (c) of the 297 proteins that were identified in the Taenia
solium metacestode excretion/secretion proteins. Values within parentheses are the number of
sequences associated with each Gene Ontology term. All charts were created using Blast2GO with
the sequence filter set to 10.
Page 83
Use of ESTs for the Identification of T. solium Metacestode ESPs.
7
In general, the findings reported in this study are comparable to recent studies on other
helminth genera like Echinococcus (Virginio et al., 2012), Schistosoma (Liu et al., 2009)
and Clonorchis (Zheng et al., 2011), indicating that excretion/secretion proteomes are not
very different between helminth genera/species.
7.3.2 Comparison between the two studies
When comparing the level 2 GO terms identified in both studies (Table 7.2), all GO terms
from the previous study were identified here as well. Additionally, we identified six new
GO terms with the EST analyses: rhythmic process (GO:0048511), antioxidant activity
(GO:0016209), molecular transducer activity (GO:0060089), protein binding transcription
factor activity (GO:0000988), receptor activity (GO:0004872) and synapse (GO:0045202).
Although a direct comparison between numbers should be avoided (due to proteins having
multiple GOs and the presence of homologous proteins in the proteins groups, especially
in the previous study where it is a logical result of the target database construction),
the general levels of abundance (= proteins in each GO term) are largely comparable
between the two studies e.g. in both studies, cellular process, metabolic process and
biological stimulation are the largest groups for ’biological process’ while binding and
catalytic activity are the largest groups for ’molecular function’ and cell and organelle are
the largest groups for ’cellular component’.
The six new GO terms were identified by a very small number of proteins and may be a
result of proteins being linked to multiple GO terms. This is supported by the fact that
the proteins linked to these GO terms are homologous to other proteins identified in both
studies, so none of these GO terms was identified by a ’new’ protein group.
7.4 Conclusions
In this study, a library of translated ESTs combined with BLAST and mapping strategies
was used not only to confirm previously identified T. solium metacestode excretion/secre-
tion proteins, but to identify several new proteins as well, thereby effectively increasing
the overall number of protein identifications.
The larger and more complete the EST database, the better proteomic coverage likely
obtained. No ESTs from other Taeniidae were used in this study, since the available
T. solium ESTs were already a merge of EST submissions by different groups and were
therefore likely to offer decent proteome coverage. However, in cases where only a small
EST library is available with low coverage, one could also include protein sequences
and/or ESTs from related organisms in a combined database. This may be particularly
advantageous in proteomic studies on less studied, unsequenced, organisms. It should be
noted that research on non-sequenced organisms mostly relies on homology to already
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Table 7.2: Gene Ontology level 2 annotations identified in this study alongside the ones identified
in the previous study. Although a direct comparison between numbers should be avoided (due
to proteins having multiple GOs and the presence of homologous proteins in the proteins groups,
especially in the previous study where it is a logical result of the target database construction),
the general levels of abundance are largely comparable between the two studies. Additionally, this
study revealed six new GO annotations.
Gene Ontology information
Current Previous
(EST) study studya)
Biological process
cellular process GO:0009987 185 162
metabolic process GO:0008152 182 150
biological regulation GO:0065007 91 153
response to stimulus GO:0050896 82 147
multicellular organismal process GO:0032501 75 107
cellular component organisation or biogenesis GO:0071840 74 92
developmental process GO:0032502 68 85
localisation GO:0051179 60 88
signaling GO:0023052 32 55
death GO:0016265 32 65
immune system process GO:0002376 20 59
locomotion GO:0040011 20 29
growth GO:0040007 18 28
multi-organism process GO:0051704 14 65
reproduction GO:0000003 10 36
biological adhesion GO:0022610 9 13
viral reproduction GO:0016032 8 12
cell proliferation GO:0008283 5 24
cell killing GO:0001906 2 21
rhythmic process GO:0048511 2 -
Molecular function
binding GO:0005488 176 168
catalytic activity GO:0003824 175 129
structural molecule activity GO:0005198 26 20
enzyme regulator activity GO:0030234 11 21
electron carrier activity GO:0009055 7 13
antioxidant activity GO:0016209 7 -
transporter activity GO:0005215 6 14
molecular transducer activity GO:0060089 4 -
protein binding transcription factor activity GO:0000988 3 -
nucleic acid binding transcription factor activity GO:0001071 2 17
receptor activity GO:0004872 1 -
Cellular component
cell GO:0005623 182 168
organelle GO:0043226 120 155
macromolecular complex GO:0032991 72 79
membrane GO:0016020 53 76
membrane-enclosed lumen GO:0031974 27 63
extracellular region GO:0005576 26 71
extracellular matrix GO:0031012 10 11
synapse GO:0045202 5 -
cell junction GO:0030054 2 12
a) Chapter 6 and Victor et al. (2012b)
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existing proteins from other (preferably closely related) organisms. Therefore, there is no
possibility of finding unique proteins, unless (i) de novo sequencing is performed on the
good quality unmatched experimental spectra or (ii) ESTs that were identified by spectra
but remained unmatched during BLAST are further investigated.
The results of SignalP and SecretomeP show a number of proteins that are negative for
both analyses. This indicates that some identified proteins were neither secreted through
the classical pathways (SignalP), nor through the non-classical pathway (SecretomeP). The
possibility of leaked proteins in the ESPs should therefore not be overlooked, especially
since dead cysts were observed in the ESP cultures in Peru (but not in Zambia). However,
the presence of proteins that are not predicted to be secreted by SignalP or SecretomeP
analysis has been reported in a number of other studies as well. Liu et al. (2009) estimated
that 48% of the excretory/secretory proteome of adult Schistosoma japonicum flukes were
released through an unknown mechanism. Similar observations were made by e.g. Knudsen
et al. (2005) for Schistosoma mansoni, by Mulvenna et al. (2009) for Ancylostoma caninum
and by Craig et al. (2006a) for Teladorsagia circumcincta.
Finally, it is important to realise that, although the mapping to the E. granulosus
supercontigs helped to remove S. scrofa host proteins (e.g. albumin, protegrin and
hemopexin), some may still be present. Heat shock protein 70, for example, is identified
both in S. scrofa and E. granulosus.
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The Search for Differential Proteins
Abstract: Circulating Taenia solium antigens are currently detected with two
ELISAs that were originally developed to detect T. saginata cysticerci in cattle,
implying a cross-reaction with T. solium antigens. Unfortunately, T. asiatica
and T. hydatigena, two Taenia species that can co-occur in pigs also cross-
react, thereby seriously impairing the usefulness of antigen detection in pigs.
Diagnosis of porcine cysticercosis would benefit greatly from a T. solium-specific
assay. To achieve this, a comparison between the different Taenia proteomes
could result in the identification of unique T. solium peptides/proteins. Three
comparison methods are explored, of which a novel spectral comparison pipeline
showed the most potential. The preliminary results of this comparison hint at
members of the 8 kDa protein family and phosphoenolpyruvate carboxykinase.
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8.1 Introduction
Circulating antigens that are excreted and secreted by viable Taenia spp. cysticerci are
currently detected by two different monoclonal antibody-based antigen detecting ELISAs:
the HP10 ELISA (Harrison et al., 1989) and the B158/B60 ELISA (Brandt et al., 1992;
Van Kerckhoven et al., 1998; Dorny et al., 2000). Both assays were originally developed
to detect excretion/secretion proteins from T. saginata cysticerci in cattle. From this
it follows that their use in humans and pigs is based on cross reactions with T. solium
antigens. Although convenient for the detection of human (neuro)cysticercosis, the use
of these assays is compromised in pigs, more specifically, in regions where T. solium, T.
hydatigena and/or T. asiatica are sympatric.
Diagnosis of porcine cysticercosis would benefit from a more specific assay. To achieve
this, one needs to not only study the excretion/secretion proteins (ESPs) from T. solium,
but compare these proteins with the ESPs from the other Taenia parasites as well. The
main objective of such a comparison is to identify unique proteins and target them in a
modified or new antigen detection assay.
There are at least three possible ways to compare the ESPs.
A first method is to analyse the ESPs of the other Taenia species in the same way the
ESPs for T. solium were analysed [Chapter 6 and Victor et al. (2012b)] and to compare the
protein output lists. For the analysis of the T. solium ESPs, the protein database was sup-
plemented with protein sequences from closely related helminths (including other Taenia
species) and expressed sequence tags. This increased the proteome coverage significantly
and allowed a more detailed proteomic study of T. solium. However, for comparative
studies, especially between closely related Taenia species, this approach quickly fails due
to the necessary emphasis on the small differences in protein sequence that separate these
species. This option is not considered to be suitable for the task at hand and is therefore
immediately discarded.
A second option is to separate the ESPs with two-dimensional polyacrylamide gel elec-
trophoresis (2D-PAGE) and to identify spots that are present in one sample, but not in
another. These differential spots can then be further analysed with liquid chromatography
and tandem mass spectrometry (LC-MS/MS). Although the identification of the proteins
after LC-MS/MS will likely be difficult because of the above mentioned reasons, it is much
more targeted then the first option i.e. at least now the analysis is focussed on a much
smaller subgroup of proteins that appear to be unique on gel. However, 2D-PAGE is not
without its shortcomings (see also Section 3.2.1) e.g. the tendency to identify only the
most abundant proteins. Obviously, this immediately puts a number of possible candidate
Page 88
8The Search for Differential Proteins
proteins out of the equation.
A third option is to analyse the ESPs with LC-MS/MS, but then to employ a new
methodology that bypasses the identification stage and instead considers all spectra from
all analyses, ensuring that none of the acquired information is lost at the all-important
comparison stage. In other words, the experimental spectra will be compared directly
with each other in order to identify which spectra are unique for the organism of interest.
The comparison phase uses Spearman’s rank correlation coefficients (ρ) and in addition,
the analysis methodology also identifies contaminating host proteins and filters spectra
by their quality. More specifically, this last step will flag all spectra unlikely to be of
peptide origin (e.g. spectra from polymers) as well as overall poor spectra (e.g. very few
peaks). This is achieved by training the SpecQual software tool with known identified and
unidentified spectra recorded on the same instrument, but from different samples (Flikka
et al., 2006). The final output of this methodology is a complete set of across-organism
matched spectra with contaminant and quality status annotations. From this set, unique
and relevant spectra for any of the organisms can be readily deduced, although logically, in
this case, unique T. solium spectra are of particular importance. Ultimately, identifications
should be obtained for (at least some of) the differential spectra and this still requires a
protein database to search against. This is where the recently published T. solium genome
becomes relevant (Tsai et al., 2013). From this genome, and the preceding expressed
sequence tag (EST) libraries, it is possible to derive a protein database that should ideally
cover the entire proteome. This database can then be used to identify the peptides and
proteins that correspond to the unique spectra that were retained after the analysis with
the spectral comparison tools.
Unfortunately, no T. asiatica material was available, so only T. solium and T. hydatigena
ESPs were compared.
8.2 Materials and methods
8.2.1 Parasite material and excretion/secretion proteins
T. solium metacestode collection from a naturally infected pig and 24h in vitro ESP
production were done in Zambia as previously described [Chapter 6 and Victor et al.
(2012b)]. T. hydatigena metacestodes of various sizes (n = 14) were collected from the
omentum and liver of naturally infected Zambian goats and carefully separated from the
host tissue. ESPs were prepared as described for T. solium, except that the number of cysts
per culture dish was modified according to the size of the cysts. T. solium metacestode
viability was assessed by incubating 20 cysts in 10% porcine bile in culture medium and
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subsequent evaluation of scolex evagination. No ’bile evagination test’ was performed for
T. hydatigena, but the metacestode movement was monitored. Protein concentration of
the ESPs was determined with a Pierce BCA Protein Assay Kit (Thermo Fisher Scientific
Inc., Rockford, IL). Species confirmation of the Taenia metacestodes was done with a
polymerase chain reaction assay followed by enzymatic digestion (PCR-RFLP) as described
by Devleesschauwer et al. (2013).
8.2.2 Two-dimensional polyacrylamide gel electrophoresis
The 2D-PAGE protocol was modified from Borloo et al. (2013). Briefly, 200 µg of T. solium
and T. hydatigena ESPs were precipitated by adding four volumes of ice-cold acetone. This
was vortexed briefly and incubated at −20℃ for one hour. Protein pellet was recovered by
centrifugation at 5,000×g for five minutes. The supernatant was discarded and the pellet
was resolubilised in 8 M urea, 2 M thiourea, 2% w/v CHAPS, 20 mM dithiothreitol (DTT)
and 0.2% v/v carrier ampholytes (pH 3-10; GE Healthcare Bio-Sciences AB; Uppsala,
Sweden). Dissolved proteins were centrifuged again at 8,000×g for five minutes to remove
any remaining insoluble proteins. The protein solution was applied to 7 cm, pH 3-10,
ImmobilineTM DryStrip IEF strips (GE Healthcare), covered with mineral oil and left
overnight for rehydration. An Ettan IPGphor3 instrument (GE Healthcare) was used
for the isoelectric focussing (IEF) with an initial three hour focussing period at 300 V,
followed by a five hour linear gradient from 300 to 3500 V and a final 18 h at 3500 V,
yielding a total voltage load of approximately 73 kVh. Proteins in the IEF strips were
reduced and alkylated prior to the second dimension separation, i.e. strips were incubated
for 15 minutes at room temperature in a 50 mM Tris-HCl, pH 8.8, 6 M urea, 30% v/v
glycerol, 2% w/v sodium dodecyl sulfate (SDS) and 2% w/v DTT solution followed by
another 15 minutes in an similar solution containing 2.5% w/v iodoacetamide instead of
the DTT. Second dimension separation was performed according to Laemmli (1970) i.e.
a 12% bis-acrylamide gel (pH 8.8) resolving gel and a stacking gel at pH 6.8 were used.
The treated IEF strips were imbedded in the stacking gel prior to the gel run. Finally,
staining was done with SimplyBlue SafeStain (Invitrogen, Carlsbad, CA) according to the
manufacturers’ instructions.
8.2.3 One-dimensional polyacrylamide gel electrophoresis and
in-gel trypsin digest
T. solium and T. hydatigena ESP aliquots (40 µg) were precipitated in four volumes
of ice-cold acetone and pellets were resuspended in NuPAGE Sample Reducing Agent
(10x) and NuPAGE LDS Sample Buffer (4x). Protein separation was done on a 4-12%
NuPAGE Novex Bis-Tris gel. Gels were stained overnight with the Colloidal Blue Staining
Kit (all reagents from Invitrogen). Each gel lane was cut in 48 identical slices using a
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custom designed gel cutter (Gel Company Inc., San Francisco, CA) and all slices were
transferred to a 96-well plate (Greiner Bio-One, Frickenhausen, Germany; one slice/well).
Gel slices were washed three times: first with 100 µL 25 mM ammonium bicarbonate (ABC;
Sigma-Aldrich Corp.), then with 100 µL 30% acetonitrile (Biosolve, Valkenswaard, The
Netherlands) in ABC and finally with 100 µL 100% acetonitrile. Cystines were reduced
by adding 75 µL 10 mM DTT in ABC for 30 minutes at 56℃. Gel slices were shrunk
with 100 µL of 100% acetonitrile and cysteines were alkylated with the addition of 75
µL 55 mM iodoacetamide (Sigma-Aldrich Corp.) in ABC for 20 minutes (in the dark) at
ambient temperature. Gel slices were washed and shrunk again with the addition of 100
µL 25 mM ABC followed by 100 µL 100% acetonitrile. Proteins were digested overnight
at 37℃ with sequencing grade porcine trypsin (5 µg/mL ABC; Promega, Southampton,
UK; 30 µL/well). From each well, 20 µL of supernatant was extracted and mixed with 2
µL 5% TFA (Sigma-Aldrich Corp.), while 20 µL 0.1% TFA was added to the gel pieces for
another hour of incubation. A second supernatant sample of 20 µL was extracted and the
two supernatants were pooled. The total volume per well was reduced to 20 µL with a
vacuum centrifuge and plates were stored at −30℃ pending further analysis.
8.2.4 Liquid chromatography – tandem mass spectrometry
Peptides were analysed on an amaZon ETD ion trap mass spectrometer (Bruker Daltonics,
Bremen, Germany) equipped with an Apollo II ESI source and coupled on-line with a
NanoLC-Ultra 2D plus LC (Eksigent, Dublin, CA, USA). A total volume of 10 µL was first
desalted on a C18 PepMap300 trap column (5 µm, 300 µm × 5 mm; Dionex, Sunnyvale,
CA) and then separated on a 15 cm C18 ChromXP analytical column (3 µm, 150 × 0.3
mm; Eksigent) by a 45-minute linear gradient from 4% to 35% acetonitrile, 0.05% formic
acid (Sigma-Aldrich Corp.) with a flow rate of 4 µL/minute. Mass spectra were acquired
in m/z 300-1,300 with the ion charge control (ICC) set to 200,000 and the maximum
accumulation time set to 200 ms. The 10 most abundant precursors were selected for CID
MS/MS in m/z 100-2,000 with the ICC and maximum accumulation time set to 200,000
and 50 ms respectively, but were excluded for 0.5 minutes after having been selected once.
Singly charged ions were excluded for MS/MS. The LC system was controlled by HyStar
3.2 and the ion trap by trapControl 7.0.
8.2.5 Data analysis – spectral comparison
An overview of the spectral comparison workflow is shown in Figure 8.1. Raw LC-
MS/MS data were converted to line spectra mzXML files with the Bruker compassXport
tool (version 3.0.4) and then to MGF files with MSConvert (ProteoWizard; version
3.0.4388) (Kessner et al., 2008; Chambers et al., 2012) with the assumption that all
spectra are either doubly or triply charged. T. solium spectra were searched against a
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Figure 8.1: Overview of the spectral comparison methodology. First, spectra matching host proteins
and common contaminations are removed. The remaining spectra are filtered to remove the
non-peptide spectra and spectra of lower quality. Then, the high quality spectra are transformed
to binned spectra, which are then compared between datasets with a Spearman’s rank correlation
coefficient threshold set to 0.2. The result is a list of unique spectra for each Taenia species.
Finally, the spectra that remained after the host and common contaminations were removed, are
searched against a six reading frame translation of the genome. The spectra that match to T.
solium peptides are then compared to the unique spectra to allow the identification of peptides
that are only matched by unique spectra.
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Sus scrofa protein database (25,883 sequences; http://www.ensembl.org/index.html)
with SearchGUI (Vaudel et al., 2011a) and PeptideShaker (https://code.google.com/
p/peptide-shaker/) (Barsnes et al., 2011) with the following settings: precursor and
fragment tolerances were set to 0.9 Da and 0.5 Da, respectively. Accepted number of missed
cleavages was set to one. Fixed modification was carbamidomethylation of cysteine, while
oxidation of methionine and pyroglutamate for N-terminal glutamine were set as variable
modifications. All assigned spectra at a false discovery rate (FDR) of 1% were discarded.
Similarly, T. hydatigena data were matched to a Capra hircus protein database (1,841
sequences; http://www.uniprot.org) and all assigned spectra at FDR 1% were discarded.
Next, the remaining datasets were searched against the common Repository of Adventitious
Proteins database (112 protein sequences; ftp://ftp.thegpm.org/fasta/cRAP/crap.
fasta) to detect common and/or accidental contaminations in the protein samples. Again,
assigned spectra at FDR 1% were discarded. The spectral quality filtering tool SpecQual
(Flikka et al., 2006) was trained with spectra from Escherichia coli standards (run on the
same instrument) and all experimental spectra were subsequently filtered with the “cost”
parameter c set to 10. Noise filtering was then applied to all remaining spectra, with the
cut-off intensity determined for each spectrum individually. The similarity comparison
process was initiated by transforming each individual high quality spectrum in each dataset
to a binned spectrum, with bin sizes equal to two times the fragment tolerance. Each bin
intensity was then adjusted to reflect the sum of the peak intensities in that bin. These
transformed spectra were subsequently compared to a subset of (transformed) spectra in the
other dataset, with subsets determined by allowing a retention time window of 2.5 minutes
around the retention time of the spectra. The actual spectral comparison was performed
with Spearman’s rank correlation coefficient and all spectra with a coefficient > 0.2 were
discarded. Below or equal to that value, they were considered unique. A six reading frame
translation of the T. solium genome (ftp://bioinformatica.biomedicas.unam.mx/)
was performed with no start codon restrictions i.e. proteins could start with any amino
acid, not only methionine (AUG) (Barsnes et al., 2011). After translation, DBToolKit
(Martens et al., 2005) was used to discard any entries shorter than five amino acids. Finally,
the spectra that remained after removal of the host proteins and the common and/or
accidental contaminations were searched against this six reading frame translation with
search parameters as described above. The resulting set of peptide spectrum matches
were subsequently compared to the list of unique spectra to identify peptides that were
matched only by unique spectra.
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8.3 Results and discussion
8.3.1 Parasite material and excretion/secretion proteins
Metacestode viability/scolex evagination was determined at 100% for T. solium. T. hy-
datigena metacestodes moved actively and were evaginating and invaginating continuously.
No dead cysts were observed during the 24h culture period. Protein concentrations were
determined at 4.565 mg/mL and 1.478 mg/mL for the T. solium and T. hydatigena
ESPs, respectively. PCR-RFLP analysis confirmed genus and species of the collected
metacestodes (Figure 8.2).
Figure 8.2: Restriction fragment length polymorphism profiles of Taenia metacestodes; M: DNA
size marker; Lanes 1-3: Taenia solium; Lanes 4-8: Taenia hydatigena.
8.3.2 Two-dimensional polyacrylamide gel electrophoresis
Despite multiple attempts, the basic protocol did not yield a suitable result. A large
number of adjustments were made to the sample preparation, the protein concentration,
the second dimension separation system and the staining method, but none of these
modifications resulted in gels that enabled us to repeatedly spot the same differences. For
informational purposes only, ESP profiles of T. solium and T. hydatigena are shown in
Figure 8.3a and Figure 8.3b, respectively. Isoelectric focussing was done on 7 cm, pH 3-10,
ImmobilineTM DryStrip IEF strips (GE Healthcare), while the second dimension separa-
tion was performed with NuPAGE Novex 4-12% Bis-Tris ZOOM protein gels (Invitrogen,
Carlsbad, CA). Silver staining was done according to Schaegger (2006).
Comparison of both proteomes with 2D-PAGE and subsequent LC-MS/MS analysis of the
visually unique proteins was the second of the three suggested options. The advantage of
this option over the first one, is that by first (visually) identifying the proteins of interest,
the approach becomes much more targeted. Unfortunately, the many shortcomings of 2D-
PAGE make for a realistic chance of missing potentially interesting proteins. Nonetheless,
the option was explored, but ultimately abandoned due to issues with reproducibility and
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(a) 2D-PAGE profile of Taenia solium excre-
tion/secretion proteins.
(b) 2D-PAGE profile of Taenia hydatigena ex-
cretion/secretion proteins.
Figure 8.3: Two-dimensional polyacrylamide gel electrophoresis (2D-PAGE) profiles of Taenia solium
(a) and Taenia hydatigena (b) excretion/secretion proteins. Lane M is a protein size marker. The
pH values mark the direction in which the isoelectric focussing strip was inserted into the gel. The
profiles were not reproducible and therefore, did not allow for a reliable selection of differential
proteins.
(horizontal) streaking of the gel. The problem of 2D-PAGE reproducibility was one of
the reasons 2D DIGE became so popular, but unfortunately, 2D DIGE was not available
at the time. The streaking issue can have multiple reasons, ranging from incomplete
focussing in the first dimension (too much or too little voltage) and protein overloading
(protein aggregation), to sample preparation issues (contaminating salts, charged detergents,
nucleic acids, lipids,...) and failure to completely solubilise all the proteins in the sample.
Pinpointing the exact cause (or causes) of the streaking requires time, evaluation of various
sample clean-up kits and methods and large sample volumes. However, due to the limited
amounts of sample available for further experiments and the other remaining issues specific
to 2D-PAGE, this was not considered a priority.
8.3.3 One-dimensional polyacrylamide gel electrophoresis
Figure 8.4 shows the protein profiles of the T. solium and T. hydatigena ESPs. Each gel
lane was cut in 48 identical slices and all slices were subjected to the in-gel tryptic digest
protocol.
8.3.4 Data analysis – spectral comparison
Figure 8.5 provides a visual overview of the numbers of spectra that were discarded at each
step of the process. More specifically, database searching against host proteins and common
contaminations reduced the number of spectra in the T. solium dataset from 453,532 to
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Figure 8.4: One-dimensional polyacrylamide gel electrophoresis profiles of Taenia metacestode
excretion/secretion proteins; M: Protein size marker; Lane 1: Taenia solium; Lane 2: Taenia
hydatigena.
Taenia solium Taenia hydatigena
453,532 spectra 449,758 spectra
host proteins and
common contaminations
450,496 spectra 444,527 spectra
non-peptide and
low quality spectra
49,258 spectra 32,690 spectra
spectral comparison
Spearman’s ρ = 0.2
16,278 unique spectra 6,883 unique spectra
database search based on
Taenia solium genome
303 matched unique
peptides in the translated
Taenia solium genome.
Figure 8.5: Filtering of the Taenia solium and Taenia hydatigena experimental spectra with the
spectral comparison methodology.
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450,496. Similarly, the T. hydatigena dataset was reduced from 449,758 to 444,527 spectra.
The removed spectra mainly matched to host albumin, human keratin and porcine trypsin.
The spectral quality filter (at c = 10) further reduced the number of spectra to 49,258 and
32,690 for T. solium and T. hydatigena, respectively. Ultimately, spectral matching with
a Spearman’s rank correlation coefficient threshold set to 0.2 retained 16,278 and 6,883
unique spectra for T. solium and T. hydatigena, respectively. Database searching with
the 450,496 T. solium spectra against the translated genome resulted in 9,071 peptide
spectrum matches and 1,545 peptides (FDR = 1%). The 16,278 unique spectra matched
624 of these peptides of which a subset of 303 peptides were identified ONLY by unique
spectra. The remaining 321 peptides were identified by both unique spectra and at least one
non-unique spectrum. Logically, these were not considered as unique peptides. Although
the analysis of these peptides is still ongoing, preliminary results were further explored
by first setting a spectral count > 10 threshold to reduce the number of peptides to 11.
Then, the sequences were analysed with BLASTP (version 2.2.29+, optimised for queries
shorter than 30 residues) against (i) the National Centre for Biotechnology Information
non-redundant (NCBInr) database and (ii) the protein database derived from the T. solium
genome (TsM1 13.12.11.prot.faa; http://www.taeniasolium.unam.mx/taenia/) on May
4, 2014 (Table 8.1).
Since low BLASTP E-values (e.g. E-value < 1e-10) signify a better match, the most
promising results in this list are peptides 1 and 2. In the NCBInr database, peptide 1
matched to “Ts18 variant 5”, an 86 amino acids long protein sequence that was published
by Kim et al. in 2011. Remarkably, in 2003, Hancock et al. already reported an “8
kDa diagnostic antigen Ts18 variant 5, partial” protein (GI:19879938), which is highly
similar to the “Ts18 variant 5” identified in Table 8.1 (BLASTP E-value 1e-57 with a 99%
identity score). In the genome derived database, peptide 1 matched an “8 kDa glycoprotein”
sequence which is almost identical to a “Ts18 variant 2” (GI:347546161) also reported by
Kim et al. (2011) (BLASTP E-value 6e-56 with a 99% identity score). The Ts18 variant
proteins are part of the Ts18 clade of the 8 kDa protein family (Hancock et al., 2003) of
which several members were found to be abundantly present in T. solium metacestode
excretion/secretion proteins [Chapters 6 and 7 and Victor et al. (2012b, 2013)]. However,
a family of genes encoding 8 kDa antigens was identified in both Echinococcus and Taenia
species (Jia et al., 2011), so whether (monoclonal) antibodies are able to differentiate
between the closely related 8 kDa proteins remains to be elucidated. Furthermore, since
two different genotypes of T. solium have already been identified (Ito et al., 2003), it is not
unlikely that this might result in differences in the proteome as well. That being said, the
“Ts18 variant 5” proteins reported by both Hancock et al. and Kim et al. came from cysts
that were sourced in China. The next result (peptide 2) matches to phosphoenolpyruvate
carboxykinase in both databases.
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Table 8.1: Peptides (n = 11) identified using the spectral comparison method. The sequences were
analysed with BLASTP (optimised for queries shorter than 30 residues) against the NCBInr database
and the genome derived TsM1 13.12.11.prot.faa protein database (http://www.taeniasolium.
unam.mx/taenia/) on May 4, 2014. Where applicable, the top result is mentioned as well as the
corresponding BLASTP E-value for each database.
Peptide sequence
Spectral Top protein match in BLASTP analysis E-value
count [Organism] Identification Database
1) EIEYIHNWFFHDDPIGK 11 Ts18 variant 5 9e-10
[Taenia solium] GI:347546167 NCBInr
8 kDa glycoprotein 8e-13
[Taenia solium] TsM 000105300 genome
2) AINPEAGFFGVAPGTNHK 11 Phosphoenolpyruvate carboxykinase 3e-09
[Hymenolepis microstoma] GI:555931973 NCBInr
Phosphoenolpyruvate carboxykinase 2e-12
[Taenia solium] TsM 000763700 genome
3) GEQGPPGPQGPAGALGPAGS- 14 Collagen alpha-2(I) chain 7e-04
IGDAGER [Echinococcus granulosus ] GI:576700155 NCBInr
Collagen alpha 2(I) chain 2e-08
[Taenia solium] TsM 000807400 genome
4) NNYLYETTYFTK 16 Fasciclin-1 0.002
[Taenia solium] GI:576902497 NCBInr
Gynecophoral canal protein 5e-07
[Taenia solium] TsM 000655200 genome
5) VFLLHSSQGQGSR 13 Collagen type XI alpha 2 5.5
[Echinococcus granulosus ] GI:556518320 NCBInr
Collagen type XI alpha 2 3e-07
[Taenia solium] TsM 000632700 genome
6) SIIYAAIACGPR 17 Putative vesicle-associated membrane protein 0.23
[Echinococcus granulosus ] GI:576700607 NCBInr
Vesicle associated membrane protein 1e-06
[Taenia solium] TsM 000458800 genome
7) SWGDIVSHADK 10 No match in NCBInr
N acetylated alpha linked acidic dipeptidase 2 7e-06
[Taenia solium] TsM 000691600 genome
8) YIAEERPCGDK 11 Trypsin-like protein 0.035
[Taenia solium] GI:311335041 NCBInr
Mastin 1e-05
[Taenia solium] TsM 000238300 genome
9) VMCVGDDIAWMR 19 Hypothetical protein LOTGIDRAFT 178121 0.039
[Lottia gigantea] GI:556109577 NCBInr
Phosphoenolpyruvate carboxykinase 0.007
[Taenia solium] TsM 000763700 genome
10) WAVCQVGILLAR 19 No match in NCBInr
RhoGAP 0.72
[Taenia solium] TsM 000922100 genome
11) VVDGLAMDEWGK 10 PglZ domain containing protein 1.8
[Sporomusa ovata] GI:544738427 NCBInr
Cytosolic malate dehydrogenase 0.025
[Taenia solium] TsM 000048200 genome
Page 98
8The Search for Differential Proteins
Although the top NCBInr result in the BLASTP analysis originated from Hymenolepis
microstoma, the (partial) protein from T. solium was also in the list (GI:283466482;
E-value 7e-09). The H. microstoma protein was published by Tsai et al. (2013) (the
same paper that also presented the T. solium draft genome), while the T. solium protein
was mentioned by Knapp et al. (2011), who used the gene that codes for this protein
(amongst others) to study the phylogenetic relationships within the Taeniidae family
(Echinococcus and Taenia) and to trace back the evolutionary histories of these tapeworms.
A phosphoenolpyruvate carboxykinase protein was also recognised by serum samples
from neurocysticercosis patients (Salazar-Anton and Lindh, 2011), which highlights the
immunogenicity and potential diagnostic use of the protein. However, the study did not
examine cross-reactivity with other helminth infections. Peptide 9 also matched phospho-
enolpyruvate carboxykinase in the genome derived database albeit with a higher E-value
and, although the hypothetical protein LOTGIDRAFT 178121 was the top results in the
NCBInr database, all other results in the list were also phosphoenolpyruvate carboxykinase.
However, the E-value were equally high, making the identified match much less confident.
Finally, and as was also mentioned for the 8 kDa proteins above, whether (monoclonal)
antibodies will be able to differentiate between the closely related carboxykinases remains
to be determined.
Spectral comparison and matching of unique spectra to a six reading frame translation of
the T. solium genome was the third of the three suggested options. Although this novel
methodology is still under active development, the initial results show promise and the
method offers a number of advantages over the above mentioned comparison methods. The
first one is that this methodology employs all available information (i.e. spectra), no matter
how low in abundance they are, before any identification of proteins is attempted. The
obvious advantage there is that protein identification through database searching mainly
focusses on the abundant proteins (i.e. peptides/proteins identified by many spectra)
and peptides identified by very few spectra are often classified as incorrect. A second
advantage involves 2D-PAGE limitations. The spectral comparison methodology is per-
fectly suitable for use in combination with the latest advancements in shotgun proteomics
and multidimensional liquid chromatography. These gel-free strategies effectively sidestep
the limitations observed with 2D-PAGE (or even 1D-PAGE for that matter). A third
advantage is the fact that, in theory, one could make do with only the protein database of
the organism of interest i.e. the methodology does not depend on protein identifications
for the other organism in the comparison. However, there is definitely value in knowing
what the unique spectra of the other organisms match to as well, especially since it could
be very interesting to find out which of the identified spectra unique for T. solium can not
be matched to the T. hydatigena proteins database.
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As stated above, the method is still under development. Going back to Figure 8.1, it is easy
to see that there are a number of steps in the spectral comparison process that offer the
possibility of setting thresholds (e.g. a different FDR for host proteins and contaminations,
another C parameter in SpecQual and different Spearman’s thresholds). Finding the
optimal “sweet spot” will require further evaluation and even then, it is possible that
re-evaluation will be necessary for every dataset, especially when the data is created on
another mass spectrometer. Furthermore, it should be made clear that unique proteins
should also be evaluated with T. asiatica data. It is possible that unique proteins identified
here turn out to be shared by T. asiatica. Therefore, further development and evaluation
must include T. asiatica metacestode ESPs as well.
8.4 Conclusions
In this study, three methods were considered that could all potentially identify proteins
that are unique for T. solium.
The first method involved LC-MS/MS analysis of the ESPs followed by protein identification
through database searching and comparison of the identified proteins. Since there is no
complete protein database for T. hydatigena (and no curated database for T. solium
for that matter), protein identification is already compromised and supplementing the
protein database with sequences from other Taenia would obviously achieve the opposite
of what was intended in the experimental set-up i.e. a (large) number of proteins would
be shared between both databases, inhibiting any identification of differential proteins.
Therefore, this option was immediately discarded. The second option involved 2D-PAGE
comparison of both proteomes, followed by LC-MS/MS analysis of the visually unique
proteins. Although a workhorse in many proteomics labs, 2D-PAGE remains labour
intensive, expensive (both in the financial sense as well as in the use of valuable proteins
samples), subject to many issues, and overall, unsuitable for the intended purpose. In the
end, the third option was the only one remaining and involved spectral comparison and
matching of unique spectra to a six reading frame translation of the T. solium genome.
The fact that no tools are currently available to facilitate this type of analysis only serves
to highlight the novelty of this approach. There is huge potential in this method, not
only for this study on Taenia. Nonetheless, additional work will be required before this
approach can be presented in a ready-to-use format.
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General Discussion
9.1 Introduction
The main objective of this thesis was to analyse Taenia solium excretion/secretion proteins
(ESPs) with the aim of identifying species-specific diagnostic antigens by means of a
high throughput proteomics approach involving liquid chromatography and tandem mass
spectrometry analysis. Although the generic workflow of a proteomics experiment is rather
straightforward, it quickly became apparent that studying an organism that was neither
Homo sapiens nor one of the common model organisms like Escherichia coli or yeast,
was going to be quite the opposite. The performed study in Chapter 5 illustrated that
the bioinformatics tools that assist with the data analysis (e.g. global false discovery
rate estimations) are commonly developed and evaluated using “ideal world” conditions.
However, as is often the case, real world conditions are not entirely ideal, making re-
evaluation of such tools worthwhile. Furthermore, in Chapters 6 and 7, it was shown that
by supplementing an incomplete protein database with proteins sequences from (closely)
related helminths or by using expressed sequence tags, it was possible to significantly
increase the number of protein identifications for T. solium. These two approaches can
definitely be combined and should be usable when studying other organisms for which
limited information is available. Finally, in Chapter 8, the need for a species-specific
antigen detection assay for porcine cysticercosis was addressed by evaluating a number of
possible options to identify one or more (novel) diagnostic target(s). Here, however, the
database strategies that were used for the previous analyses proved unsuitable when the
intended use was a comparative analysis. This fact, combined with the limitations and
shortcomings of 2D-PAGE required the development and evaluation of novel tools, which,
although still under active development, already show very promising results.
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In this final chapter, the encountered shortcomings of current bioinformatics are further
discussed, the value of the database strategies in unsequenced organisms and the resulting
identifications are discussed in a broader context and the potential road towards a species-
specific assay is further explored.
9.2 Proteomics bioinformatics
The false discovery rate (FDR) is a mandatory metric in proteomics literature and is used
to determine how many identifications are included in the published list of proteins. Given
the importance of this metric, it made sense to establish if and how it would be influenced
by incomplete databases. The research described in Chapter 5 and Victor et al. (2012a)
deals with this particular issue and after evaluation of the empirical evidence, the mixture
model-based FDR estimation came out as being a stable, robust and reproducible method,
regardless of the way the decoy databases were constructed. However, while preparing
that paper, it was remarkable to see how most of the research done on FDR estimations
was performed by groups who work mainly on bioinformatics or mass spectrometry related
to the well studied model organisms. Very little is written about the behaviour of the
current bioinformatic tools in relation to less than ideal conditions.
Arguably, the FDR is of lesser importance when simply trying to identify one or even a few
proteins, but it does become more relevant when studying the whole proteome. It should
be stressed that the bioinformatics behind LC-MS/MS data analysis are not suitable to
be used as most other tools in the lab, i.e. as a simple “means to an end” like PCR or
ELISA. The currently available tools still require a great deal of critical user intervention
and at least a working understanding of how the algorithms work. Unfortunately, none of
the tools generate helpful errors in that regard, making it very tempting to blindly rely on
them [the black box concept (Cauer, 1941)].
The fact that (i) LC-MS/MS is indeed more and more becoming a common component
in biological studies and (ii) universally accepted and widely available computational
tools for validation of (published) data are absent, has prompted the publication of strict
guidelines that list the minimal informational requirements for publishing large datasets
with protein identifications. Originally, these guidelines were limited to the Molecular
& Cellular Proteomics journal1 (Carr et al., 2004), but they are slowly being updated
and adopted by other proteomics journals like Proteomics2 and the Journal of Proteome
Research3 as well (Bradshaw et al., 2006; Barnouin, 2011). However, an increasing amount
of proteomics studies are being submitted to non-proteomics journals, where even basic
1http://www.mcponline.org
2http://onlinelibrary.wiley.com/journal/10.1002/(ISSN)1615-9861
3http://pubs.acs.org/journal/jprobs
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information is often missing and the peer review process is less likely to pick up on this.
It would therefore be very desirable to extend these guidelines to the publication of all
proteomics data, regardless of the journal. Going even further, strongly encouraging (or
even requiring!) that authors submit all data to a public repository for other researchers
to use/review would undoubtedly be beneficial to scientific progress in any field.
9.3 Taenia solium protein analysis
Having established the best way to estimate the FDR, the next issue to tackle was how to
make an incomplete database as complete as possible. Two methods were explored and
described in Chapters 6 and 7 and Victor et al. (2012b, 2013). The main conclusion of
this work is that proteins from (closely) related organisms and expressed sequence tags
(ESTs) can be used to significantly increase the proteome coverage of the protein database.
This was evidenced in the first study by the identification of 32 proteins in the ESPs of T.
solium by matching proteins from other helminths on top of the 27 that were identified
by matching to T. solium proteins. In the second study, an additional 58 proteins were
identified when a library of translated ESTs was combined with BLAST and mapping
strategies. A further observation after the EST analysis was that, although the absolute
number of protein identification had been increased, none of the new proteins identified a
new Gene Ontology (GO) term. The six additional GO terms were identified by proteins
homologous to other proteins identified in both studies. A logical conclusion here is that
both approaches are largely complementary and therefore, when faced with an incomplete
protein database and having only one organism to study (i.e. no comparisons will be
made) it is advised to add both ESTs and related protein sequences.
Since the sequence of T. solium has recently been published (Tsai et al., 2013), a better
approach would now be to derive proteins from the genome by performing a six reading
frame translation of the genome or by running gene prediction software like AUGUSTUS
(Stanke and Waack, 2003; Stanke and Morgenstern, 2005) and to use these predictions as
a protein database. However, both approaches used in this thesis still hold value for the
study of other non-sequenced organisms.
Since parasite modulation of the immune system is most likely to be effected through
the release of soluble mediators which interact with host immune cells and molecules
(Hewitson et al., 2009), it is logical to find an overlap between these mediators and excre-
tion/secretion proteins. For example, cystatins (cysteine protease inhibitors) that inhibit
host cysteine proteases from processing and presenting parasite antigens were identified
in the T. solium ESPs (Dainichi et al., 2001). Taenia metacestodes also produce their
own cysteine proteinases, which have been identified as a predominant enzyme involved
in host immunoglobulin degradation, most likely to serve as a source of nutrients (White
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et al., 1997a). Also, since reactive oxygen species production by phagocytes is a primary
pathway of immune attack against parasites, it was not surprising to find evidence of the
enzymatic antioxidant system of Taeniidae e.g. Cu/Zn-superoxide dismutase, glutathione
S-transferase and 2-cys peroxiredoxin (Castellanos-Gonza´lez et al., 2002; Vibanco-Pe´rez
et al., 2002; Plancarte et al., 2004; Torres-Rivera and Landa, 2008; Vaca-Paniagua et al.,
2009; Nguyen et al., 2010). A complete explanation of the function and role of all identified
proteins would be very difficult, since it is possible that not all proteins have a purpose in
immune regulation as some of them may be a result of cyst damage and would normally
not be present in the excretion/secretion proteome of a viable metacestode. Furthermore,
many proteins have multiple functions! However, it can be agreed upon that many of
the proteins secreted by viable cysts serve to direct the host immune response towards
a T-helper 2 (Th2) non-inflammatory response in a certain way (Hewitson et al., 2009;
Moreau and Chauvin, 2010; Peo´n et al., 2013; Singh et al., 2013a).
The presence of host proteins like immunoglobulin and albumin in the ESPs may sound
slightly odd at first, but simply dismissing them as mere sample contamination would be
unwise. Experimental work on Taenia crassiceps showed that cysticerci secrete varying
amounts of albumin while maintaining a constant albumin concentration in the cyst
fluid. This form of albumin cycling may be an evolved mechanism providing cysticerci
with a means of osmoregulation (Aldridge et al., 2006). More recently, Navarrete-Perea
et al. (2014) also confirmed the presence of serum albumin (as well as hemoglobin, hap-
toglobin and immunoglobulin G) in the vesicular fluid of T. solium cysticerci that were
dissected from the central nervous system and the skeletal muscle of naturally infected pigs.
Another important consideration is the existence of two distinct T. solium genotypes.
Based on differences in mitochondrial DNA sequences, Ito et al. (2003) have shown that
isolates from Asia from one cluster, while isolates from Latin America and Africa formed
another. That these two genotypes also represent (slightly) different proteomes is probable,
but since all ESP samples used in this thesis came from Peru and Zambia, there was no
way of verifying that.
Although it is certain that the work presented in this thesis has identified proteins that
had not yet been reported in T. solium ESPs, it is important to remain critical, especially
towards those proteins that are not predicted to be secreted by SignalP and SecretomeP
analysis. Those proteins could be a result of cyst damage and subsequent leakage in the
culture medium, although a number of publications have mentioned the presence of such
proteins in trematodes and nematodes as well [e.g. Schistosoma mansoni (Knudsen et al.,
2005), Schistosoma japonicum (Liu et al., 2009), Ancylostoma caninum (Mulvenna et al.,
2009) and Teladorsagia circumcincta (Craig et al., 2006a)].
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In principle, a more “conservative” list of identified proteins could be constructed by
filtering out the non-secretory proteins, but given the fact that (i) protein sequences from
NCBInr may be incomplete (truncated) and could therefore lack the signal peptide and
(ii) many other studies have also reported “non-secretory” proteins in their parasite ESPs,
no such filtering was performed for our analyses. However, for informational purposes,
SigP/SecP analyses were added to the tables.
Furthermore, repeating the entire ESP production is not always an option given the
sometimes less than ideal local working circumstances.
Since the main objective of this thesis was to analyse Taenia solium excretion/secretion
proteins with the aim of identifying species-specific diagnostic antigens, it is worthwhile
to reflect upon a recent paper in which Diaz-Masmela et al. (2013) presented seven
antigens that were exclusively recognised by pooled sera from cysticercotic pigs, namely,
tropomyosin 2, alpha-1 tubulin, beta-tubulin 2, annexin B1, small heat-shock protein,
14-3-3 protein, and cAMP-dependent protein kinase. A number of these proteins were also
identified in the studies described in this thesis, but annexin B1 and cAMP-dependent
protein kinase are of particular interest to the authors as they possess highly specific
regions that make them suitable candidates for T. solium-specific diagnosis.
Although the approach taken by Diaz-Masmela et al. is certainly interesting and shows
great potential, it would have been helpful if the authors had included more information
on the number of samples that was used in each pool. It is therefore possible that the
sample size was not large enough to draw conclusions. Also, it would be interesting to
see how each individual serum sample reacted to the antigens, i.e. if one of the animals
would react to an antigen not recognised by the others, one could wonder whether the
seven suggested proteins would get recognised as well had the sample size been larger.
Logically, this would include running many more 2D-PAGE gels and given the known issue
with 2D-PAGE reproducibility, the decision to pool the samples is justifiable. Nonetheless,
knowing that the immunological response between pigs, as measured by IgG antibodies, is
never identical and that the protein profiles of the cyst fluid are also variable (mainly due
to differences in the glycosylation) (Esquivel-Vela´zquez et al., 2011a), the logical conclusion
would be that further validation is definitely required. Indeed, using more samples to
further evaluate the proteins was suggested by the authors in their conclusions, but the
inclusion of sera from pigs positive for Taenia asiatica would undoubtedly be beneficial as
well.
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9.4 Towards a Taenia solium-specific antigen detec-
tion assay
As is also mentioned in Chapter 2 and Chapter 8, diagnosis of porcine cysticercosis would
benefit greatly from a species-specific test, not only because that would make epidemiolog-
ical studies and assessment of control measures a great deal more reliable since it would
solve the cross reaction of the current assays with T. hydatigena and T. asiatica, but also
because it could be a major step towards the development of a “pen-side” test that can be
used by farmers, butchers and “middlemen” to identify infected animals and subsequently
remove them from the food chain. Of course, such a test would ideally be 100% specific
and 100% sensitive, very fast, very simple, just as functional in the lab as in the field,
cheap, and if possible, not dependant on a cold chain.
Realistically however, such a test will likely never exist. Any assay is always a compromise,
but depending on the intended purpose, certain characteristics can be stressed more than
others e.g. a very simple and quick lateral flow immunochromatographic assay that is
85% sensitive can be preferred over a laborious and expensive assay that is 99% sensitive
when it is being used to identify and remove infected animals from the food chain at the
slaughter slabs in the field. Alternatively, infected animals can be identified a few months
prior to slaughter and treated on the spot with a single dose of 30 mg/kg oxfendazole.
By the time they are slaughtered, the 17 day withdrawal period (due to the presence of
drug residues) will have passed (Moreno et al., 2012), the cysts will be dead (except for
some in the brain!) (Gonzalez et al., 1996, 1997, 1998) and the meat will have become
aesthetically suitable for human consumption (Gonzalez et al., 1998; Sikasunge et al., 2008).
Furthermore, there is a protective effect for up to three months after treatment (Gonzalez
et al., 2001), so the chance of reinfection after treatment is very limited, especially if
combined with vaccination at the time of treatment.
Such a “pen-side” test need not even be limited to porcine cysticercosis. Having a “bed-side”
test would also be very useful in a clinical setting, especially where screenings or follow-ups
of people are being conducted in relatively simple field hospitals!
The above scenario is highly desirable, but there is still a long way to go.
Candidate proteins need to be identified first and to this end, the development of the
spectral comparison (highlighted in Chapter 8) will need to be continued and should also
incorporate T. asiatica ESPs as well as a better way to match the unique spectra to
(unique) proteins. To this end, it would be interesting to look into deep transcriptional
sequencing (RNA-Seq) techniques to construct libraries for T. solium, T. hydatigena and
T. asiatica that cover gene expression across the genome, and then translate these into
custom protein databases for identification with tools like customProDB, developed by
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Wang and Zhang (2013). RNA-Seq analysis is cheaper than whole genome sequencing and
eliminates many of the difficulties encountered when predicting proteins from DNA, since
the sequenced mRNAs are already much closer to the translated protein sequence. Further-
more, the efficacy of such an approach has recently been proven by Menschaert et al. (2013).
Once specific proteins have been identified, they must be either isolated from the ESP
samples by e.g. a number of HPLC separation steps, produced as recombinant proteins or
synthetically constructed based on the amino acid sequence of the protein in the database.
The best option is of course to use the native proteins, since they have the proper glycosy-
lations as well as the linear and conformational epitopes. However, separating the ESPs
until only the proteins of interest remain will likely proved (very) difficult. Moreover, it
requires a constant source of ESPs which in turn depends on obtaining viable cysticerci.
Alternatively, the production of recombinant proteins is an option worth considering.
For example, the GP50 protein, one of the seven diagnostic bands in the EITB assay
(Tsang et al., 1989), has been produced as a recombinant protein using the baculovirus
expression system in an antigenically active form i.e. correct formation of disulfide bonds
(Hancock et al., 2004). Reduction of these disulfide bonds resulted in a loss of antibody
reactivity with infection serum samples, indicating the importance of the conformational
epitopes. Furthermore, glycosylations also play a role in antigen - antibody recognition
(Obrego´n-Henao et al., 2001), but unfortunately, glycosylation in insect cells is different
from glycosylation in mammalian cells and is likely to be different from the glycosylation
that occurs in T. solium (Bueno et al., 2005). This may result in a reduced sensitivity
compared to native proteins. Synthetic peptide production is a further option with proven
potential (Scheel et al., 2005), but synthetic peptides generally perform worse than recom-
binant proteins, most likely because part of the antibody response is directed towards
conformational epitopes (Ferrer et al., 2012; Rodriguez et al., 2012).
Since monoclonal antibodies have long been the tool of choice for the development of
antigen detecting assays they can be produced for this purpose as well. Mice can be
immunised with purified proteins or protein fractions. Since IgG antibodies are less prone
to non-specific reactions, are generally more stable and are more easily linked to biotin or
horseradish peroxidase than IgM antibodies, immunised mice should be selected based
on maximal IgG and minimal IgM titers. An alternative option is the production of
nanobodies [the antigen recognising part of a camelid heavy chain antibody (Hamers-
Casterman et al., 1993; Muyldermans and Lauwereys, 1999)]. Previous experimental work
by Deckers et al. (2009) already proved their potential, but unfortunately, no functional
assay could be developed. Since the ultimate goal is to make a species-specific assay for T.
solium, it is recommended to evaluate any possible cross reactions in more detail. To this
end, an extra validation step can be included in which the Taenia ESPs will be separated
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by 1D/2D-PAGE, blotted on nitrocellulose paper and probed with (i) the monoclonal
antibodies/nanobodies and (ii) serum samples from pigs with various helminth infections
(e.g. Trichinella spp., Ascaris suum, Echinococcus spp. etc.). The purpose of these blots is
to identify those proteins that are commonly recognised by various sera and to evaluate if
there are any unexpected cross reactions with the proteins originally identified as unique as
well as to evaluate any cross reaction between the monoclonal antibodies/nanobodies and
other Taenia ESPs. The above described steps are schematically presented in Figure 9.1.
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9.5 Conclusions and recommendations
The studies in this thesis have (i) demonstrated that mixture model-based FDR esti-
mations can be used when studying organisms whose genome is not yet (completely)
known, (ii) presented the first proteomic analysis of the T. solium metacestode ESPs
using one-dimensional polyacrylamide gel electrophoresis and LC-MS/MS and (iii) illus-
trated the potential of the novel spectral comparison methodology for the identification of
unique T. solium proteins, which may, in turn, lead to a T. solium-specific diagnostic assay.
A logical recommendation is therefore to continue with the development and evaluation
of the spectral comparison pipeline with the aim of developing a new assay that targets
unique proteins.
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CHAPTER 11
Summary
Chapter 1 introduces the two main topics of this thesis. The first one is the Taenia
solium taeniasis/cysticercosis complex, a neglected zoonotic disease affecting both human
health and economy in large parts of Africa, Asia and Latin America. The second topic
is proteomics, or more specifically, the use of liquid chromatography and tandem mass
spectrometry to study proteins.
Chapter 2 further focusses on the T. solium literature by exploring the morphology, the
life cycle and the different infections related to the life cycle stages: taeniasis and porcine
and human (neuro)cysticercosis. Then, the clinical aspects of human neurocysticercosis
are discussed as well as the impact of cysticercosis on human health and economy in
large parts of many developing countries. The main part is this chapter is, however,
dedicated to diagnosis. The use of diagnostic tools varies depending on the life cycle stage
of the parasite and the intended use. However, most of the available tools have certain
shortcomings (labour intensive, expensive, lack of sensitivity and/or specificity,...). Specific
attention goes to immunological assays for the detection of (neuro)cysticercosis. These
tools can be divided into antigen detection (used for the detection of living parasites) and
antibody detection (detection of host reaction to exposure to the parasite). Two antigen
detection assays are currently being used, but both assays were originally designed to
detect antigens produced by Taenia saginata parasites in cattle. The fact that they are
used in the detection of T. solium (neuro)cysticercosis is due to a cross reaction between
Taenia species. However, the same cross reaction compromises the usability of the assay in
pigs where not only T. solium can be present, but other Taenia species like T. hydatigena
and T. asiatica as well.
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Chapter 3 provides a more thorough introduction into the field of proteomics, which
focusses on the study of proteins and is located between other “omics” fields like genomics
(study of DNA), transcriptomics (study of the transcriptome or mRNA) and metabolomics
(study of metabolites). The literature study on proteomics is based on a generic workflow,
similar to the one that was followed for the analyses described in this thesis. Basically,
samples are collected and separated using several gel-based methods. Once separated, the
proteins (of choice) are digested with an enzyme i.e. they are cut into smaller peptides,
usually with trypsin. Since this process again adds complexity to the samples, the peptides
are further separated, this time using liquid chromatography. Since mass spectrometry
is the measurement of the mass-to-charge ratio (m/z ) of gas-phase ions, peptides need
to be ionised and transferred to the gas phase before they can be analysed. Sample
ionisation is explained using the examples of matrix-assisted laser desorption/ionisation
(MALDI) and electrospray ionisation (ESI) and several types of mass spectrometers are
briefly mentioned. For the studies in this thesis, a Bruker Daltonics amaZon ETD ion
trap mass spectrometer was used to perform tandem mass spectrometry (MS/MS). This
means that a first scan (MS) is meant to isolate an ion, called the precursor ion, while
the second scan (MS/MS) will determine the m/z ratios of the fragment ions formed
by fragmentation of the precursor ion. The result of these actions is MS spectra (with
precursors mass information) and, for a number of precursors, MS/MS spectra (with
fragmentation information). The rest of the chapter deals with the methods to link these
spectra to peptides and ultimately to proteins and elaborates on the metrics that are used
to estimate probability of correctness of each spectrum match and the number of incorrect
identification in the entire dataset, also known as the false discovery rate (FDR). As a
closing note, the state of parasite proteomics is discussed.
The main objective of this thesis discussed in Chapter 4 and involves the analysis of T.
solium excretion/secretion proteins with the aim of identifying species-specific diagnostic
antigens. This objective is broken up into three sub-objectives.
The first sub-objective is outlined in Chapter 5 and deals with the effect of incomplete
protein databases on the FDR estimations. Global FDRs can be defined as the expected
number of incorrect peptide spectrum matches (PSMs) amongst all PSMs that pass a
certain search score threshold, but the problem is that nearly all published work on FDR
estimations has been done using complete protein databases from fully sequenced organ-
isms, or known well-defined protein mixtures. When working with incomplete databases
(from partially sequenced organisms), FDR estimation may become more challenging i.e it
is reasonable to assume that a significant number of high-quality spectra coming from the
studied organism will not find a match in the target database, simply because the protein
is not in that database. A fraction of these spectra will instead match a decoy sequence (or
Page 142
11
Summary
another peptide in the target database). To study the effect of incomplete target databases,
partial databases approximately covering 1 to 99% of the full database were combined
with equally sized reversed, scrambled or randomised decoy databases. In this study, it
was demonstrated that mixture model-based FDR estimations using incomplete databases
from partially sequenced organisms are stable, highly reproducible and comparable to the
estimations based on complete databases, irrespective of the manner in which the decoy
database was constructed, until the databases become so small that the mixture models
can no longer be correctly fitted to the observed distributions.
The second sub-objective involves the use of protein sequences from other (closely related)
helminths and expressed sequence tags to increase the proteome coverage of the incomplete
protein database and identify T. solium excretion/secretion proteins (ESPs). These ESPs
are often involved in diverse mechanisms to evade the host immune system and, from a
diagnostic point of view, ESPs are also of interest as they can often be detected in the
blood. A more thorough knowledge of T. solium ESPs would be an important step in
improving current diagnostic techniques. At the time of publication, a complete proteomic
analysis of many parasite ESPs was still hampered by incomplete protein databases due
to the lack of genomic information. To get around this limitation, our approach relied
on homology to other helminth species and supplemented the T. solium database with
protein sequences from other helminths. This study, described in Chapter 6, resulted in
the identification of 76 proteins including 27 already described T. solium proteins, 17 host
proteins and 32 proteins likely to be of T. solium origin, but identified using sequences
from other helminths, effectively demonstrating the value of this approach. In a second
study, described in Chapter 7, translated T. solium expressed sequence tags (ESTs)
combined with the Basic Local Alignment Search Tool (BLAST) and protein mapping to
supercontigs of Echinococcus granulosus (a member of the Taeniidae family) were used
to investigate whether this would increase the number of T. solium metacestode ESP
identifications compared to the previous study. Here, 106 protein groups were identified
and the groups were further organised by Gene Ontology (GO) annotation information
on biological process and molecular function. A total of 48 protein groups were also
identified in the previous study while 58 protein groups were new identifications. Despite
this difference in absolute protein identifications, all GO terms from the previous study
were identified here as well and only six new GO terms were identified with the EST
analyses. However, they were identified by a very small number of proteins and may be a
result of proteins being linked to multiple GO terms. This is supported by the fact that
the proteins linked to these GO terms are homologous to other proteins identified in both
studies, so none of these GO terms was identified by a “new” protein group.
The third sub-objective is the comparison of the T. solium excretion/secretion proteome
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with other Taenia proteomes in order to identify unique proteins (Chapter 8). These
unique proteins can then be targeted in a T. solium-specific assay. Three methods of
proteome comparison are explored. A first option is to analyse the ESPs of the other
Taenia species (i.e Taenia asiatica and Taenia hydatigena) in the same way the ESPs for
T. solium were analysed (Chapter 6) and to compare the protein output lists. However,
the then used approach relied on homology between related species and it therefore fails
here, when comparing Taenia species. A second option is to separate the ESPs with
two-dimensional polyacrylamide gel electrophoresis (2D-PAGE) and to identify spots that
are present in one sample, but not in another. However, 2D-PAGE is not without its
shortcomings. Although this method was explored, it was later abandoned due to too
many problems. A third option is to analyse the ESPs with LC-MS/MS, but then to
employ a new methodology that bypasses the identification stage and instead considers all
spectra from all analyses, ensuring that none of the acquired information is lost at the
all-important comparison stage. In other words, the experimental spectra are compared
directly with each other in order to identify which spectra are unique for the organism of
interest. These unique spectra can then be matched to a protein database derived from the
recently published T. solium genome to identify unique peptides and proteins. Although
still under active development, this option already shows great potential. However, further
refinement is required.
The general discussion in Chapter 9 is the final chapter in this thesis and here, the
performed research is reviewed in a broader context. Improvements to the way data is
published in non-proteomics journals are suggested and the obtained ESP identifications
are reviewed in light of recently made progress by other research groups. Finally, an
overview of the workflow that could lead to a species-specific assay is presented and
discussed.
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CHAPTER 12
Samenvatting
Hoofdstuk 1 introduceert de twee hoofdonderwerpen van dit proefschrift. Het Taenia
solium taeniase/cysticercose complex is het eerste onderwerp: een verwaarloosde zoo¨nose
met gevolgen voor zowel de volksgezondheid als de economie in grote delen van Afrika,
Azie¨ en Latijns-Amerika. Het tweede onderwerp gaat over proteomics, meer bepaald het
gebruik van vloeistofchromatografie en tandem massaspectrometrie voor de studie van
eiwitten.
Hoofdstuk 2 richt zich op de T. solium literatuur en onderzoekt de morfologie, de levens-
cyclus en de verschillende infecties die gerelateerd zijn aan de stadia van de levenscyclus:
taeniasis en porciene en humane (neuro)cysticercose. Vervolgens worden de klinische
aspecten van humane neurocysticercose besproken, evenals de impact van cysticercose
op de volksgezondheid en de economie in grote delen van veel ontwikkelingslanden. Het
grootste deel van dit hoofdstuk is gewijd aan de diagnose. Het gebruik van diagnostische
technieken hangt af van de fase van de levenscyclus van de parasiet en het beoogde doel.
De meeste technieken hebben echter tekortkomingen (arbeidsintensief, prijs, gebrek aan
gevoeligheid en/of specificiteit, ...). Specifieke aandacht gaat naar immunologische testen
voor de detectie van (neuro)cysticercose. Deze testen kunnen worden onderverdeeld in
antigeen detectie technieken (die de levende parasiet aantonen) en antilichaam detectie
technieken (die de reactie van de gastheer op de aanwezigheid van de parasiet aanto-
nen). Twee verschillende antigeen detectie technieken worden momenteel gebruikt, maar
beide technieken werden oorspronkelijk ontworpen om antigenen van Taenia saginata
bij runderen te detecteren. Een kruisreactie tussen Taenia soorten verklaart waarom
de technieken ook worden gebruikt voor de detectie van T. solium (neuro)cysticercose.
Dezelfde kruisreactie bemoeilijkt echter het gebruik van de test bij varkens waar niet alleen
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T. solium aanwezig kan zijn, maar ook andere Taenia soorten zoals T. hydatigena en T.
asiatica.
Hoofdstuk 3 bevat een grondige inleiding over proteomics. Deze richt zich op de studie
van eiwitten en situeert zich tussen andere “omics” gebieden zoals genomics (DNA-
onderzoek), transcriptomics (studie van de DNA transcriptie of mRNA) en metabolomics
(studie van afbraakproducten). De literatuurstudie betreffende proteomics is gebaseerd
op een generieke workflow, vergelijkbaar met degene die werd gevolgd voor de in dit
proefschrift beschreven analyses. Eens de eiwitstalen verzameld zijn, worden ze gescheiden
met behulp van verschillende op gelscheiding gebaseerde methoden. Eenmaal gescheiden,
worden de eiwitten “geknipt” met een enzym (meestal trypsine) in kleinere peptiden.
Vermits dit proces opnieuw complexiteit van de stalen teweegbrengt, worden de peptiden
verder gescheiden, ditmaal met vloeistofchromatografie. Aangezien massaspectrometrie
het meten is van de massa-tot-lading verhouding (m/z ) van ionen in de gasfase, moeten
peptiden worden ge¨ıoniseerd en overgedragen naar de gasfase alvorens te kunnen worden
geanalyseerd. Ionisatie wordt toegelicht aan de hand van matrix geassisteerde laser des-
orptie/ionisatie (MALDI) en electrospray ionisatie (ESI). Tevens worden verschillende
soorten massaspectrometers kort vermeld. Voor de studies in dit proefschrift, werd een
Bruker Daltonics Amazon ETD ion trap massaspectrometer gebruikt om tandem massas-
pectrometrie (MS/MS) uit te voeren. Dit betekent dat een eerste scan (MS) een (precursor)
ion isoleert, terwijl de tweede scan (MS/MS) de m/z verhouding van de fragment ionen
gevormd door fragmentatie van de precursor ionen bepaalt. Het resultaat van deze acties
is MS spectra (met precursor informatie) en, voor een aantal precursors, MS/MS spectra
(met fragmentatie informatie). De rest van het hoofdstuk behelst het koppelen van deze
spectra aan peptiden en eiwitten en de statistische technieken die worden gebruikt om de
probabiliteit te bepalen of een dergelijke spectrum-peptide link correct is. Tevens wordt
een schatting gemaakt van het aantal mogelijk niet correcte identificaties. Om af te sluiten
worden de moeilijkheden van eiwitanalyses bij parasieten besproken.
Het hoofdobjectief van dit proefschrift (hoofdstuk 4) omvat een analyse van T. solium
excretie/secretie eiwitten met als doel het identificeren van T. solium-specifieke diagnos-
tische antigenen. Dit objectief is onderverdeeld in drie sub-objectieven.
Een eerste sub-objectief is omschreven in hoofdstuk 5 en gaat over het effect van
onvolledige eiwit databases op de “false discovery rate” (FDR). De FDR kan worden
gedefinieerd als het verwachte aantal onjuiste peptide identificaties binnen alle peptide
identificaties die een bepaalde score-drempel overschrijden. Het probleem hierbij is dat
bijna al het gepubliceerde werk steunt op FDR schattingen gebaseerd op complete eiwit
databases van volledig gesequeneerde organismen of bekende welomschreven eiwitstalen.
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Bij het werken met onvolledige databases (van gedeeltelijk gesequeneerde organismen),
wordt een FDR schatting minder eenvoudig en kan men veronderstellen dat een aanzienlijk
aantal van de spectra afkomstig van het bestudeerde organisme, een peptide in de database
niet vinden, simpelweg omdat het eiwit niet in die database aanwezig is. Een fractie van
deze spectra zal in plaats daarvan overeenkomen met een decoy peptide (of een ander
peptide in de database). Om het effect van onvolledige databases te bestuderen, werden
gedeeltelijke databases van 1 tot 99% van de volledige database gecombineerd met even
grote omgekeerde, herschikte of gerandomiseerde decoy databases. In deze studie wordt
aangetoond dat “mixture model-based” FDR schattingen met onvolledige databases stabiel,
reproduceerbaar en vergelijkbaar zijn met de schattingen van volledige databases, ongeacht
de wijze waarop de decoy database is opgebouwd.
Het tweede sub-objectief gaat over het gebruik van eiwit sequenties van andere (nauw
verwante) wormen en “expressed sequence tags” (ESTs) om de proteoom dekking van de
onvolledige eiwitdatabase te verhogen en T. solium excretie/secretie eiwitten (ESPs) te
identificeren. Deze ESPs zijn vaak betrokken bij diverse mechanismen om het immuunsys-
teem van de gastheer te omzeilen en vanuit diagnostisch oogpunt zijn ESPs ook interessant
omdat ze vaak kunnen worden gedetecteerd in het bloed. Een grondigere kennis van T.
solium ESPs zou een belangrijke stap zijn in de verbetering van de huidige diagnostische
technieken. Op het moment van publicatie, werd een volledige proteoom analyse van de
vele parasieten nog steeds gehinderd door onvolledige eiwit databases. Om deze beperking
te omzeilen, is onze aanpak gebaseerd op homologie met andere wormsoorten en werd
de T. solium databank aangevuld met eiwit sequenties van andere wormen. Deze studie,
beschreven in hoofdstuk 6, resulteerde in de identificatie van 76 eiwitten waarvan 27
reeds gekende T. solium eiwitten, 17 gastheereiwitten en 32 eiwitten die waarschijnlijk
van oorsprong T. solium zijn, maar ge¨ıdentificeerd werden met behulp van sequenties van
andere wormen. In een tweede studie, beschreven in hoofdstuk 7, werden T. solium
ESTs in combinatie met de Basic Local Alignment Search Tool (BLAST) en eiwit vergeli-
jkingen met supercontigs van Echinococcus granulosus (een lid van de Taeniidae familie)
gebruikt om te onderzoeken of dit het aantal T. solium ESP identificaties zou vergroten
in vergelijking met de vorige studies. Hierbij werden 106 eiwit groepen ge¨ıdentificeerd
die vervolgens verder onderverdeeld werden op basis van Gene Ontology (GO) informatie
over biologisch processen en moleculaire functies. Ook werden in totaal 48 eiwit groepen
uit de vorige studie bevestigd, terwijl er 58 nieuwe eiwit groepen ge¨ıdentificeerd werden.
Ondanks dit verschil in absolute eiwitidentificaties, werden alle GO termen uit de vorige
studie hier ook ge¨ıdentificeerd en werden slechts zes nieuwe GO termen ge¨ıdentificeerd
met de EST analyses. Ze werden echter ge¨ıdentificeerd door een klein aantal eiwitten die
tevens homoloog zijn aan andere eiwitten die in beide studies gevonden werden. Geen van
deze GO termen werd dus ge¨ıdentificeerd door een nieuwe eiwit groep.
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Het derde sub-objectief is de vergelijking van het T. solium excretie/secretie proteoom
met andere Taenia proteomen met als doel unieke eiwitten te identificeren (hoofdstuk
8). Deze unieke eiwitten kunnen vervolgens gebruikt worden in een T. solium-specifieke
assay. Drie methoden van proteoom vergelijking werden verkend. Een eerste mogelijkheid
is de ESPs van de andere Taenia soorten (T. asiatica en T. hydatigena) op dezelfde wijze
te analyseren als de ESPs voor T. solium (hoofdstuk 6) en dan de eiwit identificaties te
vergelijken. De toen gebruikte aanpak vertrouwde echter op homologie tussen verwante
soorten. Bij het vergelijken van Taenia soorten schiet deze dan ook duidelijk tekort. Een
tweede optie is om de ESPs te scheiden met behulp van twee-dimensionale polyacrylamide
gelelektroforese (2D-PAGE) en zodoende eiwitten te identificeren die een afwijkend profiel
geven tussen de twee stalen. 2D-PAGE heeft echter ook tekortkomingen. Deze methode
werd wel onderzocht, maar werd later opgegeven door de vele problemen. Een derde optie
is om de ESPs te analyseren met LC-MS/MS, maar dan wel met behulp van een nieuwe
methode die het identificatie stadium omzeilt en in plaats daarvan alle spectra van alle
analyses in overweging neemt en er zo voor zorgt dat er geen informatie verloren gaat.
Met andere woorden, de experimentele spectra worden direct met elkaar vergeleken om te
bepalen welke spectra uniek zijn voor het te bestuderen organisme. Deze unieke spectra
kunnen dan worden gelinkt aan een eiwit databank afgeleid van het onlangs gepubliceerde
T. solium genoom, om zo unieke peptiden en eiwitten te identificeren. Hoewel deze methode
nog steeds actief wordt ontwikkeld, is er nu reeds groot potentieel merkbaar. Verdere
verfijning is echter nodig.
Het laatste deel van dit proefschrift is de algemene discussie (hoofdstuk 9). Hierin wordt
het uitgevoerd onderzoek beoordeeld in een bredere context. Verbeteringen in de manier
waarop gegevens worden gepubliceerd in niet-proteomics tijdschriften worden voorgesteld
en de verkregen ESP identificaties worden beoordeeld in het licht van de recent gemaakte
vooruitgang door andere onderzoeksgroepen. Tot slot wordt een overzicht gegeven van de
workflow die kan leiden tot een T. solium-specifieke test.
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Appendix
A.1 Supporting information for Chapter 5
Figure A.1 shows the false discovery rate (FDR) estimations for composite databases
consisting of target databases (1-100% of the total size) without redundancy (Figures A.1a
to A.1c) or with (limited) redundancy (Figures A.1d to A.1f) and an equally sized decoy
database (reversed, scrambled or randomised). The three curves represent three different
probability thresholds (p > 0.90, p > 0.95 and p > 0.99, respectively). A p > 0.95
minimum probability cut-off results in an FDR around 1% which is currently commonly
reported and accepted in proteomics.
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Figure A.1: False discovery rate behaviour at three different probability thresholds for composite
databases consisting of a target database with only canonical sequences (a-c) or canonical sequences
and isoforms (d-f) and an equally sized reversed (n = 1), scrambled (n = 10) or randomised (n =
10) decoy database. The boxes in figures b, c, e and f show the median, the 25th and the 75th
percentile, while the error bars show the minimum and maximum values.
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Figure A.2 shows the FDR estimations for target databases (1-100% of the total size)
without redundancy (Figure A.2a) or with (limited) redundancy (Figure A.2b) without
any decoy database at 3 different probability thresholds (p > 0.90, p > 0.95 and p > 0.99,
respectively).
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Figure A.2: False discovery rate behaviour at three different probability thresholds for target databases
with only canonical sequences (a) or canonical sequences and isoforms (b) without any decoy
database.
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